| 1 | KIDS Distribution saved on Aug 06, 2012@11:32:48
|
|---|
| 2 | QUALITY MEASURES 1.0 PATCH 3
|
|---|
| 3 | **KIDS**:C0Q*1.0*3^
|
|---|
| 4 |
|
|---|
| 5 | **INSTALL NAME**
|
|---|
| 6 | C0Q*1.0*3
|
|---|
| 7 | "BLD",7936,0)
|
|---|
| 8 | C0Q*1.0*3^QUALITY MEASURES^0^3120806^y
|
|---|
| 9 | "BLD",7936,1,0)
|
|---|
| 10 | ^^155^155^3120803^
|
|---|
| 11 | "BLD",7936,1,1,0)
|
|---|
| 12 | Summary
|
|---|
| 13 | "BLD",7936,1,2,0)
|
|---|
| 14 | =======
|
|---|
| 15 | "BLD",7936,1,3,0)
|
|---|
| 16 | This build contains the Quality Measures file (#1130580001.101) fully
|
|---|
| 17 | "BLD",7936,1,4,0)
|
|---|
| 18 | populated with the Reminder Rule Sets and if applicable Reminder Extract
|
|---|
| 19 | "BLD",7936,1,5,0)
|
|---|
| 20 | definitions for use with the Quality Measures package for reporting for
|
|---|
| 21 | "BLD",7936,1,6,0)
|
|---|
| 22 | Meaningful use Stage I.
|
|---|
| 23 | "BLD",7936,1,7,0)
|
|---|
| 24 |
|
|---|
| 25 | "BLD",7936,1,8,0)
|
|---|
| 26 | Source, Copyright, & Licensing:
|
|---|
| 27 | "BLD",7936,1,9,0)
|
|---|
| 28 | ===============================
|
|---|
| 29 | "BLD",7936,1,10,0)
|
|---|
| 30 | This patch to WorldVistA 2.0 was produced by Sam Habiel on a copy of Dew
|
|---|
| 31 | "BLD",7936,1,11,0)
|
|---|
| 32 | Drop and tested on a virgin instance of WV EHR 3-09 patched with PXRM 2.0
|
|---|
| 33 | "BLD",7936,1,12,0)
|
|---|
| 34 | patches 12 and 17. The build was produced in July 2012.
|
|---|
| 35 | "BLD",7936,1,13,0)
|
|---|
| 36 | Copyright WorldVistA 2012.
|
|---|
| 37 | "BLD",7936,1,14,0)
|
|---|
| 38 | Licensed under GPL version 2 or later. Find it here:
|
|---|
| 39 | "BLD",7936,1,15,0)
|
|---|
| 40 | http://www.gnu.org/licenses/gpl-2.0.html
|
|---|
| 41 | "BLD",7936,1,16,0)
|
|---|
| 42 | Released through VISTA Forum.
|
|---|
| 43 | "BLD",7936,1,17,0)
|
|---|
| 44 |
|
|---|
| 45 | "BLD",7936,1,18,0)
|
|---|
| 46 | Functionality:
|
|---|
| 47 | "BLD",7936,1,19,0)
|
|---|
| 48 | ==============
|
|---|
| 49 | "BLD",7936,1,20,0)
|
|---|
| 50 | This patch is a pure data patch. It only installs reference data in the
|
|---|
| 51 | "BLD",7936,1,21,0)
|
|---|
| 52 | C0Q QUALITY MEASURE file (#1130580001.101). It relies on Reminder Package
|
|---|
| 53 | "BLD",7936,1,22,0)
|
|---|
| 54 | data (specifically rule sets and extracts) sent in C0Q*1.0*2.
|
|---|
| 55 | "BLD",7936,1,23,0)
|
|---|
| 56 |
|
|---|
| 57 | "BLD",7936,1,24,0)
|
|---|
| 58 | Package Elements:
|
|---|
| 59 | "BLD",7936,1,25,0)
|
|---|
| 60 | =================
|
|---|
| 61 | "BLD",7936,1,26,0)
|
|---|
| 62 | This build transports entries in the C0Q QUALITY MEASURE file.
|
|---|
| 63 | "BLD",7936,1,27,0)
|
|---|
| 64 |
|
|---|
| 65 | "BLD",7936,1,28,0)
|
|---|
| 66 | Routines:
|
|---|
| 67 | "BLD",7936,1,29,0)
|
|---|
| 68 | =========
|
|---|
| 69 | "BLD",7936,1,30,0)
|
|---|
| 70 | <None>
|
|---|
| 71 | "BLD",7936,1,31,0)
|
|---|
| 72 |
|
|---|
| 73 | "BLD",7936,1,32,0)
|
|---|
| 74 | Documentation:
|
|---|
| 75 | "BLD",7936,1,33,0)
|
|---|
| 76 | <None besides this KIDS description>
|
|---|
| 77 | "BLD",7936,1,34,0)
|
|---|
| 78 |
|
|---|
| 79 | "BLD",7936,1,35,0)
|
|---|
| 80 | Test Sites:
|
|---|
| 81 | "BLD",7936,1,36,0)
|
|---|
| 82 | ===========
|
|---|
| 83 | "BLD",7936,1,37,0)
|
|---|
| 84 | <None>
|
|---|
| 85 | "BLD",7936,1,38,0)
|
|---|
| 86 |
|
|---|
| 87 | "BLD",7936,1,39,0)
|
|---|
| 88 | Compliance:
|
|---|
| 89 | "BLD",7936,1,40,0)
|
|---|
| 90 | ===========
|
|---|
| 91 | "BLD",7936,1,41,0)
|
|---|
| 92 | This software complies with the VA MUMPS Programming Standards and
|
|---|
| 93 | "BLD",7936,1,42,0)
|
|---|
| 94 | Conventions (version 3 April 2007).
|
|---|
| 95 | "BLD",7936,1,43,0)
|
|---|
| 96 |
|
|---|
| 97 | "BLD",7936,1,44,0)
|
|---|
| 98 | Installation Instructions:
|
|---|
| 99 | "BLD",7936,1,45,0)
|
|---|
| 100 | ==========================
|
|---|
| 101 | "BLD",7936,1,46,0)
|
|---|
| 102 | Pre-installation:
|
|---|
| 103 | "BLD",7936,1,47,0)
|
|---|
| 104 |
|
|---|
| 105 | "BLD",7936,1,48,0)
|
|---|
| 106 | Prerequisite patches: (both found on the trac server here:
|
|---|
| 107 | "BLD",7936,1,49,0)
|
|---|
| 108 | https://trac.opensourcevista.net/svn/qrda/C0Q/trunk/kids/)
|
|---|
| 109 | "BLD",7936,1,50,0)
|
|---|
| 110 | C0Q*1.0*2
|
|---|
| 111 | "BLD",7936,1,51,0)
|
|---|
| 112 | QUALITY MEASURES 1.0
|
|---|
| 113 | "BLD",7936,1,52,0)
|
|---|
| 114 |
|
|---|
| 115 | "BLD",7936,1,53,0)
|
|---|
| 116 | Users can remain on the system while this patch is installed.
|
|---|
| 117 | "BLD",7936,1,54,0)
|
|---|
| 118 |
|
|---|
| 119 | "BLD",7936,1,55,0)
|
|---|
| 120 | Install Time - less than 1 minute.
|
|---|
| 121 | "BLD",7936,1,56,0)
|
|---|
| 122 |
|
|---|
| 123 | "BLD",7936,1,57,0)
|
|---|
| 124 | 1. LOAD TRANSPORT GLOBAL
|
|---|
| 125 | "BLD",7936,1,58,0)
|
|---|
| 126 |
|
|---|
| 127 | "BLD",7936,1,59,0)
|
|---|
| 128 | Choose the PackMan message containing this patch and invoke the
|
|---|
| 129 | "BLD",7936,1,60,0)
|
|---|
| 130 | INSTALL/CHECK MESSAGE PackMan option to unload the build, or
|
|---|
| 131 | "BLD",7936,1,61,0)
|
|---|
| 132 | Use the Load a Distribution option in KIDS to load it from a
|
|---|
| 133 | "BLD",7936,1,62,0)
|
|---|
| 134 | host file.
|
|---|
| 135 | "BLD",7936,1,63,0)
|
|---|
| 136 |
|
|---|
| 137 | "BLD",7936,1,64,0)
|
|---|
| 138 | 2. START UP KIDS
|
|---|
| 139 | "BLD",7936,1,65,0)
|
|---|
| 140 |
|
|---|
| 141 | "BLD",7936,1,66,0)
|
|---|
| 142 | Start up the Kernel Installation and Distribution System Menu
|
|---|
| 143 | "BLD",7936,1,67,0)
|
|---|
| 144 | [XPD MAIN]:
|
|---|
| 145 | "BLD",7936,1,68,0)
|
|---|
| 146 |
|
|---|
| 147 | "BLD",7936,1,69,0)
|
|---|
| 148 | Edits and Distribution ...
|
|---|
| 149 | "BLD",7936,1,70,0)
|
|---|
| 150 | Utilities ...
|
|---|
| 151 | "BLD",7936,1,71,0)
|
|---|
| 152 | Installation ...
|
|---|
| 153 | "BLD",7936,1,72,0)
|
|---|
| 154 |
|
|---|
| 155 | "BLD",7936,1,73,0)
|
|---|
| 156 | Select Kernel Installation & Distribution System Option: INStallation
|
|---|
| 157 | "BLD",7936,1,74,0)
|
|---|
| 158 | ---
|
|---|
| 159 | "BLD",7936,1,75,0)
|
|---|
| 160 | Load a Distribution
|
|---|
| 161 | "BLD",7936,1,76,0)
|
|---|
| 162 | Print Transport Global
|
|---|
| 163 | "BLD",7936,1,77,0)
|
|---|
| 164 | Compare Transport Global to Current System
|
|---|
| 165 | "BLD",7936,1,78,0)
|
|---|
| 166 | Verify Checksums in Transport Global
|
|---|
| 167 | "BLD",7936,1,79,0)
|
|---|
| 168 | Install Package(s)
|
|---|
| 169 | "BLD",7936,1,80,0)
|
|---|
| 170 | Restart Install of Package(s)
|
|---|
| 171 | "BLD",7936,1,81,0)
|
|---|
| 172 | Unload a Distribution
|
|---|
| 173 | "BLD",7936,1,82,0)
|
|---|
| 174 | Backup a Transport Global
|
|---|
| 175 | "BLD",7936,1,83,0)
|
|---|
| 176 |
|
|---|
| 177 | "BLD",7936,1,84,0)
|
|---|
| 178 | Select Installation Option:
|
|---|
| 179 | "BLD",7936,1,85,0)
|
|---|
| 180 |
|
|---|
| 181 | "BLD",7936,1,86,0)
|
|---|
| 182 | 3. Select Installation Option:
|
|---|
| 183 | "BLD",7936,1,87,0)
|
|---|
| 184 |
|
|---|
| 185 | "BLD",7936,1,88,0)
|
|---|
| 186 | NOTE: The following are OPTIONAL - (When prompted for the INSTALL
|
|---|
| 187 | "BLD",7936,1,89,0)
|
|---|
| 188 | NAME, enter C0Q*1.0*3):
|
|---|
| 189 | "BLD",7936,1,90,0)
|
|---|
| 190 |
|
|---|
| 191 | "BLD",7936,1,91,0)
|
|---|
| 192 | a. Backup a Transport Global - This option will create a backup
|
|---|
| 193 | "BLD",7936,1,92,0)
|
|---|
| 194 | message of any routines exported with this patch. It will not
|
|---|
| 195 | "BLD",7936,1,93,0)
|
|---|
| 196 | backup any other changes such as DD's or templates.
|
|---|
| 197 | "BLD",7936,1,94,0)
|
|---|
| 198 | b. Compare Transport Global to Current System - This option will
|
|---|
| 199 | "BLD",7936,1,95,0)
|
|---|
| 200 | allow you to view all changes that will be made when this patch
|
|---|
| 201 | "BLD",7936,1,96,0)
|
|---|
| 202 | is installed. It compares all components of this patch
|
|---|
| 203 | "BLD",7936,1,97,0)
|
|---|
| 204 | (routines, DD's, templates, etc.).
|
|---|
| 205 | "BLD",7936,1,98,0)
|
|---|
| 206 | c. Verify Checksums in Transport Global - This option will allow
|
|---|
| 207 | "BLD",7936,1,99,0)
|
|---|
| 208 | you to ensure the integrity of the routines that are in the
|
|---|
| 209 | "BLD",7936,1,100,0)
|
|---|
| 210 | transport global.
|
|---|
| 211 | "BLD",7936,1,101,0)
|
|---|
| 212 |
|
|---|
| 213 | "BLD",7936,1,102,0)
|
|---|
| 214 | 4. Select Installation Option: Install Package(s)
|
|---|
| 215 | "BLD",7936,1,103,0)
|
|---|
| 216 |
|
|---|
| 217 | "BLD",7936,1,104,0)
|
|---|
| 218 | **This is the step to start the installation of this KIDS patch:
|
|---|
| 219 | "BLD",7936,1,105,0)
|
|---|
| 220 |
|
|---|
| 221 | "BLD",7936,1,106,0)
|
|---|
| 222 | a. Choose the Install Package(s) option to start the patch install
|
|---|
| 223 | "BLD",7936,1,107,0)
|
|---|
| 224 | and enter "C0Q*1.0*3" at the INSTALL NAME prompt.
|
|---|
| 225 | "BLD",7936,1,108,0)
|
|---|
| 226 | b. When prompted 'Want KIDS to Rebuild Menu Trees Upon Completion of
|
|---|
| 227 | "BLD",7936,1,109,0)
|
|---|
| 228 | Install? NO//' answer NO
|
|---|
| 229 | "BLD",7936,1,110,0)
|
|---|
| 230 | c. When prompted 'Want KIDS to INHIBIT LOGONs during the install?
|
|---|
| 231 | "BLD",7936,1,111,0)
|
|---|
| 232 | NO//' answer NO
|
|---|
| 233 | "BLD",7936,1,112,0)
|
|---|
| 234 | d. When prompted 'Want to DISABLE Scheduled Options, Menu Options,
|
|---|
| 235 | "BLD",7936,1,113,0)
|
|---|
| 236 | and Protocols? NO//' answer NO
|
|---|
| 237 | "BLD",7936,1,114,0)
|
|---|
| 238 |
|
|---|
| 239 | "BLD",7936,1,115,0)
|
|---|
| 240 |
|
|---|
| 241 | "BLD",7936,1,116,0)
|
|---|
| 242 | Here is an example installation log.
|
|---|
| 243 | "BLD",7936,1,117,0)
|
|---|
| 244 | Select INSTALL NAME: C0Q*1.0*3 Loaded from Distribution Loaded
|
|---|
| 245 | "BLD",7936,1,118,0)
|
|---|
| 246 | from Di
|
|---|
| 247 | "BLD",7936,1,119,0)
|
|---|
| 248 | stribution 8/3/12@16:32:30
|
|---|
| 249 | "BLD",7936,1,120,0)
|
|---|
| 250 | => SDFGHJKL ;Created on Aug 03, 2012@16:31:28
|
|---|
| 251 | "BLD",7936,1,121,0)
|
|---|
| 252 |
|
|---|
| 253 | "BLD",7936,1,122,0)
|
|---|
| 254 | This Distribution was loaded on Aug 03, 2012@16:32:30 with header of
|
|---|
| 255 | "BLD",7936,1,123,0)
|
|---|
| 256 | SDFGHJKL ;Created on Aug 03, 2012@16:31:28
|
|---|
| 257 | "BLD",7936,1,124,0)
|
|---|
| 258 | It consisted of the following Install(s):
|
|---|
| 259 | "BLD",7936,1,125,0)
|
|---|
| 260 | C0Q*1.0*3
|
|---|
| 261 | "BLD",7936,1,126,0)
|
|---|
| 262 |
|
|---|
| 263 | "BLD",7936,1,127,0)
|
|---|
| 264 | Checking C0Q*1.0*3 for overlap with VOE 1.0 . OK
|
|---|
| 265 | "BLD",7936,1,128,0)
|
|---|
| 266 | No overlap found
|
|---|
| 267 | "BLD",7936,1,129,0)
|
|---|
| 268 | DEVICE: HOME// PHOME HOME PRINTER
|
|---|
| 269 | "BLD",7936,1,130,0)
|
|---|
| 270 |
|
|---|
| 271 | "BLD",7936,1,131,0)
|
|---|
| 272 |
|
|---|
| 273 | "BLD",7936,1,132,0)
|
|---|
| 274 | Install Started for C0Q*1.0*3 :
|
|---|
| 275 | "BLD",7936,1,133,0)
|
|---|
| 276 | Aug 03, 2012@16:35:24
|
|---|
| 277 | "BLD",7936,1,134,0)
|
|---|
| 278 |
|
|---|
| 279 | "BLD",7936,1,135,0)
|
|---|
| 280 | Build Distribution Date: Aug 03, 2012
|
|---|
| 281 | "BLD",7936,1,136,0)
|
|---|
| 282 |
|
|---|
| 283 | "BLD",7936,1,137,0)
|
|---|
| 284 | Installing Routines:.
|
|---|
| 285 | "BLD",7936,1,138,0)
|
|---|
| 286 | Aug 03, 2012@16:35:24
|
|---|
| 287 | "BLD",7936,1,139,0)
|
|---|
| 288 |
|
|---|
| 289 | "BLD",7936,1,140,0)
|
|---|
| 290 | Installing Data Dictionaries: ..
|
|---|
| 291 | "BLD",7936,1,141,0)
|
|---|
| 292 | Aug 03, 2012@16:35:24
|
|---|
| 293 | "BLD",7936,1,142,0)
|
|---|
| 294 |
|
|---|
| 295 | "BLD",7936,1,143,0)
|
|---|
| 296 | Installing Data:
|
|---|
| 297 | "BLD",7936,1,144,0)
|
|---|
| 298 | Aug 03, 2012@16:35:24
|
|---|
| 299 | "BLD",7936,1,145,0)
|
|---|
| 300 |
|
|---|
| 301 | "BLD",7936,1,146,0)
|
|---|
| 302 | Updating Routine file.....
|
|---|
| 303 | "BLD",7936,1,147,0)
|
|---|
| 304 |
|
|---|
| 305 | "BLD",7936,1,148,0)
|
|---|
| 306 | Updating KIDS files.......
|
|---|
| 307 | "BLD",7936,1,149,0)
|
|---|
| 308 |
|
|---|
| 309 | "BLD",7936,1,150,0)
|
|---|
| 310 | C0Q*1.0*3 Installed.
|
|---|
| 311 | "BLD",7936,1,151,0)
|
|---|
| 312 | Aug 03, 2012@16:35:24
|
|---|
| 313 | "BLD",7936,1,152,0)
|
|---|
| 314 |
|
|---|
| 315 | "BLD",7936,1,153,0)
|
|---|
| 316 | Not a VA primary domain
|
|---|
| 317 | "BLD",7936,1,154,0)
|
|---|
| 318 |
|
|---|
| 319 | "BLD",7936,1,155,0)
|
|---|
| 320 | NO Install Message sent
|
|---|
| 321 | "BLD",7936,4,0)
|
|---|
| 322 | ^9.64PA^1130580001.101^1
|
|---|
| 323 | "BLD",7936,4,1130580001.101,0)
|
|---|
| 324 | 1130580001.101
|
|---|
| 325 | "BLD",7936,4,1130580001.101,222)
|
|---|
| 326 | y^y^f^^y^^y^o^n
|
|---|
| 327 | "BLD",7936,4,"B",1130580001.101,1130580001.101)
|
|---|
| 328 |
|
|---|
| 329 | "BLD",7936,6.3)
|
|---|
| 330 | 12
|
|---|
| 331 | "BLD",7936,"ABPKG")
|
|---|
| 332 | n
|
|---|
| 333 | "BLD",7936,"KRN",0)
|
|---|
| 334 | ^9.67PA^779.2^20
|
|---|
| 335 | "BLD",7936,"KRN",.4,0)
|
|---|
| 336 | .4
|
|---|
| 337 | "BLD",7936,"KRN",.401,0)
|
|---|
| 338 | .401
|
|---|
| 339 | "BLD",7936,"KRN",.402,0)
|
|---|
| 340 | .402
|
|---|
| 341 | "BLD",7936,"KRN",.403,0)
|
|---|
| 342 | .403
|
|---|
| 343 | "BLD",7936,"KRN",.5,0)
|
|---|
| 344 | .5
|
|---|
| 345 | "BLD",7936,"KRN",.84,0)
|
|---|
| 346 | .84
|
|---|
| 347 | "BLD",7936,"KRN",3.6,0)
|
|---|
| 348 | 3.6
|
|---|
| 349 | "BLD",7936,"KRN",3.8,0)
|
|---|
| 350 | 3.8
|
|---|
| 351 | "BLD",7936,"KRN",9.2,0)
|
|---|
| 352 | 9.2
|
|---|
| 353 | "BLD",7936,"KRN",9.8,0)
|
|---|
| 354 | 9.8
|
|---|
| 355 | "BLD",7936,"KRN",19,0)
|
|---|
| 356 | 19
|
|---|
| 357 | "BLD",7936,"KRN",19.1,0)
|
|---|
| 358 | 19.1
|
|---|
| 359 | "BLD",7936,"KRN",101,0)
|
|---|
| 360 | 101
|
|---|
| 361 | "BLD",7936,"KRN",409.61,0)
|
|---|
| 362 | 409.61
|
|---|
| 363 | "BLD",7936,"KRN",771,0)
|
|---|
| 364 | 771
|
|---|
| 365 | "BLD",7936,"KRN",779.2,0)
|
|---|
| 366 | 779.2
|
|---|
| 367 | "BLD",7936,"KRN",870,0)
|
|---|
| 368 | 870
|
|---|
| 369 | "BLD",7936,"KRN",8989.51,0)
|
|---|
| 370 | 8989.51
|
|---|
| 371 | "BLD",7936,"KRN",8989.52,0)
|
|---|
| 372 | 8989.52
|
|---|
| 373 | "BLD",7936,"KRN",8994,0)
|
|---|
| 374 | 8994
|
|---|
| 375 | "BLD",7936,"KRN","B",.4,.4)
|
|---|
| 376 |
|
|---|
| 377 | "BLD",7936,"KRN","B",.401,.401)
|
|---|
| 378 |
|
|---|
| 379 | "BLD",7936,"KRN","B",.402,.402)
|
|---|
| 380 |
|
|---|
| 381 | "BLD",7936,"KRN","B",.403,.403)
|
|---|
| 382 |
|
|---|
| 383 | "BLD",7936,"KRN","B",.5,.5)
|
|---|
| 384 |
|
|---|
| 385 | "BLD",7936,"KRN","B",.84,.84)
|
|---|
| 386 |
|
|---|
| 387 | "BLD",7936,"KRN","B",3.6,3.6)
|
|---|
| 388 |
|
|---|
| 389 | "BLD",7936,"KRN","B",3.8,3.8)
|
|---|
| 390 |
|
|---|
| 391 | "BLD",7936,"KRN","B",9.2,9.2)
|
|---|
| 392 |
|
|---|
| 393 | "BLD",7936,"KRN","B",9.8,9.8)
|
|---|
| 394 |
|
|---|
| 395 | "BLD",7936,"KRN","B",19,19)
|
|---|
| 396 |
|
|---|
| 397 | "BLD",7936,"KRN","B",19.1,19.1)
|
|---|
| 398 |
|
|---|
| 399 | "BLD",7936,"KRN","B",101,101)
|
|---|
| 400 |
|
|---|
| 401 | "BLD",7936,"KRN","B",409.61,409.61)
|
|---|
| 402 |
|
|---|
| 403 | "BLD",7936,"KRN","B",771,771)
|
|---|
| 404 |
|
|---|
| 405 | "BLD",7936,"KRN","B",779.2,779.2)
|
|---|
| 406 |
|
|---|
| 407 | "BLD",7936,"KRN","B",870,870)
|
|---|
| 408 |
|
|---|
| 409 | "BLD",7936,"KRN","B",8989.51,8989.51)
|
|---|
| 410 |
|
|---|
| 411 | "BLD",7936,"KRN","B",8989.52,8989.52)
|
|---|
| 412 |
|
|---|
| 413 | "BLD",7936,"KRN","B",8994,8994)
|
|---|
| 414 |
|
|---|
| 415 | "BLD",7936,"QUES",0)
|
|---|
| 416 | ^9.62^^
|
|---|
| 417 | "BLD",7936,"REQB",0)
|
|---|
| 418 | ^9.611^2^2
|
|---|
| 419 | "BLD",7936,"REQB",1,0)
|
|---|
| 420 | C0Q*1.0*2^2
|
|---|
| 421 | "BLD",7936,"REQB",2,0)
|
|---|
| 422 | QUALITY MEASURES 1.0^2
|
|---|
| 423 | "BLD",7936,"REQB","B","C0Q*1.0*2",1)
|
|---|
| 424 |
|
|---|
| 425 | "BLD",7936,"REQB","B","QUALITY MEASURES 1.0",2)
|
|---|
| 426 |
|
|---|
| 427 | "DATA",1130580001.101,4,0)
|
|---|
| 428 | PQRI MEASURE 124^^^2.16.840.1.113883.3.249.11.11
|
|---|
| 429 | "DATA",1130580001.101,4,1)
|
|---|
| 430 | Measure #124: Health Information Technology (HIT): Adoption/Use of Electronic Health Records
|
|---|
| 431 | "DATA",1130580001.101,4,4)
|
|---|
| 432 | PQRI-124
|
|---|
| 433 | "DATA",1130580001.101,4,5)
|
|---|
| 434 | Adoption/Use of Electronic Health Records (EHR)
|
|---|
| 435 | "DATA",1130580001.101,4,6,0)
|
|---|
| 436 | ^^3^3^3101013^
|
|---|
| 437 | "DATA",1130580001.101,4,6,1,0)
|
|---|
| 438 | Documents whether provider has adopted and is using health inf
|
|---|
| 439 | "DATA",1130580001.101,4,6,2,0)
|
|---|
| 440 | ormation technology. To qualify, the provider must havea adopted and be
|
|---|
| 441 | "DATA",1130580001.101,4,6,3,0)
|
|---|
| 442 | using a certified/qualified electronic health record (EHR)
|
|---|
| 443 | "DATA",1130580001.101,6,0)
|
|---|
| 444 | PQRI MEASURE 47^^^2.16.840.1.113883.3.249.11.52
|
|---|
| 445 | "DATA",1130580001.101,6,1)
|
|---|
| 446 | Measure #47: Advance Care Plan
|
|---|
| 447 | "DATA",1130580001.101,6,4)
|
|---|
| 448 | PQRI-47
|
|---|
| 449 | "DATA",1130580001.101,6,5)
|
|---|
| 450 | Advance Care Plan
|
|---|
| 451 | "DATA",1130580001.101,6,6,0)
|
|---|
| 452 | ^1130580001.111^5^5^3101014^^^
|
|---|
| 453 | "DATA",1130580001.101,6,6,1,0)
|
|---|
| 454 | Percentage of patients age 65 and older who have an advanced care plan or
|
|---|
| 455 | "DATA",1130580001.101,6,6,2,0)
|
|---|
| 456 | surrogate decision maker documented in the medical record or documented
|
|---|
| 457 | "DATA",1130580001.101,6,6,3,0)
|
|---|
| 458 | in the medical record that an advance care plan was discussed but the
|
|---|
| 459 | "DATA",1130580001.101,6,6,4,0)
|
|---|
| 460 | patient did not wish or was not able to name a surrogate decision maker
|
|---|
| 461 | "DATA",1130580001.101,6,6,5,0)
|
|---|
| 462 | or provide an advance care plan.
|
|---|
| 463 | "DATA",1130580001.101,7,0)
|
|---|
| 464 | PQRI MEASURE 48^^^2.16.840.1.113883.3.249.11.53
|
|---|
| 465 | "DATA",1130580001.101,7,1)
|
|---|
| 466 | Measure #48: Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older
|
|---|
| 467 | "DATA",1130580001.101,7,4)
|
|---|
| 468 | PQRI-48
|
|---|
| 469 | "DATA",1130580001.101,7,5)
|
|---|
| 470 | Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older
|
|---|
| 471 | "DATA",1130580001.101,7,6,0)
|
|---|
| 472 | ^^3^3^3101013^
|
|---|
| 473 | "DATA",1130580001.101,7,6,1,0)
|
|---|
| 474 | Percentage of patients equal to or older than 65 years of age at the
|
|---|
| 475 | "DATA",1130580001.101,7,6,2,0)
|
|---|
| 476 | beginning of the measurement perion who were assesed for the presence or
|
|---|
| 477 | "DATA",1130580001.101,7,6,3,0)
|
|---|
| 478 | absence of urinary incontinence within 12 months
|
|---|
| 479 | "DATA",1130580001.101,12,0)
|
|---|
| 480 | MU EP NQF 0043^^^2.16.840.1.113883.3.249.11.8
|
|---|
| 481 | "DATA",1130580001.101,12,1)
|
|---|
| 482 | Measure #111: Preventive Care and Screening: Pneumonia Vaccination for Patients 65 Years and Older
|
|---|
| 483 | "DATA",1130580001.101,12,4)
|
|---|
| 484 | PQRI-111
|
|---|
| 485 | "DATA",1130580001.101,12,5)
|
|---|
| 486 | Pneumonia Vaccination for Patients 65 Years and Older
|
|---|
| 487 | "DATA",1130580001.101,12,6,0)
|
|---|
| 488 | ^1130580001.111^2^2^3120730^^
|
|---|
| 489 | "DATA",1130580001.101,12,6,1,0)
|
|---|
| 490 | Percentage of patients afed 65 years and older who have ever r
|
|---|
| 491 | "DATA",1130580001.101,12,6,2,0)
|
|---|
| 492 | eceived a pneumoccal vaccine
|
|---|
| 493 | "DATA",1130580001.101,12,7)
|
|---|
| 494 | NQF0043
|
|---|
| 495 | "DATA",1130580001.101,14,0)
|
|---|
| 496 | PQRI MEASURE 39^^^2.16.840.1.113883.3.249.11.51
|
|---|
| 497 | "DATA",1130580001.101,14,1)
|
|---|
| 498 | Measure #39: Screening or Therapy for Osteoporosis for Women Aged 65 Years and Older
|
|---|
| 499 | "DATA",1130580001.101,14,4)
|
|---|
| 500 | PQRI-39
|
|---|
| 501 | "DATA",1130580001.101,14,5)
|
|---|
| 502 | Screening or Therapy for Osteoporosis for Women Aged 65 Years and Older
|
|---|
| 503 | "DATA",1130580001.101,14,6,0)
|
|---|
| 504 | ^^3^3^3101013^
|
|---|
| 505 | "DATA",1130580001.101,14,6,1,0)
|
|---|
| 506 | Percentage of patients who had a DXA measurement ordered or pe
|
|---|
| 507 | "DATA",1130580001.101,14,6,2,0)
|
|---|
| 508 | rformed at least once since age 60 or pharmacologic therapy prescribed
|
|---|
| 509 | "DATA",1130580001.101,14,6,3,0)
|
|---|
| 510 | within 12 months before the end of the measurement period
|
|---|
| 511 | "DATA",1130580001.101,16,0)
|
|---|
| 512 | PQRI MEASURE 173^^^2.16.840.1.113883.3.249.11.55
|
|---|
| 513 | "DATA",1130580001.101,16,1)
|
|---|
| 514 | Measure #173: Preventive Care and Screening: Unhealthy Alcohol Use - Screening
|
|---|
| 515 | "DATA",1130580001.101,16,4)
|
|---|
| 516 | PQRI-173
|
|---|
| 517 | "DATA",1130580001.101,16,5)
|
|---|
| 518 | Preventive Care and Screening: Unhealthy Alcohol Use - Screening
|
|---|
| 519 | "DATA",1130580001.101,16,6,0)
|
|---|
| 520 | ^^2^2^3101013^
|
|---|
| 521 | "DATA",1130580001.101,16,6,1,0)
|
|---|
| 522 | Percentage of patients aged 18 years and older who were screen
|
|---|
| 523 | "DATA",1130580001.101,16,6,2,0)
|
|---|
| 524 | ed for unhealthy alcohol use using a systematic method within 24 months
|
|---|
| 525 | "DATA",1130580001.101,23,0)
|
|---|
| 526 | MU HOS NQF 0495
|
|---|
| 527 | "DATA",1130580001.101,23,1)
|
|---|
| 528 | ED THROUGHPUT ARRIVAL TO DEPARTURE
|
|---|
| 529 | "DATA",1130580001.101,23,5)
|
|---|
| 530 | ED THROUGHPUT ARRIVAL TO DEPARTURE
|
|---|
| 531 | "DATA",1130580001.101,23,6,0)
|
|---|
| 532 | ^1130580001.111^3^3^3110430^^^^
|
|---|
| 533 | "DATA",1130580001.101,23,6,1,0)
|
|---|
| 534 | Median time from emergency department arrival to time of departure from
|
|---|
| 535 | "DATA",1130580001.101,23,6,2,0)
|
|---|
| 536 | the emergency room for patients admitted to the facility from the
|
|---|
| 537 | "DATA",1130580001.101,23,6,3,0)
|
|---|
| 538 | emergency department
|
|---|
| 539 | "DATA",1130580001.101,23,7)
|
|---|
| 540 | NQF0495^^^^^^88^165
|
|---|
| 541 | "DATA",1130580001.101,24,0)
|
|---|
| 542 | MU HOS NQF 0497
|
|---|
| 543 | "DATA",1130580001.101,24,1)
|
|---|
| 544 | ED THROUGHPUT ADMITTING DECISION TO DEPARTURE
|
|---|
| 545 | "DATA",1130580001.101,24,5)
|
|---|
| 546 | ED THROUGHPUT ADMITTING DECISION TO DEPARTURE
|
|---|
| 547 | "DATA",1130580001.101,24,6,0)
|
|---|
| 548 | ^^3^3^3110430^
|
|---|
| 549 | "DATA",1130580001.101,24,6,1,0)
|
|---|
| 550 | Median time from admit decision time to time of departure from the
|
|---|
| 551 | "DATA",1130580001.101,24,6,2,0)
|
|---|
| 552 | emergency department of emergency department patients admitted to
|
|---|
| 553 | "DATA",1130580001.101,24,6,3,0)
|
|---|
| 554 | inpatient status
|
|---|
| 555 | "DATA",1130580001.101,24,7)
|
|---|
| 556 | NQF0497^^^^^^90^168
|
|---|
| 557 | "DATA",1130580001.101,25,0)
|
|---|
| 558 | MU HOS NQF 0435
|
|---|
| 559 | "DATA",1130580001.101,25,1)
|
|---|
| 560 | Ischemic stroke.Discharge on anti-thrombotics
|
|---|
| 561 | "DATA",1130580001.101,25,5)
|
|---|
| 562 | Ischemic stroke.Discharge on anti-thrombotic
|
|---|
| 563 | "DATA",1130580001.101,25,6,0)
|
|---|
| 564 | ^^2^2^3110430^
|
|---|
| 565 | "DATA",1130580001.101,25,6,1,0)
|
|---|
| 566 | Ischemic stroke patients prescribed antithrombotic therapy at hospital
|
|---|
| 567 | "DATA",1130580001.101,25,6,2,0)
|
|---|
| 568 | discharge
|
|---|
| 569 | "DATA",1130580001.101,25,7)
|
|---|
| 570 | NQF0435^^^^^^114^115
|
|---|
| 571 | "DATA",1130580001.101,26,0)
|
|---|
| 572 | MU HOS NQF 0436
|
|---|
| 573 | "DATA",1130580001.101,26,1)
|
|---|
| 574 | Ischemic stroke.Anticoagulation for A-fib/flutter
|
|---|
| 575 | "DATA",1130580001.101,26,5)
|
|---|
| 576 | Ischemic stroke.Anticoagulation for A-fib/flutter
|
|---|
| 577 | "DATA",1130580001.101,26,6,0)
|
|---|
| 578 | ^1130580001.111^2^2^3110430^^^
|
|---|
| 579 | "DATA",1130580001.101,26,6,1,0)
|
|---|
| 580 | Ischemic stroke patients with atrial fibrillation/flutter who are
|
|---|
| 581 | "DATA",1130580001.101,26,6,2,0)
|
|---|
| 582 | prescribed anticoagulation therapy at hospital discharge
|
|---|
| 583 | "DATA",1130580001.101,26,7)
|
|---|
| 584 | NQF0436^^^^^^116^117
|
|---|
| 585 | "DATA",1130580001.101,27,0)
|
|---|
| 586 | MU HOS NQF 0437
|
|---|
| 587 | "DATA",1130580001.101,27,1)
|
|---|
| 588 | Ischemic stroke.Thrombolytic therapy for patients arriving within 2 hours of symptom onset
|
|---|
| 589 | "DATA",1130580001.101,27,5)
|
|---|
| 590 | Ischemic stroke.Thrombolytic therapy for patients arriving within 2 hours of symptom onset
|
|---|
| 591 | "DATA",1130580001.101,27,6,0)
|
|---|
| 592 | ^^3^3^3110430^
|
|---|
| 593 | "DATA",1130580001.101,27,6,1,0)
|
|---|
| 594 | Acute ischemic stroke patients who arrive at this hospital within 2
|
|---|
| 595 | "DATA",1130580001.101,27,6,2,0)
|
|---|
| 596 | hours of time last known well and for whom IV t-PA was initiated at this
|
|---|
| 597 | "DATA",1130580001.101,27,6,3,0)
|
|---|
| 598 | hospital within 3 hours of time last known well.
|
|---|
| 599 | "DATA",1130580001.101,27,7)
|
|---|
| 600 | NQF0437^^^^^^119^118
|
|---|
| 601 | "DATA",1130580001.101,28,0)
|
|---|
| 602 | MU HOS NQF 0438
|
|---|
| 603 | "DATA",1130580001.101,28,1)
|
|---|
| 604 | Ischemic or hemorrhagic stroke.Antithrombotic therapy by day 2
|
|---|
| 605 | "DATA",1130580001.101,28,5)
|
|---|
| 606 | Ischemic or hemorrhagic stroke.Antithrombotic therapy by day 2
|
|---|
| 607 | "DATA",1130580001.101,28,6,0)
|
|---|
| 608 | ^^2^2^3110430^
|
|---|
| 609 | "DATA",1130580001.101,28,6,1,0)
|
|---|
| 610 | Ischemic stroke patients administered antithrombotic therapy by the
|
|---|
| 611 | "DATA",1130580001.101,28,6,2,0)
|
|---|
| 612 | end of hospital day 2.
|
|---|
| 613 | "DATA",1130580001.101,28,7)
|
|---|
| 614 | NQF0438^^^^^^120^121
|
|---|
| 615 | "DATA",1130580001.101,29,0)
|
|---|
| 616 | MU HOS NQF 0439
|
|---|
| 617 | "DATA",1130580001.101,29,1)
|
|---|
| 618 | Ischemic stroke.Discharge on statins
|
|---|
| 619 | "DATA",1130580001.101,29,5)
|
|---|
| 620 | Ischemic stroke.Discharge on statins
|
|---|
| 621 | "DATA",1130580001.101,29,6,0)
|
|---|
| 622 | ^^3^3^3110430^
|
|---|
| 623 | "DATA",1130580001.101,29,6,1,0)
|
|---|
| 624 | Ischemic stroke patients with LDL > 100 mg/dL, or LDL not measured, or,
|
|---|
| 625 | "DATA",1130580001.101,29,6,2,0)
|
|---|
| 626 | who were on a lipid-lowering medication prior to hospital arrival are
|
|---|
| 627 | "DATA",1130580001.101,29,6,3,0)
|
|---|
| 628 | prescribed statin medication at hospital discharge
|
|---|
| 629 | "DATA",1130580001.101,29,7)
|
|---|
| 630 | NQF0439^^^^^^122^123
|
|---|
| 631 | "DATA",1130580001.101,30,0)
|
|---|
| 632 | MU HOS NQF 0440
|
|---|
| 633 | "DATA",1130580001.101,30,1)
|
|---|
| 634 | Ischemic or hemorrhagic stroke.Stroke education
|
|---|
| 635 | "DATA",1130580001.101,30,5)
|
|---|
| 636 | Ischemic or hemorrhagic stroke.Stroke education
|
|---|
| 637 | "DATA",1130580001.101,30,6,0)
|
|---|
| 638 | ^^5^5^3110430^
|
|---|
| 639 | "DATA",1130580001.101,30,6,1,0)
|
|---|
| 640 | Ischemic or hemorrhagic stroke patients or their caregivers who were
|
|---|
| 641 | "DATA",1130580001.101,30,6,2,0)
|
|---|
| 642 | given educational materials during the hospital stay addressing all of the
|
|---|
| 643 | "DATA",1130580001.101,30,6,3,0)
|
|---|
| 644 | following: activation of emergency medical system, need for follow-up
|
|---|
| 645 | "DATA",1130580001.101,30,6,4,0)
|
|---|
| 646 | after discharge, medications prescribed at discharge, risk factors for
|
|---|
| 647 | "DATA",1130580001.101,30,6,5,0)
|
|---|
| 648 | stroke, and warning signs and symptoms of stroke.
|
|---|
| 649 | "DATA",1130580001.101,30,7)
|
|---|
| 650 | NQF0440^^^^^^124^125
|
|---|
| 651 | "DATA",1130580001.101,31,0)
|
|---|
| 652 | MU HOS NQF 0441
|
|---|
| 653 | "DATA",1130580001.101,31,1)
|
|---|
| 654 | Ischemic or hemorrhagic stroke.Rehabilitation assessment
|
|---|
| 655 | "DATA",1130580001.101,31,5)
|
|---|
| 656 | Ischemic or hemorrhagic stroke.Rehabilitation assessment
|
|---|
| 657 | "DATA",1130580001.101,31,6,0)
|
|---|
| 658 | ^^2^2^3110430^
|
|---|
| 659 | "DATA",1130580001.101,31,6,1,0)
|
|---|
| 660 | Ischemic or hemorrhagic stroke patients who were assessed for
|
|---|
| 661 | "DATA",1130580001.101,31,6,2,0)
|
|---|
| 662 | rehabilitation services.
|
|---|
| 663 | "DATA",1130580001.101,31,7)
|
|---|
| 664 | NQF0441^^^^^^126^127
|
|---|
| 665 | "DATA",1130580001.101,32,0)
|
|---|
| 666 | MU HOS NQF 0371
|
|---|
| 667 | "DATA",1130580001.101,32,1)
|
|---|
| 668 | VTE prophylaxis within 24 hours of arrival
|
|---|
| 669 | "DATA",1130580001.101,32,5)
|
|---|
| 670 | VTE prophylaxis within 24 hours of arrival
|
|---|
| 671 | "DATA",1130580001.101,32,6,0)
|
|---|
| 672 | ^^4^4^3110430^
|
|---|
| 673 | "DATA",1130580001.101,32,6,1,0)
|
|---|
| 674 | This measure assesses the number of patients who received VTE prophylaxis
|
|---|
| 675 | "DATA",1130580001.101,32,6,2,0)
|
|---|
| 676 | or have documentation why no VTE prophylaxis was given the day of or the
|
|---|
| 677 | "DATA",1130580001.101,32,6,3,0)
|
|---|
| 678 | day after hospital admission or surgery end date for surgeries that start
|
|---|
| 679 | "DATA",1130580001.101,32,6,4,0)
|
|---|
| 680 | the day of or the day after hospital admission.
|
|---|
| 681 | "DATA",1130580001.101,32,7)
|
|---|
| 682 | NQF0371^^^^^^69^67
|
|---|
| 683 | "DATA",1130580001.101,33,0)
|
|---|
| 684 | MU HOS NQF 0372
|
|---|
| 685 | "DATA",1130580001.101,33,1)
|
|---|
| 686 | ICU VTE prophylaxis
|
|---|
| 687 | "DATA",1130580001.101,33,5)
|
|---|
| 688 | ICU VTE prophylaxis
|
|---|
| 689 | "DATA",1130580001.101,33,6,0)
|
|---|
| 690 | ^^5^5^3110430^
|
|---|
| 691 | "DATA",1130580001.101,33,6,1,0)
|
|---|
| 692 | This measure assesses the number of patients who received VTE prophylaxis
|
|---|
| 693 | "DATA",1130580001.101,33,6,2,0)
|
|---|
| 694 | or have documentation why no VTE prophylaxis was given the day of or the
|
|---|
| 695 | "DATA",1130580001.101,33,6,3,0)
|
|---|
| 696 | day after the initial admission (or transfer) to the Intensive Care Unit
|
|---|
| 697 | "DATA",1130580001.101,33,6,4,0)
|
|---|
| 698 | (ICU) or surgery end date for surgeries that start the day of or the day
|
|---|
| 699 | "DATA",1130580001.101,33,6,5,0)
|
|---|
| 700 | after ICU admission (or transfer).
|
|---|
| 701 | "DATA",1130580001.101,33,7)
|
|---|
| 702 | NQF0372^^^^^^128^71
|
|---|
| 703 | "DATA",1130580001.101,34,0)
|
|---|
| 704 | MU HOS NQF 0373
|
|---|
| 705 | "DATA",1130580001.101,34,1)
|
|---|
| 706 | Anticoagulation overlap therapy
|
|---|
| 707 | "DATA",1130580001.101,34,5)
|
|---|
| 708 | Anticoagulation overlap therapy
|
|---|
| 709 | "DATA",1130580001.101,34,6,0)
|
|---|
| 710 | ^^8^8^3110430^
|
|---|
| 711 | "DATA",1130580001.101,34,6,1,0)
|
|---|
| 712 | This measure assesses the number of patients diagnosed with confirmed VTE
|
|---|
| 713 | "DATA",1130580001.101,34,6,2,0)
|
|---|
| 714 | who received an overlap of parenteral (intravenous [IV] or subcutaneous
|
|---|
| 715 | "DATA",1130580001.101,34,6,3,0)
|
|---|
| 716 | [subcu]) anticoagulation and warfarin therapy. For patients who received
|
|---|
| 717 | "DATA",1130580001.101,34,6,4,0)
|
|---|
| 718 | less than five days of overlap therapy, they must be discharged on both
|
|---|
| 719 | "DATA",1130580001.101,34,6,5,0)
|
|---|
| 720 | medications. Overlap therapy must be administered for at least five days
|
|---|
| 721 | "DATA",1130580001.101,34,6,6,0)
|
|---|
| 722 | with an international normalized ratio (INR) . 2 prior to discontinuation
|
|---|
| 723 | "DATA",1130580001.101,34,6,7,0)
|
|---|
| 724 | of the parenteral anticoagulation therapy or the patient must be
|
|---|
| 725 | "DATA",1130580001.101,34,6,8,0)
|
|---|
| 726 | discharged on both medications.
|
|---|
| 727 | "DATA",1130580001.101,34,7)
|
|---|
| 728 | NQF0373^^^^^^129^144
|
|---|
| 729 | "DATA",1130580001.101,35,0)
|
|---|
| 730 | MU HOS NQF 0374
|
|---|
| 731 | "DATA",1130580001.101,35,1)
|
|---|
| 732 | Platelet monitoring on unfractionated heparin
|
|---|
| 733 | "DATA",1130580001.101,35,5)
|
|---|
| 734 | Platelet monitoring on unfractionated heparin
|
|---|
| 735 | "DATA",1130580001.101,35,6,0)
|
|---|
| 736 | ^^10^10^3110430^
|
|---|
| 737 | "DATA",1130580001.101,35,6,1,0)
|
|---|
| 738 | This measure assesses the number of patients diagnosed with confirmed VTE
|
|---|
| 739 | "DATA",1130580001.101,35,6,2,0)
|
|---|
| 740 | who received intravenous (IV) UFH therapy dosages AND had their platelet
|
|---|
| 741 | "DATA",1130580001.101,35,6,3,0)
|
|---|
| 742 | counts monitored using defined parameters such as a nomogram or
|
|---|
| 743 | "DATA",1130580001.101,35,6,4,0)
|
|---|
| 744 | protocol This measure assesses the number of patients diagnosed with
|
|---|
| 745 | "DATA",1130580001.101,35,6,5,0)
|
|---|
| 746 | confirmed VTE who received intravenous (IV) UFH therapy dosages AND had
|
|---|
| 747 | "DATA",1130580001.101,35,6,6,0)
|
|---|
| 748 | their platelet counts monitored using defined parameters such as a
|
|---|
| 749 | "DATA",1130580001.101,35,6,7,0)
|
|---|
| 750 | nomogram or protocol This measure assesses the number of patients
|
|---|
| 751 | "DATA",1130580001.101,35,6,8,0)
|
|---|
| 752 | diagnosed with confirmed VTE who received intravenous (IV) UFH therapy
|
|---|
| 753 | "DATA",1130580001.101,35,6,9,0)
|
|---|
| 754 | dosages AND had their platelet counts monitored using defined parameters
|
|---|
| 755 | "DATA",1130580001.101,35,6,10,0)
|
|---|
| 756 | such as a nomogram or protocol
|
|---|
| 757 | "DATA",1130580001.101,35,7)
|
|---|
| 758 | NQF0374^^^^^^145^146
|
|---|
| 759 | "DATA",1130580001.101,36,0)
|
|---|
| 760 | MU HOS NQF 0375
|
|---|
| 761 | "DATA",1130580001.101,36,1)
|
|---|
| 762 | VTE discharge instructions
|
|---|
| 763 | "DATA",1130580001.101,36,5)
|
|---|
| 764 | VTE discharge instructions
|
|---|
| 765 | "DATA",1130580001.101,36,6,0)
|
|---|
| 766 | ^^11^11^3110430^
|
|---|
| 767 | "DATA",1130580001.101,36,6,1,0)
|
|---|
| 768 | This measure assesses the number of patients diagnosed with confirmed VTE
|
|---|
| 769 | "DATA",1130580001.101,36,6,2,0)
|
|---|
| 770 | that are discharged to home, to home with home health, home hospice or
|
|---|
| 771 | "DATA",1130580001.101,36,6,3,0)
|
|---|
| 772 | discharged/transferred to court/law enforcement on warfarin with written
|
|---|
| 773 | "DATA",1130580001.101,36,6,4,0)
|
|---|
| 774 | discharge instructions that address all four criteria: compliance issues,
|
|---|
| 775 | "DATA",1130580001.101,36,6,5,0)
|
|---|
| 776 | dietary advice, follow-up This measure assesses the number of patients
|
|---|
| 777 | "DATA",1130580001.101,36,6,6,0)
|
|---|
| 778 | diagnosed with confirmed VTE that are discharged to home, to home with
|
|---|
| 779 | "DATA",1130580001.101,36,6,7,0)
|
|---|
| 780 | home health, home hospice or discharged/transferred to court/law
|
|---|
| 781 | "DATA",1130580001.101,36,6,8,0)
|
|---|
| 782 | enforcement on warfarin with written discharge instructions that address
|
|---|
| 783 | "DATA",1130580001.101,36,6,9,0)
|
|---|
| 784 | all four criteria: compliance issues, dietary advice, follow-up
|
|---|
| 785 | "DATA",1130580001.101,36,6,10,0)
|
|---|
| 786 | monitoring, and information about the potential for adverse drug
|
|---|
| 787 | "DATA",1130580001.101,36,6,11,0)
|
|---|
| 788 | reactions/interactions.
|
|---|
| 789 | "DATA",1130580001.101,36,7)
|
|---|
| 790 | NQF0375^^^^^^147^156
|
|---|
| 791 | "DATA",1130580001.101,37,0)
|
|---|
| 792 | MU HOS NQF 0376
|
|---|
| 793 | "DATA",1130580001.101,37,1)
|
|---|
| 794 | Incidence of potentially preventable VTE
|
|---|
| 795 | "DATA",1130580001.101,37,5)
|
|---|
| 796 | Incidence of potentially preventable VTE
|
|---|
| 797 | "DATA",1130580001.101,37,6,0)
|
|---|
| 798 | ^^4^4^3110430^
|
|---|
| 799 | "DATA",1130580001.101,37,6,1,0)
|
|---|
| 800 | This measure assesses the number of patients diagnosed with confirmed VTE
|
|---|
| 801 | "DATA",1130580001.101,37,6,2,0)
|
|---|
| 802 | during hospitalization (not present on arrival) who did not receive VTE
|
|---|
| 803 | "DATA",1130580001.101,37,6,3,0)
|
|---|
| 804 | prophylaxis between hospital admission and the day before the VTE
|
|---|
| 805 | "DATA",1130580001.101,37,6,4,0)
|
|---|
| 806 | diagnostic testing order date.
|
|---|
| 807 | "DATA",1130580001.101,37,7)
|
|---|
| 808 | NQF0376^^^^^^158^162
|
|---|
| 809 | "DATA",1130580001.101,39,0)
|
|---|
| 810 | MU EP NQF 0421^^^2.16.840.1.113883.3.249.11.54
|
|---|
| 811 | "DATA",1130580001.101,39,1)
|
|---|
| 812 | NQF0421 Adult Weight Screening and Follow-Up
|
|---|
| 813 | "DATA",1130580001.101,39,4)
|
|---|
| 814 | PQRI-128
|
|---|
| 815 | "DATA",1130580001.101,39,5)
|
|---|
| 816 | NQF0421 Adult Weight Screening and Follow-Up
|
|---|
| 817 | "DATA",1130580001.101,39,6,0)
|
|---|
| 818 | ^1130580001.111^6^6^3110628^^^^
|
|---|
| 819 | "DATA",1130580001.101,39,6,1,0)
|
|---|
| 820 | Percentage of patients aged 18
|
|---|
| 821 | "DATA",1130580001.101,39,6,2,0)
|
|---|
| 822 | years and older with a calculated BMI in the past
|
|---|
| 823 | "DATA",1130580001.101,39,6,3,0)
|
|---|
| 824 | six months or during the current visit documented in
|
|---|
| 825 | "DATA",1130580001.101,39,6,4,0)
|
|---|
| 826 | the medical record AND if the most recent BMI is
|
|---|
| 827 | "DATA",1130580001.101,39,6,5,0)
|
|---|
| 828 | outside parameters, a follow-up plan is
|
|---|
| 829 | "DATA",1130580001.101,39,6,6,0)
|
|---|
| 830 | documented.
|
|---|
| 831 | "DATA",1130580001.101,39,7)
|
|---|
| 832 | NQF0421^^^^^^321^320^10
|
|---|
| 833 | "DATA",1130580001.101,40,0)
|
|---|
| 834 | MU EP NQF 0013^^^2.16.840.1.113883.3.249.11.56
|
|---|
| 835 | "DATA",1130580001.101,40,1)
|
|---|
| 836 | NQF0013 Hypertension: Blood Pressure Measurement
|
|---|
| 837 | "DATA",1130580001.101,40,4)
|
|---|
| 838 | PQRI-13
|
|---|
| 839 | "DATA",1130580001.101,40,5)
|
|---|
| 840 | NQF0013 Hypertension: Blood Pressure Measurement
|
|---|
| 841 | "DATA",1130580001.101,40,6,0)
|
|---|
| 842 | ^1130580001.111^4^4^3110628^^
|
|---|
| 843 | "DATA",1130580001.101,40,6,1,0)
|
|---|
| 844 | Percentage of patient visits for patients
|
|---|
| 845 | "DATA",1130580001.101,40,6,2,0)
|
|---|
| 846 | aged 18 years and older with a diagnosis of hypertension
|
|---|
| 847 | "DATA",1130580001.101,40,6,3,0)
|
|---|
| 848 | who have been seen for at least 2 office visits, with blood
|
|---|
| 849 | "DATA",1130580001.101,40,6,4,0)
|
|---|
| 850 | pressure (BP) recorded
|
|---|
| 851 | "DATA",1130580001.101,40,7)
|
|---|
| 852 | NQF0013^^^^^^142^167
|
|---|
| 853 | "DATA",1130580001.101,41,0)
|
|---|
| 854 | MU EP NQF 0028A^^^2.16.840.1.113883.3.249.11.59
|
|---|
| 855 | "DATA",1130580001.101,41,1)
|
|---|
| 856 | NQF0028A Preventive Care and Screening Measure Pair: a. Tobacco Use Assessment,b. Tobacco Cessation Intervention
|
|---|
| 857 | "DATA",1130580001.101,41,4)
|
|---|
| 858 | PQRI-28
|
|---|
| 859 | "DATA",1130580001.101,41,5)
|
|---|
| 860 | NQF0028A Tobacco Use Assessment
|
|---|
| 861 | "DATA",1130580001.101,41,6,0)
|
|---|
| 862 | ^1130580001.111^7^7^3110625^^^
|
|---|
| 863 | "DATA",1130580001.101,41,6,1,0)
|
|---|
| 864 | Percentage of patients aged 18 years and
|
|---|
| 865 | "DATA",1130580001.101,41,6,2,0)
|
|---|
| 866 | older who have been seen for at least 2 office visits who
|
|---|
| 867 | "DATA",1130580001.101,41,6,3,0)
|
|---|
| 868 | were queried about tobacco use one or more times within
|
|---|
| 869 | "DATA",1130580001.101,41,6,4,0)
|
|---|
| 870 | 24 months b. Percentage of patients aged 18 years and
|
|---|
| 871 | "DATA",1130580001.101,41,6,5,0)
|
|---|
| 872 | older identified as tobacco users within the past 24
|
|---|
| 873 | "DATA",1130580001.101,41,6,6,0)
|
|---|
| 874 | months and have been seen for at least 2 office visits,
|
|---|
| 875 | "DATA",1130580001.101,41,6,7,0)
|
|---|
| 876 | who received cessation intervention.
|
|---|
| 877 | "DATA",1130580001.101,41,7)
|
|---|
| 878 | NQF0028A^^^^^^157^160
|
|---|
| 879 | "DATA",1130580001.101,42,0)
|
|---|
| 880 | MU EP NQF 0041^^^2.16.840.1.113883.3.249.11.7
|
|---|
| 881 | "DATA",1130580001.101,42,1)
|
|---|
| 882 | Preventive Care and Screening: Influenza Immunization for Patients >= 50 Years Old
|
|---|
| 883 | "DATA",1130580001.101,42,4)
|
|---|
| 884 | PQRI-110
|
|---|
| 885 | "DATA",1130580001.101,42,5)
|
|---|
| 886 | NQF0041 Influenza Immunization 50 years and older
|
|---|
| 887 | "DATA",1130580001.101,42,6,0)
|
|---|
| 888 | ^^4^4^3110430^
|
|---|
| 889 | "DATA",1130580001.101,42,6,1,0)
|
|---|
| 890 | Percentage of patients aged 50 years
|
|---|
| 891 | "DATA",1130580001.101,42,6,2,0)
|
|---|
| 892 | and older who received an influenza immunization
|
|---|
| 893 | "DATA",1130580001.101,42,6,3,0)
|
|---|
| 894 | during the flu season (September through
|
|---|
| 895 | "DATA",1130580001.101,42,6,4,0)
|
|---|
| 896 | February).
|
|---|
| 897 | "DATA",1130580001.101,42,7)
|
|---|
| 898 | NQF0041^^^^^^242^243
|
|---|
| 899 | "DATA",1130580001.101,43,0)
|
|---|
| 900 | MU EP NQF 0024
|
|---|
| 901 | "DATA",1130580001.101,43,1)
|
|---|
| 902 | NQF0024 Weight Assessment and Counseling for Children and Adolescents (ALL)
|
|---|
| 903 | "DATA",1130580001.101,43,5)
|
|---|
| 904 | NQF0024 Weight Assessment and Counseling for Children and Adolescents (ALL)
|
|---|
| 905 | "DATA",1130580001.101,43,6,0)
|
|---|
| 906 | ^^6^6^3120803^
|
|---|
| 907 | "DATA",1130580001.101,43,6,1,0)
|
|---|
| 908 | Percentage of patients 2 -17 years of age
|
|---|
| 909 | "DATA",1130580001.101,43,6,2,0)
|
|---|
| 910 | who had an outpatient visit with a Primary Care Physician
|
|---|
| 911 | "DATA",1130580001.101,43,6,3,0)
|
|---|
| 912 | (PCP) or OB/GYN and who had evidence of BMI
|
|---|
| 913 | "DATA",1130580001.101,43,6,4,0)
|
|---|
| 914 | percentile documentation, counseling for nutrition and
|
|---|
| 915 | "DATA",1130580001.101,43,6,5,0)
|
|---|
| 916 | counseling for physical activity during the measurement
|
|---|
| 917 | "DATA",1130580001.101,43,6,6,0)
|
|---|
| 918 | year. This specific Quality Measure is for all the children.
|
|---|
| 919 | "DATA",1130580001.101,43,7)
|
|---|
| 920 | NQF0024 ALL^^^^^^151^149
|
|---|
| 921 | "DATA",1130580001.101,44,0)
|
|---|
| 922 | MU EP NQF 0038^^^2.16.840.1.113883.3.249.11.60
|
|---|
| 923 | "DATA",1130580001.101,44,1)
|
|---|
| 924 | Childhood Immunization Status
|
|---|
| 925 | "DATA",1130580001.101,44,4)
|
|---|
| 926 | PQRI-38
|
|---|
| 927 | "DATA",1130580001.101,44,5)
|
|---|
| 928 | Childhood Immunization Status
|
|---|
| 929 | "DATA",1130580001.101,44,6,0)
|
|---|
| 930 | ^^14^14^3110430^
|
|---|
| 931 | "DATA",1130580001.101,44,6,1,0)
|
|---|
| 932 | Percentage of children 2 years of age who
|
|---|
| 933 | "DATA",1130580001.101,44,6,2,0)
|
|---|
| 934 | had four diphtheria, tetanus and acellular pertussis
|
|---|
| 935 | "DATA",1130580001.101,44,6,3,0)
|
|---|
| 936 | (DTaP); three polio(IPV), one measles, ,mumps and
|
|---|
| 937 | "DATA",1130580001.101,44,6,4,0)
|
|---|
| 938 | rubella (MMR); two H influenza type B (HiB); three
|
|---|
| 939 | "DATA",1130580001.101,44,6,5,0)
|
|---|
| 940 | Percentage of children 2 years of age who
|
|---|
| 941 | "DATA",1130580001.101,44,6,6,0)
|
|---|
| 942 | had four diphtheria, tetanus and acellular pertussis
|
|---|
| 943 | "DATA",1130580001.101,44,6,7,0)
|
|---|
| 944 | (DTaP); three polio(IPV), one measles, ,mumps and
|
|---|
| 945 | "DATA",1130580001.101,44,6,8,0)
|
|---|
| 946 | rubella (MMR); two H influenza type B (HiB); three
|
|---|
| 947 | "DATA",1130580001.101,44,6,9,0)
|
|---|
| 948 | hepatitis B (Hep B); one chicken pox (VZV); four
|
|---|
| 949 | "DATA",1130580001.101,44,6,10,0)
|
|---|
| 950 | pneumococcal conjugate (PCV); two hepatitis A (Hep A);
|
|---|
| 951 | "DATA",1130580001.101,44,6,11,0)
|
|---|
| 952 | two or three rotavirus (RV); and two influenza (flu)
|
|---|
| 953 | "DATA",1130580001.101,44,6,12,0)
|
|---|
| 954 | vaccines by their second birthday. The measure
|
|---|
| 955 | "DATA",1130580001.101,44,6,13,0)
|
|---|
| 956 | calculates a rate for each vaccine and nine separate
|
|---|
| 957 | "DATA",1130580001.101,44,6,14,0)
|
|---|
| 958 | combination rates.
|
|---|
| 959 | "DATA",1130580001.101,44,7)
|
|---|
| 960 | NQF0038
|
|---|
| 961 | "DATA",1130580001.101,45,0)
|
|---|
| 962 | MU EP NQF 0059^^^2.16.840.1.113883.3.249.11.2
|
|---|
| 963 | "DATA",1130580001.101,45,1)
|
|---|
| 964 | Diabetes: Hemoglobin A1c Poor Contro
|
|---|
| 965 | "DATA",1130580001.101,45,4)
|
|---|
| 966 | PQRI-1
|
|---|
| 967 | "DATA",1130580001.101,45,5)
|
|---|
| 968 | Diabetes: NQF0059 Hemoglobin A1c Poor Control
|
|---|
| 969 | "DATA",1130580001.101,45,6,0)
|
|---|
| 970 | ^^2^2^3110430^
|
|---|
| 971 | "DATA",1130580001.101,45,6,1,0)
|
|---|
| 972 | Percentage of patients 18 - 75 years of age with diabetes (type 1
|
|---|
| 973 | "DATA",1130580001.101,45,6,2,0)
|
|---|
| 974 | or type 2) who had hemoglobin A1c > 9.0%.
|
|---|
| 975 | "DATA",1130580001.101,45,7)
|
|---|
| 976 | NQF0059^^^^^^260^258
|
|---|
| 977 | "DATA",1130580001.101,46,0)
|
|---|
| 978 | MU EP NQF 0064^^^2.16.840.1.113883.3.249.11.3
|
|---|
| 979 | "DATA",1130580001.101,46,1)
|
|---|
| 980 | Diabetes: Low Density Lipoprotein (LDL) Management and Control
|
|---|
| 981 | "DATA",1130580001.101,46,4)
|
|---|
| 982 | PQRI-2
|
|---|
| 983 | "DATA",1130580001.101,46,5)
|
|---|
| 984 | NQF0064 Diabetes: Low Density Lipoprotein (LDL) Management and Control
|
|---|
| 985 | "DATA",1130580001.101,46,6,0)
|
|---|
| 986 | ^^3^3^3110430^
|
|---|
| 987 | "DATA",1130580001.101,46,6,1,0)
|
|---|
| 988 | Percentage of patients 18-75 years of age with diabetes (type 1
|
|---|
| 989 | "DATA",1130580001.101,46,6,2,0)
|
|---|
| 990 | or type 2) who had LDL-C < 100 mg/dL).Percentage of patients 18-75 years
|
|---|
| 991 | "DATA",1130580001.101,46,6,3,0)
|
|---|
| 992 | of age with diabetes (type 1 or type 2) who had LDL-C < 100 mg/dL).
|
|---|
| 993 | "DATA",1130580001.101,46,7)
|
|---|
| 994 | NQF0064^^^^^^248^258
|
|---|
| 995 | "DATA",1130580001.101,47,0)
|
|---|
| 996 | MU EP NQF 0061^^^2.16.840.1.113883.3.249.11.4
|
|---|
| 997 | "DATA",1130580001.101,47,1)
|
|---|
| 998 | Blood Pressure Management
|
|---|
| 999 | "DATA",1130580001.101,47,4)
|
|---|
| 1000 | PQRI-3
|
|---|
| 1001 | "DATA",1130580001.101,47,5)
|
|---|
| 1002 | NQF0061 Diabetes: Blood Pressure Management
|
|---|
| 1003 | "DATA",1130580001.101,47,6,0)
|
|---|
| 1004 | ^^2^2^3110430^
|
|---|
| 1005 | "DATA",1130580001.101,47,6,1,0)
|
|---|
| 1006 | Percentage of patients 18 - 75 years of age with
|
|---|
| 1007 | "DATA",1130580001.101,47,6,2,0)
|
|---|
| 1008 | diabetes (type 1 or type 2) who had blood pressure <140/90 mmHg.
|
|---|
| 1009 | "DATA",1130580001.101,47,7)
|
|---|
| 1010 | NQF0061^^^^^^262^258
|
|---|
| 1011 | "DATA",1130580001.101,48,0)
|
|---|
| 1012 | MU EP NQF 0081^^^2.16.840.1.113883.3.249.11.5
|
|---|
| 1013 | "DATA",1130580001.101,48,1)
|
|---|
| 1014 | Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
|
|---|
| 1015 | "DATA",1130580001.101,48,4)
|
|---|
| 1016 | PQRI-5
|
|---|
| 1017 | "DATA",1130580001.101,48,5)
|
|---|
| 1018 | Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
|
|---|
| 1019 | "DATA",1130580001.101,48,6,0)
|
|---|
| 1020 | ^^3^3^3110430^
|
|---|
| 1021 | "DATA",1130580001.101,48,6,1,0)
|
|---|
| 1022 | Percentage of patients aged 18 years and older with a
|
|---|
| 1023 | "DATA",1130580001.101,48,6,2,0)
|
|---|
| 1024 | diagnosis of heart failure and LVSD (LVEF < 40%) who were
|
|---|
| 1025 | "DATA",1130580001.101,48,6,3,0)
|
|---|
| 1026 | prescribed ACE inhibitor or ARB therapy
|
|---|
| 1027 | "DATA",1130580001.101,48,7)
|
|---|
| 1028 | NQF0081
|
|---|
| 1029 | "DATA",1130580001.101,49,0)
|
|---|
| 1030 | MU EP NQF 0070^^^2.16.840.1.113883.3.249.11.6
|
|---|
| 1031 | "DATA",1130580001.101,49,1)
|
|---|
| 1032 | CMS Measure #7: Coronary Artery Disease (CAD): Beta-Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI)
|
|---|
| 1033 | "DATA",1130580001.101,49,4)
|
|---|
| 1034 | PQRI-7
|
|---|
| 1035 | "DATA",1130580001.101,49,5)
|
|---|
| 1036 | Percentage of patients 18 aged 18 years and older wit a diagnosis of CAD and prior MI who were prescribed beta-blocker therapy
|
|---|
| 1037 | "DATA",1130580001.101,49,6,0)
|
|---|
| 1038 | ^^3^3^3101013^
|
|---|
| 1039 | "DATA",1130580001.101,49,6,1,0)
|
|---|
| 1040 | Percentage of patients aged 18 years and older with a diagnosis of
|
|---|
| 1041 | "DATA",1130580001.101,49,6,2,0)
|
|---|
| 1042 | coronary artery disease and a prior MI who where prescribed beta-blocker
|
|---|
| 1043 | "DATA",1130580001.101,49,6,3,0)
|
|---|
| 1044 | therapy
|
|---|
| 1045 | "DATA",1130580001.101,49,7)
|
|---|
| 1046 | NQF0070
|
|---|
| 1047 | "DATA",1130580001.101,50,0)
|
|---|
| 1048 | MU EP NQF 0031^^^2.16.840.1.113883.3.249.11.9
|
|---|
| 1049 | "DATA",1130580001.101,50,1)
|
|---|
| 1050 | Breast Cancer Screening
|
|---|
| 1051 | "DATA",1130580001.101,50,4)
|
|---|
| 1052 | PQRI-112
|
|---|
| 1053 | "DATA",1130580001.101,50,5)
|
|---|
| 1054 | Breast Cancer Screening
|
|---|
| 1055 | "DATA",1130580001.101,50,6,0)
|
|---|
| 1056 | ^^2^2^3110430^
|
|---|
| 1057 | "DATA",1130580001.101,50,6,1,0)
|
|---|
| 1058 | Percentage of women 40-69 years of age who had a
|
|---|
| 1059 | "DATA",1130580001.101,50,6,2,0)
|
|---|
| 1060 | mammogram to screen for breast cancer
|
|---|
| 1061 | "DATA",1130580001.101,50,7)
|
|---|
| 1062 | NQF0031
|
|---|
| 1063 | "DATA",1130580001.101,51,0)
|
|---|
| 1064 | MU EP NQF 0034^^^2.16.840.1.113883.3.249.11.10
|
|---|
| 1065 | "DATA",1130580001.101,51,1)
|
|---|
| 1066 | Colorectal Cancer Screening
|
|---|
| 1067 | "DATA",1130580001.101,51,4)
|
|---|
| 1068 | PQRI-113
|
|---|
| 1069 | "DATA",1130580001.101,51,5)
|
|---|
| 1070 | Colorectal Cancer Screening
|
|---|
| 1071 | "DATA",1130580001.101,51,6,0)
|
|---|
| 1072 | ^^2^2^3110430^
|
|---|
| 1073 | "DATA",1130580001.101,51,6,1,0)
|
|---|
| 1074 | Percentage of adults 50-75 years of age who had appropriate screening for
|
|---|
| 1075 | "DATA",1130580001.101,51,6,2,0)
|
|---|
| 1076 | colorectal cancer.
|
|---|
| 1077 | "DATA",1130580001.101,51,7)
|
|---|
| 1078 | NQF0034
|
|---|
| 1079 | "DATA",1130580001.101,52,0)
|
|---|
| 1080 | MU EP NQF 0067
|
|---|
| 1081 | "DATA",1130580001.101,52,1)
|
|---|
| 1082 | Coronary Artery Disease (CAD): Oral Antiplatelet Therapy Prescribed for Patients with CAD
|
|---|
| 1083 | "DATA",1130580001.101,52,5)
|
|---|
| 1084 | Coronary Artery Disease (CAD): Oral Antiplatelet Therapy Prescribed for Patients with CAD
|
|---|
| 1085 | "DATA",1130580001.101,52,6,0)
|
|---|
| 1086 | ^^2^2^3110430^
|
|---|
| 1087 | "DATA",1130580001.101,52,6,1,0)
|
|---|
| 1088 | Percentage of patients aged 18 years and older with a
|
|---|
| 1089 | "DATA",1130580001.101,52,6,2,0)
|
|---|
| 1090 | diagnosis of CAD who were prescribed oral antiplatelet therapy.
|
|---|
| 1091 | "DATA",1130580001.101,52,7)
|
|---|
| 1092 | NQF0067
|
|---|
| 1093 | "DATA",1130580001.101,53,0)
|
|---|
| 1094 | MU EP NQF 0083
|
|---|
| 1095 | "DATA",1130580001.101,53,1)
|
|---|
| 1096 | Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
|
|---|
| 1097 | "DATA",1130580001.101,53,5)
|
|---|
| 1098 | Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
|
|---|
| 1099 | "DATA",1130580001.101,53,6,0)
|
|---|
| 1100 | ^^3^3^3110430^
|
|---|
| 1101 | "DATA",1130580001.101,53,6,1,0)
|
|---|
| 1102 | Percentage of patients aged 18 years and older with a
|
|---|
| 1103 | "DATA",1130580001.101,53,6,2,0)
|
|---|
| 1104 | diagnosis of heart failure who also have LVSD (LVEF < 40%) and who were
|
|---|
| 1105 | "DATA",1130580001.101,53,6,3,0)
|
|---|
| 1106 | prescribed beta-blocker therapy
|
|---|
| 1107 | "DATA",1130580001.101,53,7)
|
|---|
| 1108 | NQF0083
|
|---|
| 1109 | "DATA",1130580001.101,54,0)
|
|---|
| 1110 | MU EP NQF 0105
|
|---|
| 1111 | "DATA",1130580001.101,54,1)
|
|---|
| 1112 | Anti-depressant medication management: (a) Effective Acute Phase Treatment,(b)Effective Continuation Phase Treatment
|
|---|
| 1113 | "DATA",1130580001.101,54,5)
|
|---|
| 1114 | Anti-depressant medication management: (a) Effective Acute Phase Treatment,(b)Effective Continuation Phase Treatment
|
|---|
| 1115 | "DATA",1130580001.101,54,6,0)
|
|---|
| 1116 | ^^4^4^3110430^
|
|---|
| 1117 | "DATA",1130580001.101,54,6,1,0)
|
|---|
| 1118 | The percentage of patients 18 years of age and older
|
|---|
| 1119 | "DATA",1130580001.101,54,6,2,0)
|
|---|
| 1120 | who were diagnosed with a new episode of major depression, treated
|
|---|
| 1121 | "DATA",1130580001.101,54,6,3,0)
|
|---|
| 1122 | with antidepressant medication, and who remained on an
|
|---|
| 1123 | "DATA",1130580001.101,54,6,4,0)
|
|---|
| 1124 | antidepressant medication treatment.
|
|---|
| 1125 | "DATA",1130580001.101,54,7)
|
|---|
| 1126 | NQF0105
|
|---|
| 1127 | "DATA",1130580001.101,55,0)
|
|---|
| 1128 | MU EP NQF 0086
|
|---|
| 1129 | "DATA",1130580001.101,55,1)
|
|---|
| 1130 | Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation
|
|---|
| 1131 | "DATA",1130580001.101,55,5)
|
|---|
| 1132 | Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation
|
|---|
| 1133 | "DATA",1130580001.101,55,6,0)
|
|---|
| 1134 | ^^4^4^3110430^
|
|---|
| 1135 | "DATA",1130580001.101,55,6,1,0)
|
|---|
| 1136 | Percentage of patients aged 18 years and older with a
|
|---|
| 1137 | "DATA",1130580001.101,55,6,2,0)
|
|---|
| 1138 | diagnosis of POAG who have been seen for at least two office visits
|
|---|
| 1139 | "DATA",1130580001.101,55,6,3,0)
|
|---|
| 1140 | who have an optic nerve head evaluation during one or more office
|
|---|
| 1141 | "DATA",1130580001.101,55,6,4,0)
|
|---|
| 1142 | visits within 12 months.
|
|---|
| 1143 | "DATA",1130580001.101,55,7)
|
|---|
| 1144 | NQF0086
|
|---|
| 1145 | "DATA",1130580001.101,56,0)
|
|---|
| 1146 | MU EP NQF 0088
|
|---|
| 1147 | "DATA",1130580001.101,56,1)
|
|---|
| 1148 | Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy
|
|---|
| 1149 | "DATA",1130580001.101,56,5)
|
|---|
| 1150 | Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy
|
|---|
| 1151 | "DATA",1130580001.101,56,6,0)
|
|---|
| 1152 | ^^5^5^3110430^
|
|---|
| 1153 | "DATA",1130580001.101,56,6,1,0)
|
|---|
| 1154 | Percentage of patients aged 18 years and older with a
|
|---|
| 1155 | "DATA",1130580001.101,56,6,2,0)
|
|---|
| 1156 | diagnosis of diabetic retinopathy who had a dilated macular or fundus
|
|---|
| 1157 | "DATA",1130580001.101,56,6,3,0)
|
|---|
| 1158 | exam performed which included documentation of the level of severity
|
|---|
| 1159 | "DATA",1130580001.101,56,6,4,0)
|
|---|
| 1160 | of retinopathy and the presence or absence of macular edema during
|
|---|
| 1161 | "DATA",1130580001.101,56,6,5,0)
|
|---|
| 1162 | one or more office visits within 12 months.
|
|---|
| 1163 | "DATA",1130580001.101,56,7)
|
|---|
| 1164 | NQF0088
|
|---|
| 1165 | "DATA",1130580001.101,57,0)
|
|---|
| 1166 | MU EP NQF 0089
|
|---|
| 1167 | "DATA",1130580001.101,57,1)
|
|---|
| 1168 | Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
|
|---|
| 1169 | "DATA",1130580001.101,57,5)
|
|---|
| 1170 | Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
|
|---|
| 1171 | "DATA",1130580001.101,57,6,0)
|
|---|
| 1172 | ^^6^6^3110430^
|
|---|
| 1173 | "DATA",1130580001.101,57,6,1,0)
|
|---|
| 1174 | Percentage of patients aged 18 years and older with a
|
|---|
| 1175 | "DATA",1130580001.101,57,6,2,0)
|
|---|
| 1176 | diagnosis of diabetic retinopathy who had a dilated macular or fundus
|
|---|
| 1177 | "DATA",1130580001.101,57,6,3,0)
|
|---|
| 1178 | exam performed with documented communication to the physician who
|
|---|
| 1179 | "DATA",1130580001.101,57,6,4,0)
|
|---|
| 1180 | manages the ongoing care of the patient with diabetes mellitus
|
|---|
| 1181 | "DATA",1130580001.101,57,6,5,0)
|
|---|
| 1182 | regarding the findings of the macular or fundus exam at least once
|
|---|
| 1183 | "DATA",1130580001.101,57,6,6,0)
|
|---|
| 1184 | within 12 months.
|
|---|
| 1185 | "DATA",1130580001.101,57,7)
|
|---|
| 1186 | NQF0089
|
|---|
| 1187 | "DATA",1130580001.101,58,0)
|
|---|
| 1188 | MU EP NQF 0047
|
|---|
| 1189 | "DATA",1130580001.101,58,1)
|
|---|
| 1190 | Asthma Pharmacologic Therapy
|
|---|
| 1191 | "DATA",1130580001.101,58,5)
|
|---|
| 1192 | Asthma Pharmacologic Therapy
|
|---|
| 1193 | "DATA",1130580001.101,58,6,0)
|
|---|
| 1194 | ^1130580001.111^4^4^3110430^^
|
|---|
| 1195 | "DATA",1130580001.101,58,6,1,0)
|
|---|
| 1196 | Percentage of patients aged 5 through 40 years with a
|
|---|
| 1197 | "DATA",1130580001.101,58,6,2,0)
|
|---|
| 1198 | diagnosis of mild, moderate, or severe persistent asthma who were
|
|---|
| 1199 | "DATA",1130580001.101,58,6,3,0)
|
|---|
| 1200 | prescribed either the preferred long-term control medication (inhaled
|
|---|
| 1201 | "DATA",1130580001.101,58,6,4,0)
|
|---|
| 1202 | corticosteroid) or an acceptable alternative treatment
|
|---|
| 1203 | "DATA",1130580001.101,58,7)
|
|---|
| 1204 | NQF0047
|
|---|
| 1205 | "DATA",1130580001.101,59,0)
|
|---|
| 1206 | MU EP NQF 0001
|
|---|
| 1207 | "DATA",1130580001.101,59,1)
|
|---|
| 1208 | Asthma Assessment
|
|---|
| 1209 | "DATA",1130580001.101,59,5)
|
|---|
| 1210 | Asthma Assessment
|
|---|
| 1211 | "DATA",1130580001.101,59,6,0)
|
|---|
| 1212 | ^^5^5^3110430^
|
|---|
| 1213 | "DATA",1130580001.101,59,6,1,0)
|
|---|
| 1214 | Percentage of patients aged 5 through 40 years with a
|
|---|
| 1215 | "DATA",1130580001.101,59,6,2,0)
|
|---|
| 1216 | diagnosis of asthma and who have been seen for at least 2 office
|
|---|
| 1217 | "DATA",1130580001.101,59,6,3,0)
|
|---|
| 1218 | visits, who were evaluated during at least one office visit within 12
|
|---|
| 1219 | "DATA",1130580001.101,59,6,4,0)
|
|---|
| 1220 | months for the frequency (numeric) of daytime and nocturnal asthma
|
|---|
| 1221 | "DATA",1130580001.101,59,6,5,0)
|
|---|
| 1222 | symptoms.
|
|---|
| 1223 | "DATA",1130580001.101,59,7)
|
|---|
| 1224 | NQF0001
|
|---|
| 1225 | "DATA",1130580001.101,60,0)
|
|---|
| 1226 | MU EP NQF 0002
|
|---|
| 1227 | "DATA",1130580001.101,60,1)
|
|---|
| 1228 | Oncology Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/Progesterone Receptor (ER/PR) Positive Breat Cancer
|
|---|
| 1229 | "DATA",1130580001.101,60,5)
|
|---|
| 1230 | Oncology Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/Progesterone Receptor (ER/PR) Positive Breast Cancer
|
|---|
| 1231 | "DATA",1130580001.101,60,6,0)
|
|---|
| 1232 | ^^4^4^3110430^
|
|---|
| 1233 | "DATA",1130580001.101,60,6,1,0)
|
|---|
| 1234 | Percentage of female patients aged 18 years and older
|
|---|
| 1235 | "DATA",1130580001.101,60,6,2,0)
|
|---|
| 1236 | with Stage IC through IIIC, ER or PR positive breast cancer who were
|
|---|
| 1237 | "DATA",1130580001.101,60,6,3,0)
|
|---|
| 1238 | prescribed tamoxifen or aromatase inhibitor (AI) during the 12-month
|
|---|
| 1239 | "DATA",1130580001.101,60,6,4,0)
|
|---|
| 1240 | reporting period.
|
|---|
| 1241 | "DATA",1130580001.101,60,7)
|
|---|
| 1242 | NQF0002
|
|---|
| 1243 | "DATA",1130580001.101,61,0)
|
|---|
| 1244 | MU EP NQF 0385
|
|---|
| 1245 | "DATA",1130580001.101,61,1)
|
|---|
| 1246 | Oncology Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients
|
|---|
| 1247 | "DATA",1130580001.101,61,5)
|
|---|
| 1248 | Oncology Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients
|
|---|
| 1249 | "DATA",1130580001.101,61,6,0)
|
|---|
| 1250 | ^^4^4^3110430^
|
|---|
| 1251 | "DATA",1130580001.101,61,6,1,0)
|
|---|
| 1252 | Percentage of patients aged 18 years and older with
|
|---|
| 1253 | "DATA",1130580001.101,61,6,2,0)
|
|---|
| 1254 | Stage IIIA through IIIC colon cancer who are referred for adjuvant
|
|---|
| 1255 | "DATA",1130580001.101,61,6,3,0)
|
|---|
| 1256 | chemotherapy, prescribed adjuvant chemotherapy, or have previously
|
|---|
| 1257 | "DATA",1130580001.101,61,6,4,0)
|
|---|
| 1258 | received adjuvant chemotherapy within the 12-month reporting period
|
|---|
| 1259 | "DATA",1130580001.101,61,7)
|
|---|
| 1260 | NQF0385
|
|---|
| 1261 | "DATA",1130580001.101,62,0)
|
|---|
| 1262 | MU EP NQF 0389
|
|---|
| 1263 | "DATA",1130580001.101,62,1)
|
|---|
| 1264 | Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
|
|---|
| 1265 | "DATA",1130580001.101,62,5)
|
|---|
| 1266 | Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
|
|---|
| 1267 | "DATA",1130580001.101,62,6,0)
|
|---|
| 1268 | ^^5^5^3110430^
|
|---|
| 1269 | "DATA",1130580001.101,62,6,1,0)
|
|---|
| 1270 | Percentage of patients, regardless of age, with a diagnosis of
|
|---|
| 1271 | "DATA",1130580001.101,62,6,2,0)
|
|---|
| 1272 | prostate cancer at low risk of recurrence receiving interstitial prostate
|
|---|
| 1273 | "DATA",1130580001.101,62,6,3,0)
|
|---|
| 1274 | brachytherapy, OR external beam radiotherapy to the prostate, OR radical
|
|---|
| 1275 | "DATA",1130580001.101,62,6,4,0)
|
|---|
| 1276 | prostatectomy, OR cryotherapy who did not have a bone scan performed at
|
|---|
| 1277 | "DATA",1130580001.101,62,6,5,0)
|
|---|
| 1278 | any time since diagnosis of prostate cancer.
|
|---|
| 1279 | "DATA",1130580001.101,62,7)
|
|---|
| 1280 | NQF0389
|
|---|
| 1281 | "DATA",1130580001.101,63,0)
|
|---|
| 1282 | MU EP NQF 0027
|
|---|
| 1283 | "DATA",1130580001.101,63,1)
|
|---|
| 1284 | Smoking Smokers and Tobacco Users to Quit,b. Discussing Smoking and Tobacco use Cessation Medications, c. Discussing Smoking and Tobacco use Cessation Strategies and Tobacco Use Cessation, Medical assistance: a. Advising
|
|---|
| 1285 | "DATA",1130580001.101,63,5)
|
|---|
| 1286 | Smoking and Tobacco Use Cessation
|
|---|
| 1287 | "DATA",1130580001.101,63,6,0)
|
|---|
| 1288 | ^^5^5^3110430^
|
|---|
| 1289 | "DATA",1130580001.101,63,6,1,0)
|
|---|
| 1290 | Percentage of patients 18 years of age and older who were
|
|---|
| 1291 | "DATA",1130580001.101,63,6,2,0)
|
|---|
| 1292 | current smokers or tobacco users, who were seen by a practitioner during
|
|---|
| 1293 | "DATA",1130580001.101,63,6,3,0)
|
|---|
| 1294 | the measurement year and who received advice to quit smoking or tobacco
|
|---|
| 1295 | "DATA",1130580001.101,63,6,4,0)
|
|---|
| 1296 | use or whose practitioner recommended or discussed smoking or tobacco use
|
|---|
| 1297 | "DATA",1130580001.101,63,6,5,0)
|
|---|
| 1298 | cessation medications, methods or strategies
|
|---|
| 1299 | "DATA",1130580001.101,63,7)
|
|---|
| 1300 | NQF0027
|
|---|
| 1301 | "DATA",1130580001.101,64,0)
|
|---|
| 1302 | MU EP NQF 0055
|
|---|
| 1303 | "DATA",1130580001.101,64,1)
|
|---|
| 1304 | Diabetes: Eye Exam
|
|---|
| 1305 | "DATA",1130580001.101,64,5)
|
|---|
| 1306 | Diabetes: Eye Exam
|
|---|
| 1307 | "DATA",1130580001.101,64,6,0)
|
|---|
| 1308 | ^^3^3^3110430^
|
|---|
| 1309 | "DATA",1130580001.101,64,6,1,0)
|
|---|
| 1310 | Percentage of patients 18 -75 years of age with diabetes (type 1
|
|---|
| 1311 | "DATA",1130580001.101,64,6,2,0)
|
|---|
| 1312 | or type 2) who had a retinal or dilated eye exam or a negative retinal
|
|---|
| 1313 | "DATA",1130580001.101,64,6,3,0)
|
|---|
| 1314 | exam (no evidence of retinopathy) by an eye care professional
|
|---|
| 1315 | "DATA",1130580001.101,64,7)
|
|---|
| 1316 | NQF0055
|
|---|
| 1317 | "DATA",1130580001.101,65,0)
|
|---|
| 1318 | MU EP NQF 0062
|
|---|
| 1319 | "DATA",1130580001.101,65,1)
|
|---|
| 1320 | Diabetes: Urine Screening
|
|---|
| 1321 | "DATA",1130580001.101,65,5)
|
|---|
| 1322 | Diabetes: Urine Screening
|
|---|
| 1323 | "DATA",1130580001.101,65,6,0)
|
|---|
| 1324 | ^^3^3^3110430^
|
|---|
| 1325 | "DATA",1130580001.101,65,6,1,0)
|
|---|
| 1326 | Percentage of patients 18 - 75 years of age with diabetes (type 1
|
|---|
| 1327 | "DATA",1130580001.101,65,6,2,0)
|
|---|
| 1328 | or type 2) who had a nephropathy screening test or evidence of
|
|---|
| 1329 | "DATA",1130580001.101,65,6,3,0)
|
|---|
| 1330 | nephropathy.
|
|---|
| 1331 | "DATA",1130580001.101,65,7)
|
|---|
| 1332 | NQF0062
|
|---|
| 1333 | "DATA",1130580001.101,66,0)
|
|---|
| 1334 | MU EP NQF 0056
|
|---|
| 1335 | "DATA",1130580001.101,66,1)
|
|---|
| 1336 | Diabetes: Foot Exam
|
|---|
| 1337 | "DATA",1130580001.101,66,5)
|
|---|
| 1338 | Diabetes: Foot Exam
|
|---|
| 1339 | "DATA",1130580001.101,66,6,0)
|
|---|
| 1340 | ^^3^3^3110430^
|
|---|
| 1341 | "DATA",1130580001.101,66,6,1,0)
|
|---|
| 1342 | The percentage of patients aged 18 - 75 years with diabetes
|
|---|
| 1343 | "DATA",1130580001.101,66,6,2,0)
|
|---|
| 1344 | (type 1 or type 2) who had a foot exam (visual inspection, sensory exam
|
|---|
| 1345 | "DATA",1130580001.101,66,6,3,0)
|
|---|
| 1346 | with monofilament, or pulse exam).
|
|---|
| 1347 | "DATA",1130580001.101,66,7)
|
|---|
| 1348 | NQF0056
|
|---|
| 1349 | "DATA",1130580001.101,67,0)
|
|---|
| 1350 | MU EP NQF 0074
|
|---|
| 1351 | "DATA",1130580001.101,67,1)
|
|---|
| 1352 | Coronary Artery Disease (CAD): Drug Therapy for Lowering LDLCholesterol
|
|---|
| 1353 | "DATA",1130580001.101,67,5)
|
|---|
| 1354 | Coronary Artery Disease (CAD): Drug Therapy for Lowering LDLCholesterol
|
|---|
| 1355 | "DATA",1130580001.101,67,6,0)
|
|---|
| 1356 | ^^3^3^3110430^
|
|---|
| 1357 | "DATA",1130580001.101,67,6,1,0)
|
|---|
| 1358 | Percentage of patients aged 18 years and older with a
|
|---|
| 1359 | "DATA",1130580001.101,67,6,2,0)
|
|---|
| 1360 | diagnosis of CAD who were prescribed a lipid-lowering therapy (based
|
|---|
| 1361 | "DATA",1130580001.101,67,6,3,0)
|
|---|
| 1362 | on current ACC/AHA guidelines).
|
|---|
| 1363 | "DATA",1130580001.101,67,7)
|
|---|
| 1364 | NQF0074
|
|---|
| 1365 | "DATA",1130580001.101,68,0)
|
|---|
| 1366 | MU EP NQF 0084
|
|---|
| 1367 | "DATA",1130580001.101,68,1)
|
|---|
| 1368 | Heart Failure (HF): Warfarin Therapy Patients with Atrial Fibrillation
|
|---|
| 1369 | "DATA",1130580001.101,68,5)
|
|---|
| 1370 | Heart Failure (HF): Warfarin Therapy Patients with Atrial Fibrillation
|
|---|
| 1371 | "DATA",1130580001.101,68,6,0)
|
|---|
| 1372 | ^^3^3^3110430^
|
|---|
| 1373 | "DATA",1130580001.101,68,6,1,0)
|
|---|
| 1374 | Percentage of all patients aged 18 years and older with a
|
|---|
| 1375 | "DATA",1130580001.101,68,6,2,0)
|
|---|
| 1376 | diagnosis of heart failure and paroxysmal or chronic atrial fibrillation
|
|---|
| 1377 | "DATA",1130580001.101,68,6,3,0)
|
|---|
| 1378 | who were prescribed warfarin therapy.
|
|---|
| 1379 | "DATA",1130580001.101,68,7)
|
|---|
| 1380 | NQF0084
|
|---|
| 1381 | "DATA",1130580001.101,69,0)
|
|---|
| 1382 | MU EP NQF 0073
|
|---|
| 1383 | "DATA",1130580001.101,69,1)
|
|---|
| 1384 | Ischemic Vascular Disease (IVD): Blood Pressure Management
|
|---|
| 1385 | "DATA",1130580001.101,69,5)
|
|---|
| 1386 | Ischemic Vascular Disease (IVD): Blood Pressure Management
|
|---|
| 1387 | "DATA",1130580001.101,69,6,0)
|
|---|
| 1388 | ^^11^11^3110430^
|
|---|
| 1389 | "DATA",1130580001.101,69,6,1,0)
|
|---|
| 1390 | Percentage of patients 18 years of age and older who
|
|---|
| 1391 | "DATA",1130580001.101,69,6,2,0)
|
|---|
| 1392 | were discharged alive for acute myocardial infarction (AMI), coronary
|
|---|
| 1393 | "DATA",1130580001.101,69,6,3,0)
|
|---|
| 1394 | artery bypass graft (CABG) or percutaneous transluminal coronary
|
|---|
| 1395 | "DATA",1130580001.101,69,6,4,0)
|
|---|
| 1396 | Percentage of patients 18 years of age and older who
|
|---|
| 1397 | "DATA",1130580001.101,69,6,5,0)
|
|---|
| 1398 | were discharged alive for acute myocardial infarction (AMI), coronary
|
|---|
| 1399 | "DATA",1130580001.101,69,6,6,0)
|
|---|
| 1400 | artery bypass graft (CABG) or percutaneous transluminal coronary
|
|---|
| 1401 | "DATA",1130580001.101,69,6,7,0)
|
|---|
| 1402 | angioplasty (PTCA) from January 1- November 1 of the year prior to
|
|---|
| 1403 | "DATA",1130580001.101,69,6,8,0)
|
|---|
| 1404 | the measurement year, or who had a diagnosis of ischemic vascular
|
|---|
| 1405 | "DATA",1130580001.101,69,6,9,0)
|
|---|
| 1406 | disease (IVD) during the measurement year and the year prior to the
|
|---|
| 1407 | "DATA",1130580001.101,69,6,10,0)
|
|---|
| 1408 | measurement year and whose recent blood pressure is in control
|
|---|
| 1409 | "DATA",1130580001.101,69,6,11,0)
|
|---|
| 1410 | (<140/90 mmHg).
|
|---|
| 1411 | "DATA",1130580001.101,69,7)
|
|---|
| 1412 | NQF0073
|
|---|
| 1413 | "DATA",1130580001.101,70,0)
|
|---|
| 1414 | MU EP NQF 0068
|
|---|
| 1415 | "DATA",1130580001.101,70,1)
|
|---|
| 1416 | Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic
|
|---|
| 1417 | "DATA",1130580001.101,70,5)
|
|---|
| 1418 | Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic
|
|---|
| 1419 | "DATA",1130580001.101,70,6,0)
|
|---|
| 1420 | ^^8^8^3110430^
|
|---|
| 1421 | "DATA",1130580001.101,70,6,1,0)
|
|---|
| 1422 | Percentage of patients 18 years of age and older who were
|
|---|
| 1423 | "DATA",1130580001.101,70,6,2,0)
|
|---|
| 1424 | discharged alive for acute myocardial infarction (AMI), coronary artery
|
|---|
| 1425 | "DATA",1130580001.101,70,6,3,0)
|
|---|
| 1426 | bypass graft (CABG) or percutaneous transluminal coronary
|
|---|
| 1427 | "DATA",1130580001.101,70,6,4,0)
|
|---|
| 1428 | angioplasty (PTCA) from January 1-November 1 of the year prior to the
|
|---|
| 1429 | "DATA",1130580001.101,70,6,5,0)
|
|---|
| 1430 | measurement year, or who had a diagnosis of ischemic vascular
|
|---|
| 1431 | "DATA",1130580001.101,70,6,6,0)
|
|---|
| 1432 | disease (IVD) during the measurement year and the year prior to the
|
|---|
| 1433 | "DATA",1130580001.101,70,6,7,0)
|
|---|
| 1434 | measurement year and who had documentation of use of aspirin or
|
|---|
| 1435 | "DATA",1130580001.101,70,6,8,0)
|
|---|
| 1436 | another antithrombotic during the measurement year
|
|---|
| 1437 | "DATA",1130580001.101,70,7)
|
|---|
| 1438 | NQF0068
|
|---|
| 1439 | "DATA",1130580001.101,71,0)
|
|---|
| 1440 | MU EP NQF 0004
|
|---|
| 1441 | "DATA",1130580001.101,71,1)
|
|---|
| 1442 | Initiation and Engagement of Alcohol and Other Drug Dependence Treatment:(a)Initiation,(b)Engagement
|
|---|
| 1443 | "DATA",1130580001.101,71,5)
|
|---|
| 1444 | Initiation and Engagement of Alcohol and Other Drug Dependence Treatment:(a) Initiation,(b) Engagement
|
|---|
| 1445 | "DATA",1130580001.101,71,6,0)
|
|---|
| 1446 | ^^6^6^3110430^
|
|---|
| 1447 | "DATA",1130580001.101,71,6,1,0)
|
|---|
| 1448 | The percentage of adolescent and adult patients with a new
|
|---|
| 1449 | "DATA",1130580001.101,71,6,2,0)
|
|---|
| 1450 | episode of alcohol and other drug (AOD) dependence who initiate treatment
|
|---|
| 1451 | "DATA",1130580001.101,71,6,3,0)
|
|---|
| 1452 | through an inpatient AOD admission, outpatient visit, intensive
|
|---|
| 1453 | "DATA",1130580001.101,71,6,4,0)
|
|---|
| 1454 | outpatient encounter or partial hospitalization within 14 days of the
|
|---|
| 1455 | "DATA",1130580001.101,71,6,5,0)
|
|---|
| 1456 | diagnosis and who initiated treatment and who had two or more additional
|
|---|
| 1457 | "DATA",1130580001.101,71,6,6,0)
|
|---|
| 1458 | services with an AOD diagnosis within 30 days of the initiation visit.
|
|---|
| 1459 | "DATA",1130580001.101,71,7)
|
|---|
| 1460 | NQF0004
|
|---|
| 1461 | "DATA",1130580001.101,72,0)
|
|---|
| 1462 | MU EP NQF 0012
|
|---|
| 1463 | "DATA",1130580001.101,72,1)
|
|---|
| 1464 | Prenatal Care: Screening for Human Immunodeficiency Virus (HIV)
|
|---|
| 1465 | "DATA",1130580001.101,72,5)
|
|---|
| 1466 | Prenatal Care: Screening for Human Immunodeficiency Virus (HIV)
|
|---|
| 1467 | "DATA",1130580001.101,72,6,0)
|
|---|
| 1468 | ^^3^3^3110430^
|
|---|
| 1469 | "DATA",1130580001.101,72,6,1,0)
|
|---|
| 1470 | Percentage of patients, regardless of age, who gave birth during
|
|---|
| 1471 | "DATA",1130580001.101,72,6,2,0)
|
|---|
| 1472 | a 12-month period who were screened for HIV infection during the first or
|
|---|
| 1473 | "DATA",1130580001.101,72,6,3,0)
|
|---|
| 1474 | second prenatal care visit.
|
|---|
| 1475 | "DATA",1130580001.101,72,7)
|
|---|
| 1476 | NQF0012
|
|---|
| 1477 | "DATA",1130580001.101,73,0)
|
|---|
| 1478 | MU EP NQF 0014
|
|---|
| 1479 | "DATA",1130580001.101,73,1)
|
|---|
| 1480 | Prenatal Care: Anti-D Immune Globulin
|
|---|
| 1481 | "DATA",1130580001.101,73,5)
|
|---|
| 1482 | Prenatal Care: Anti-D Immune Globulin
|
|---|
| 1483 | "DATA",1130580001.101,73,6,0)
|
|---|
| 1484 | ^^3^3^3110430^
|
|---|
| 1485 | "DATA",1130580001.101,73,6,1,0)
|
|---|
| 1486 | Percentage of D (Rh) negative, unsensitized patients, regardless
|
|---|
| 1487 | "DATA",1130580001.101,73,6,2,0)
|
|---|
| 1488 | of age, who gave birth during a 12-month period who received anti-D
|
|---|
| 1489 | "DATA",1130580001.101,73,6,3,0)
|
|---|
| 1490 | immune globulin at 26-30 weeks gestation.
|
|---|
| 1491 | "DATA",1130580001.101,73,7)
|
|---|
| 1492 | NQD0014
|
|---|
| 1493 | "DATA",1130580001.101,74,0)
|
|---|
| 1494 | MU EP NQF 0018
|
|---|
| 1495 | "DATA",1130580001.101,74,1)
|
|---|
| 1496 | Controlling High Blood Pressure
|
|---|
| 1497 | "DATA",1130580001.101,74,5)
|
|---|
| 1498 | Controlling High Blood Pressure
|
|---|
| 1499 | "DATA",1130580001.101,74,6,0)
|
|---|
| 1500 | ^^3^3^3110430^
|
|---|
| 1501 | "DATA",1130580001.101,74,6,1,0)
|
|---|
| 1502 | The percentage of patients 18-85 years of age who had a
|
|---|
| 1503 | "DATA",1130580001.101,74,6,2,0)
|
|---|
| 1504 | diagnosis of hypertension and whose BP was adequately controlled during
|
|---|
| 1505 | "DATA",1130580001.101,74,6,3,0)
|
|---|
| 1506 | the measurement year
|
|---|
| 1507 | "DATA",1130580001.101,74,7)
|
|---|
| 1508 | NQF0018
|
|---|
| 1509 | "DATA",1130580001.101,75,0)
|
|---|
| 1510 | MU EP NQF 0032
|
|---|
| 1511 | "DATA",1130580001.101,75,1)
|
|---|
| 1512 | Cervical Cancer Screening
|
|---|
| 1513 | "DATA",1130580001.101,75,5)
|
|---|
| 1514 | Cervical Cancer Screening
|
|---|
| 1515 | "DATA",1130580001.101,75,6,0)
|
|---|
| 1516 | ^^2^2^3110430^
|
|---|
| 1517 | "DATA",1130580001.101,75,6,1,0)
|
|---|
| 1518 | Percentage of women 21-64 years of age, who received one or
|
|---|
| 1519 | "DATA",1130580001.101,75,6,2,0)
|
|---|
| 1520 | more Pap tests to screen for cervical cancer
|
|---|
| 1521 | "DATA",1130580001.101,75,7)
|
|---|
| 1522 | NQF0032
|
|---|
| 1523 | "DATA",1130580001.101,76,0)
|
|---|
| 1524 | MU EP NQF 0033
|
|---|
| 1525 | "DATA",1130580001.101,76,1)
|
|---|
| 1526 | Chlamydia Screening for Women
|
|---|
| 1527 | "DATA",1130580001.101,76,5)
|
|---|
| 1528 | Chlamydia Screening for Women
|
|---|
| 1529 | "DATA",1130580001.101,76,6,0)
|
|---|
| 1530 | ^^3^3^3110430^
|
|---|
| 1531 | "DATA",1130580001.101,76,6,1,0)
|
|---|
| 1532 | Percentage of women 15- 24 years of age who were identified as sexually
|
|---|
| 1533 | "DATA",1130580001.101,76,6,2,0)
|
|---|
| 1534 | active and who had at least one test for chlamydia during the measurement
|
|---|
| 1535 | "DATA",1130580001.101,76,6,3,0)
|
|---|
| 1536 | year.
|
|---|
| 1537 | "DATA",1130580001.101,76,7)
|
|---|
| 1538 | NQF0033
|
|---|
| 1539 | "DATA",1130580001.101,77,0)
|
|---|
| 1540 | MU EP NQF 0036
|
|---|
| 1541 | "DATA",1130580001.101,77,1)
|
|---|
| 1542 | Use of Appropriate Medications for Asthma
|
|---|
| 1543 | "DATA",1130580001.101,77,5)
|
|---|
| 1544 | Use of Appropriate Medications for Asthma
|
|---|
| 1545 | "DATA",1130580001.101,77,6,0)
|
|---|
| 1546 | ^^4^4^3110430^
|
|---|
| 1547 | "DATA",1130580001.101,77,6,1,0)
|
|---|
| 1548 | Percentage of patients 5 - 50 years of age who were identified as having
|
|---|
| 1549 | "DATA",1130580001.101,77,6,2,0)
|
|---|
| 1550 | persistent asthma and were appropriately prescribed medication during the
|
|---|
| 1551 | "DATA",1130580001.101,77,6,3,0)
|
|---|
| 1552 | measurement year. Report three age stratifications (5-11 years, 12-50
|
|---|
| 1553 | "DATA",1130580001.101,77,6,4,0)
|
|---|
| 1554 | years, and total).
|
|---|
| 1555 | "DATA",1130580001.101,77,7)
|
|---|
| 1556 | NQF0036
|
|---|
| 1557 | "DATA",1130580001.101,78,0)
|
|---|
| 1558 | MU EP NQF 0052
|
|---|
| 1559 | "DATA",1130580001.101,78,1)
|
|---|
| 1560 | Low Back Pain: Use of Imaging Studies
|
|---|
| 1561 | "DATA",1130580001.101,78,5)
|
|---|
| 1562 | Low Back Pain: Use of Imaging Studies
|
|---|
| 1563 | "DATA",1130580001.101,78,6,0)
|
|---|
| 1564 | ^1130580001.111^3^3^3110430^^
|
|---|
| 1565 | "DATA",1130580001.101,78,6,1,0)
|
|---|
| 1566 | Percentage of patients with a primary diagnosis of low back pain
|
|---|
| 1567 | "DATA",1130580001.101,78,6,2,0)
|
|---|
| 1568 | who did not have an imaging study (plain x-ray, MRI, CT scan) within 28
|
|---|
| 1569 | "DATA",1130580001.101,78,6,3,0)
|
|---|
| 1570 | days of diagnosis.
|
|---|
| 1571 | "DATA",1130580001.101,78,7)
|
|---|
| 1572 | NQF0052
|
|---|
| 1573 | "DATA",1130580001.101,79,0)
|
|---|
| 1574 | MU EP NQF 0075
|
|---|
| 1575 | "DATA",1130580001.101,79,1)
|
|---|
| 1576 | Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control
|
|---|
| 1577 | "DATA",1130580001.101,79,5)
|
|---|
| 1578 | Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control
|
|---|
| 1579 | "DATA",1130580001.101,79,6,0)
|
|---|
| 1580 | ^^7^7^3110430^
|
|---|
| 1581 | "DATA",1130580001.101,79,6,1,0)
|
|---|
| 1582 | Percentage of patients 18 years of age and older who were discharged alive
|
|---|
| 1583 | "DATA",1130580001.101,79,6,2,0)
|
|---|
| 1584 | for acute myocardial infarction (AMI), coronary artery bypass graft (CABG)
|
|---|
| 1585 | "DATA",1130580001.101,79,6,3,0)
|
|---|
| 1586 | or percutaneous transluminal angioplasty (PTCA) from January 1-November1
|
|---|
| 1587 | "DATA",1130580001.101,79,6,4,0)
|
|---|
| 1588 | of the year prior to the measurement year, or who had a diagnosis of
|
|---|
| 1589 | "DATA",1130580001.101,79,6,5,0)
|
|---|
| 1590 | ischemic vascular disease (IVD) during the measurement year and the year
|
|---|
| 1591 | "DATA",1130580001.101,79,6,6,0)
|
|---|
| 1592 | prior to the measurement year and who had a complete lipid profile
|
|---|
| 1593 | "DATA",1130580001.101,79,6,7,0)
|
|---|
| 1594 | performed during the measurement year and whose LDL-C<100 mg/dL
|
|---|
| 1595 | "DATA",1130580001.101,79,7)
|
|---|
| 1596 | NQF0075
|
|---|
| 1597 | "DATA",1130580001.101,80,0)
|
|---|
| 1598 | MU EP NQF 0575
|
|---|
| 1599 | "DATA",1130580001.101,80,1)
|
|---|
| 1600 | Diabetes: Hemoglobin A1c Control (<8.0%)
|
|---|
| 1601 | "DATA",1130580001.101,80,5)
|
|---|
| 1602 | Diabetes: Hemoglobin A1c Control (<8.0%)
|
|---|
| 1603 | "DATA",1130580001.101,80,6,0)
|
|---|
| 1604 | ^^2^2^3110430^
|
|---|
| 1605 | "DATA",1130580001.101,80,6,1,0)
|
|---|
| 1606 | The percentage of patients 18-75 years of age with diabetes
|
|---|
| 1607 | "DATA",1130580001.101,80,6,2,0)
|
|---|
| 1608 | (type 1 or type 2) who had hemoglobin A1c <8.0%
|
|---|
| 1609 | "DATA",1130580001.101,80,7)
|
|---|
| 1610 | NQF0575
|
|---|
| 1611 | "DATA",1130580001.101,81,0)
|
|---|
| 1612 | MU EP NQF 0028B
|
|---|
| 1613 | "DATA",1130580001.101,81,1)
|
|---|
| 1614 | NQF0028B Preventive Care and Screening Measure Pair: a. Tobacco Use Assessment,b. Tobacco Cessation Intervention
|
|---|
| 1615 | "DATA",1130580001.101,81,5)
|
|---|
| 1616 | NQF0028B Tobacco Use Assessment and Cessation Intervention
|
|---|
| 1617 | "DATA",1130580001.101,81,6,0)
|
|---|
| 1618 | ^1130580001.111^7^7^3110625^^^^
|
|---|
| 1619 | "DATA",1130580001.101,81,6,1,0)
|
|---|
| 1620 | Percentage of patients aged 18 years and
|
|---|
| 1621 | "DATA",1130580001.101,81,6,2,0)
|
|---|
| 1622 | older who have been seen for at least 2 office visits who
|
|---|
| 1623 | "DATA",1130580001.101,81,6,3,0)
|
|---|
| 1624 | were queried about tobacco use one or more times within
|
|---|
| 1625 | "DATA",1130580001.101,81,6,4,0)
|
|---|
| 1626 | 24 months b. Percentage of patients aged 18 years and
|
|---|
| 1627 | "DATA",1130580001.101,81,6,5,0)
|
|---|
| 1628 | older identified as tobacco users within the past 24
|
|---|
| 1629 | "DATA",1130580001.101,81,6,6,0)
|
|---|
| 1630 | months and have been seen for at least 2 office visits,
|
|---|
| 1631 | "DATA",1130580001.101,81,6,7,0)
|
|---|
| 1632 | who received cessation intervention.
|
|---|
| 1633 | "DATA",1130580001.101,81,7)
|
|---|
| 1634 | NQF0028B^^^^^^154^160
|
|---|
| 1635 | "DATA",1130580001.101,82,0)
|
|---|
| 1636 | MU EP NQF 0024 2-10Y
|
|---|
| 1637 | "DATA",1130580001.101,82,1)
|
|---|
| 1638 | NQF0024 Weight Assessment and Counseling for Children and Adolescents (2-10)
|
|---|
| 1639 | "DATA",1130580001.101,82,5)
|
|---|
| 1640 | Weight Assessment and Counseling for Children 2-10 Years Old
|
|---|
| 1641 | "DATA",1130580001.101,82,6,0)
|
|---|
| 1642 | ^^6^6^3120803^
|
|---|
| 1643 | "DATA",1130580001.101,82,6,1,0)
|
|---|
| 1644 | Percentage of patients 2-10 years of age
|
|---|
| 1645 | "DATA",1130580001.101,82,6,2,0)
|
|---|
| 1646 | who had an outpatient visit with a Primary Care Physician
|
|---|
| 1647 | "DATA",1130580001.101,82,6,3,0)
|
|---|
| 1648 | (PCP) or OB/GYN and who had evidence of BMI
|
|---|
| 1649 | "DATA",1130580001.101,82,6,4,0)
|
|---|
| 1650 | percentile documentation, counseling for nutrition and
|
|---|
| 1651 | "DATA",1130580001.101,82,6,5,0)
|
|---|
| 1652 | counseling for physical activity during the measurement
|
|---|
| 1653 | "DATA",1130580001.101,82,6,6,0)
|
|---|
| 1654 | year. Only for those 2-10 years of age.
|
|---|
| 1655 | "DATA",1130580001.101,82,7)
|
|---|
| 1656 | NQF0024 2-10Y^^^^^^334^338
|
|---|
| 1657 | "DATA",1130580001.101,83,0)
|
|---|
| 1658 | MU EP NQF 0038 NUM1 DPT
|
|---|
| 1659 | "DATA",1130580001.101,83,5)
|
|---|
| 1660 | NQF0038 NUM1 DPT
|
|---|
| 1661 | "DATA",1130580001.101,83,7)
|
|---|
| 1662 | NQF0038 NUM1 DPT^^^^^^329^192^11
|
|---|
| 1663 | "DATA",1130580001.101,84,0)
|
|---|
| 1664 | MU EP NQF 0038 NUM2 IPV
|
|---|
| 1665 | "DATA",1130580001.101,84,5)
|
|---|
| 1666 | NQF0038 NUM2 IPV
|
|---|
| 1667 | "DATA",1130580001.101,84,7)
|
|---|
| 1668 | NQF0038 NUM2 IPV^^^^^^224^192^11
|
|---|
| 1669 | "DATA",1130580001.101,85,0)
|
|---|
| 1670 | MU EP NQF 0038 NUM3 MMR
|
|---|
| 1671 | "DATA",1130580001.101,85,5)
|
|---|
| 1672 | NQF0038 NUM3 MMR
|
|---|
| 1673 | "DATA",1130580001.101,85,7)
|
|---|
| 1674 | NQF0038 NUM3 MMR^^^^^^183^192^11
|
|---|
| 1675 | "DATA",1130580001.101,86,0)
|
|---|
| 1676 | MU EP NQF 0038 NUM4 HiB
|
|---|
| 1677 | "DATA",1130580001.101,86,5)
|
|---|
| 1678 | NQF0038 NUM4 HiB
|
|---|
| 1679 | "DATA",1130580001.101,86,7)
|
|---|
| 1680 | NQF0038 NUM4 HiB^^^^^^189^192^11
|
|---|
| 1681 | "DATA",1130580001.101,87,0)
|
|---|
| 1682 | MU EP NQF 0038 NUM5 HEP B
|
|---|
| 1683 | "DATA",1130580001.101,87,5)
|
|---|
| 1684 | NQF0038 NUM5 HEP B
|
|---|
| 1685 | "DATA",1130580001.101,87,7)
|
|---|
| 1686 | NQF0038 NUM5 HEP B^^^^^^194^192^11
|
|---|
| 1687 | "DATA",1130580001.101,88,0)
|
|---|
| 1688 | MU EP NQF 0038 NUM6 VZV
|
|---|
| 1689 | "DATA",1130580001.101,88,5)
|
|---|
| 1690 | NQF0038 NUM6 VZV
|
|---|
| 1691 | "DATA",1130580001.101,88,7)
|
|---|
| 1692 | NQF0038 NUM6 VZV^^^^^^198^192^11
|
|---|
| 1693 | "DATA",1130580001.101,89,0)
|
|---|
| 1694 | MU EP NQF 0038 NUM7 PCV
|
|---|
| 1695 | "DATA",1130580001.101,89,5)
|
|---|
| 1696 | NQF0038 NUM7 PCV
|
|---|
| 1697 | "DATA",1130580001.101,89,7)
|
|---|
| 1698 | NQF0038 NUM7 PCV^^^^^^205^192^11
|
|---|
| 1699 | "DATA",1130580001.101,90,0)
|
|---|
| 1700 | MU EP NQF 0038 NUM8 HEP A
|
|---|
| 1701 | "DATA",1130580001.101,90,5)
|
|---|
| 1702 | NQF0038 NUM8 HEP A
|
|---|
| 1703 | "DATA",1130580001.101,90,7)
|
|---|
| 1704 | NQF0038 NUM8 HEP A^^^^^^208^192^11
|
|---|
| 1705 | "DATA",1130580001.101,91,0)
|
|---|
| 1706 | MU EP NQF 0038 NUM9 RV
|
|---|
| 1707 | "DATA",1130580001.101,91,5)
|
|---|
| 1708 | NQF0038 NUM9
|
|---|
| 1709 | "DATA",1130580001.101,91,7)
|
|---|
| 1710 | NQF0038 NUM9^^^^^^216^192^11
|
|---|
| 1711 | "DATA",1130580001.101,92,0)
|
|---|
| 1712 | MU EP NQF 0038 NUM10 FLU
|
|---|
| 1713 | "DATA",1130580001.101,92,5)
|
|---|
| 1714 | NQF0038 NUM10
|
|---|
| 1715 | "DATA",1130580001.101,92,7)
|
|---|
| 1716 | NQF0038 NUM10^^^^^^331^192^11
|
|---|
| 1717 | "DATA",1130580001.101,93,0)
|
|---|
| 1718 | MU EP NQF 0038 NUM11 COMBO5
|
|---|
| 1719 | "DATA",1130580001.101,93,5)
|
|---|
| 1720 | NQF0038 NUM11 COMBO5
|
|---|
| 1721 | "DATA",1130580001.101,93,7)
|
|---|
| 1722 | NQF0038 NUM11 COMBO5^^^^^^228^192^11
|
|---|
| 1723 | "DATA",1130580001.101,94,0)
|
|---|
| 1724 | MU EP NQF 0038 NUM12 COMBO6
|
|---|
| 1725 | "DATA",1130580001.101,94,5)
|
|---|
| 1726 | NQF0038 NUM12 COMBO6
|
|---|
| 1727 | "DATA",1130580001.101,94,7)
|
|---|
| 1728 | NQF0038 NUM12 COMBO6^^^^^^231^192^11
|
|---|
| 1729 | "DATA",1130580001.101,95,0)
|
|---|
| 1730 | MU 2011 INP ADV DIRECTIVES
|
|---|
| 1731 | "DATA",1130580001.101,95,5)
|
|---|
| 1732 | Advance Directives
|
|---|
| 1733 | "DATA",1130580001.101,96,0)
|
|---|
| 1734 | MU 2011 INP CPOE
|
|---|
| 1735 | "DATA",1130580001.101,96,5)
|
|---|
| 1736 | CPOE for Medications
|
|---|
| 1737 | "DATA",1130580001.101,97,0)
|
|---|
| 1738 | MU 2011 INP MED RECON
|
|---|
| 1739 | "DATA",1130580001.101,97,5)
|
|---|
| 1740 | Medication Reconcilliation
|
|---|
| 1741 | "DATA",1130580001.101,98,0)
|
|---|
| 1742 | MU 2011 INP PROBLEM LIST
|
|---|
| 1743 | "DATA",1130580001.101,98,5)
|
|---|
| 1744 | Problem List
|
|---|
| 1745 | "DATA",1130580001.101,99,0)
|
|---|
| 1746 | MU 2011 INP VITAL SIGNS
|
|---|
| 1747 | "DATA",1130580001.101,99,5)
|
|---|
| 1748 | Record Vital Signs
|
|---|
| 1749 | "DATA",1130580001.101,100,0)
|
|---|
| 1750 | MU 2011 INP SMOKING STATUS
|
|---|
| 1751 | "DATA",1130580001.101,100,5)
|
|---|
| 1752 | Smoking Status
|
|---|
| 1753 | "DATA",1130580001.101,101,0)
|
|---|
| 1754 | MU 2011 INP MED LIST
|
|---|
| 1755 | "DATA",1130580001.101,101,5)
|
|---|
| 1756 | Active Medication List
|
|---|
| 1757 | "DATA",1130580001.101,102,0)
|
|---|
| 1758 | MU 2011 INP ALLERGY LIST
|
|---|
| 1759 | "DATA",1130580001.101,102,5)
|
|---|
| 1760 | Medication Allergy List
|
|---|
| 1761 | "DATA",1130580001.101,103,0)
|
|---|
| 1762 | MU 2011 INP DEMOGRAPHICS
|
|---|
| 1763 | "DATA",1130580001.101,103,5)
|
|---|
| 1764 | Record Demographics
|
|---|
| 1765 | "DATA",1130580001.101,104,0)
|
|---|
| 1766 | MU EP NQF 0024 11-17Y
|
|---|
| 1767 | "DATA",1130580001.101,104,1)
|
|---|
| 1768 | NQF0024 Weight Assessment and Counseling for Children and Adolescents (11-17)
|
|---|
| 1769 | "DATA",1130580001.101,104,5)
|
|---|
| 1770 | Weight Assessment and Counseling for Children and Adolescents 11-17 years old
|
|---|
| 1771 | "DATA",1130580001.101,104,6,0)
|
|---|
| 1772 | ^^6^6^3120803^
|
|---|
| 1773 | "DATA",1130580001.101,104,6,1,0)
|
|---|
| 1774 | Percentage of patients 11-17 years of age
|
|---|
| 1775 | "DATA",1130580001.101,104,6,2,0)
|
|---|
| 1776 | who had an outpatient visit with a Primary Care Physician
|
|---|
| 1777 | "DATA",1130580001.101,104,6,3,0)
|
|---|
| 1778 | (PCP) or OB/GYN and who had evidence of BMI
|
|---|
| 1779 | "DATA",1130580001.101,104,6,4,0)
|
|---|
| 1780 | percentile documentation, counseling for nutrition and
|
|---|
| 1781 | "DATA",1130580001.101,104,6,5,0)
|
|---|
| 1782 | counseling for physical activity during the measurement
|
|---|
| 1783 | "DATA",1130580001.101,104,6,6,0)
|
|---|
| 1784 | year. Only for those 11-17 years old.
|
|---|
| 1785 | "DATA",1130580001.101,104,7)
|
|---|
| 1786 | NQF0024 11-17Y^^^^^^336^340
|
|---|
| 1787 | "FIA",1130580001.101)
|
|---|
| 1788 | C0Q QUALITY MEASURE
|
|---|
| 1789 | "FIA",1130580001.101,0)
|
|---|
| 1790 | ^C0Q(101,
|
|---|
| 1791 | "FIA",1130580001.101,0,0)
|
|---|
| 1792 | 1130580001.101I
|
|---|
| 1793 | "FIA",1130580001.101,0,1)
|
|---|
| 1794 | y^y^f^^y^^y^o^n
|
|---|
| 1795 | "FIA",1130580001.101,0,10)
|
|---|
| 1796 |
|
|---|
| 1797 | "FIA",1130580001.101,0,11)
|
|---|
| 1798 |
|
|---|
| 1799 | "FIA",1130580001.101,0,"RLRO")
|
|---|
| 1800 |
|
|---|
| 1801 | "FIA",1130580001.101,0,"VR")
|
|---|
| 1802 | 1.0^C0Q
|
|---|
| 1803 | "FIA",1130580001.101,1130580001.101)
|
|---|
| 1804 | 0
|
|---|
| 1805 | "FIA",1130580001.101,1130580001.111)
|
|---|
| 1806 | 0
|
|---|
| 1807 | "FRV1",1130580001.101,"104,7",7)
|
|---|
| 1808 | MU NQF0024 BMI PERCENTILE 11-17Y RS
|
|---|
| 1809 | "FRV1",1130580001.101,"104,7",7,"F")
|
|---|
| 1810 | ;PXRM(810.4,
|
|---|
| 1811 | "FRV1",1130580001.101,"104,7",8)
|
|---|
| 1812 | MU NQF0024 BMI 11-17Y DENOM RS
|
|---|
| 1813 | "FRV1",1130580001.101,"104,7",8,"F")
|
|---|
| 1814 | ;PXRM(810.4,
|
|---|
| 1815 | "FRV1",1130580001.101,"23,7",7)
|
|---|
| 1816 | MU ED-1 NUMER RS
|
|---|
| 1817 | "FRV1",1130580001.101,"23,7",7,"F")
|
|---|
| 1818 | ;PXRM(810.4,
|
|---|
| 1819 | "FRV1",1130580001.101,"23,7",8)
|
|---|
| 1820 | MU ED-1 DENOM RS
|
|---|
| 1821 | "FRV1",1130580001.101,"23,7",8,"F")
|
|---|
| 1822 | ;PXRM(810.4,
|
|---|
| 1823 | "FRV1",1130580001.101,"24,7",7)
|
|---|
| 1824 | MU ED-2 NUMER RS
|
|---|
| 1825 | "FRV1",1130580001.101,"24,7",7,"F")
|
|---|
| 1826 | ;PXRM(810.4,
|
|---|
| 1827 | "FRV1",1130580001.101,"24,7",8)
|
|---|
| 1828 | MU ED-2 DENOM RS
|
|---|
| 1829 | "FRV1",1130580001.101,"24,7",8,"F")
|
|---|
| 1830 | ;PXRM(810.4,
|
|---|
| 1831 | "FRV1",1130580001.101,"25,7",7)
|
|---|
| 1832 | MU STK-2 NUMER RS
|
|---|
| 1833 | "FRV1",1130580001.101,"25,7",7,"F")
|
|---|
| 1834 | ;PXRM(810.4,
|
|---|
| 1835 | "FRV1",1130580001.101,"25,7",8)
|
|---|
| 1836 | MU STK-2 DENOM RS
|
|---|
| 1837 | "FRV1",1130580001.101,"25,7",8,"F")
|
|---|
| 1838 | ;PXRM(810.4,
|
|---|
| 1839 | "FRV1",1130580001.101,"26,7",7)
|
|---|
| 1840 | MU STK-3 NUMER RS
|
|---|
| 1841 | "FRV1",1130580001.101,"26,7",7,"F")
|
|---|
| 1842 | ;PXRM(810.4,
|
|---|
| 1843 | "FRV1",1130580001.101,"26,7",8)
|
|---|
| 1844 | MU STK-3 DENOM RS
|
|---|
| 1845 | "FRV1",1130580001.101,"26,7",8,"F")
|
|---|
| 1846 | ;PXRM(810.4,
|
|---|
| 1847 | "FRV1",1130580001.101,"27,7",7)
|
|---|
| 1848 | MU STK-4 NUMER RS
|
|---|
| 1849 | "FRV1",1130580001.101,"27,7",7,"F")
|
|---|
| 1850 | ;PXRM(810.4,
|
|---|
| 1851 | "FRV1",1130580001.101,"27,7",8)
|
|---|
| 1852 | MU STK-4 DENOM RS
|
|---|
| 1853 | "FRV1",1130580001.101,"27,7",8,"F")
|
|---|
| 1854 | ;PXRM(810.4,
|
|---|
| 1855 | "FRV1",1130580001.101,"28,7",7)
|
|---|
| 1856 | MU STK-5 NUMER RS
|
|---|
| 1857 | "FRV1",1130580001.101,"28,7",7,"F")
|
|---|
| 1858 | ;PXRM(810.4,
|
|---|
| 1859 | "FRV1",1130580001.101,"28,7",8)
|
|---|
| 1860 | MU STK-5 DENOM RS
|
|---|
| 1861 | "FRV1",1130580001.101,"28,7",8,"F")
|
|---|
| 1862 | ;PXRM(810.4,
|
|---|
| 1863 | "FRV1",1130580001.101,"29,7",7)
|
|---|
| 1864 | MU STK-6 NUMER RS
|
|---|
| 1865 | "FRV1",1130580001.101,"29,7",7,"F")
|
|---|
| 1866 | ;PXRM(810.4,
|
|---|
| 1867 | "FRV1",1130580001.101,"29,7",8)
|
|---|
| 1868 | MU STK-6 DENOM RS
|
|---|
| 1869 | "FRV1",1130580001.101,"29,7",8,"F")
|
|---|
| 1870 | ;PXRM(810.4,
|
|---|
| 1871 | "FRV1",1130580001.101,"30,7",7)
|
|---|
| 1872 | MU STK-8 NUMER RS
|
|---|
| 1873 | "FRV1",1130580001.101,"30,7",7,"F")
|
|---|
| 1874 | ;PXRM(810.4,
|
|---|
| 1875 | "FRV1",1130580001.101,"30,7",8)
|
|---|
| 1876 | MU STK-8 DENOM RS
|
|---|
| 1877 | "FRV1",1130580001.101,"30,7",8,"F")
|
|---|
| 1878 | ;PXRM(810.4,
|
|---|
| 1879 | "FRV1",1130580001.101,"31,7",7)
|
|---|
| 1880 | MU STK-10 NUMER RS
|
|---|
| 1881 | "FRV1",1130580001.101,"31,7",7,"F")
|
|---|
| 1882 | ;PXRM(810.4,
|
|---|
| 1883 | "FRV1",1130580001.101,"31,7",8)
|
|---|
| 1884 | MU STK-10 DENOM RS
|
|---|
| 1885 | "FRV1",1130580001.101,"31,7",8,"F")
|
|---|
| 1886 | ;PXRM(810.4,
|
|---|
| 1887 | "FRV1",1130580001.101,"32,7",7)
|
|---|
| 1888 | MU VTE-1 NUMER RS
|
|---|
| 1889 | "FRV1",1130580001.101,"32,7",7,"F")
|
|---|
| 1890 | ;PXRM(810.4,
|
|---|
| 1891 | "FRV1",1130580001.101,"32,7",8)
|
|---|
| 1892 | MU VTE-1 DENOM RS
|
|---|
| 1893 | "FRV1",1130580001.101,"32,7",8,"F")
|
|---|
| 1894 | ;PXRM(810.4,
|
|---|
| 1895 | "FRV1",1130580001.101,"33,7",7)
|
|---|
| 1896 | MU VTE-2 NUMER RS
|
|---|
| 1897 | "FRV1",1130580001.101,"33,7",7,"F")
|
|---|
| 1898 | ;PXRM(810.4,
|
|---|
| 1899 | "FRV1",1130580001.101,"33,7",8)
|
|---|
| 1900 | MU VTE-2 DENOM RS
|
|---|
| 1901 | "FRV1",1130580001.101,"33,7",8,"F")
|
|---|
| 1902 | ;PXRM(810.4,
|
|---|
| 1903 | "FRV1",1130580001.101,"34,7",7)
|
|---|
| 1904 | MU VTE-3 NUMER RS
|
|---|
| 1905 | "FRV1",1130580001.101,"34,7",7,"F")
|
|---|
| 1906 | ;PXRM(810.4,
|
|---|
| 1907 | "FRV1",1130580001.101,"34,7",8)
|
|---|
| 1908 | MU VTE-3 DENOM RS
|
|---|
| 1909 | "FRV1",1130580001.101,"34,7",8,"F")
|
|---|
| 1910 | ;PXRM(810.4,
|
|---|
| 1911 | "FRV1",1130580001.101,"35,7",7)
|
|---|
| 1912 | MU VTE-4 NUMER RS
|
|---|
| 1913 | "FRV1",1130580001.101,"35,7",7,"F")
|
|---|
| 1914 | ;PXRM(810.4,
|
|---|
| 1915 | "FRV1",1130580001.101,"35,7",8)
|
|---|
| 1916 | MU VTE-4 DENOM RS
|
|---|
| 1917 | "FRV1",1130580001.101,"35,7",8,"F")
|
|---|
| 1918 | ;PXRM(810.4,
|
|---|
| 1919 | "FRV1",1130580001.101,"36,7",7)
|
|---|
| 1920 | MU VTE-5 NUMER RS
|
|---|
| 1921 | "FRV1",1130580001.101,"36,7",7,"F")
|
|---|
| 1922 | ;PXRM(810.4,
|
|---|
| 1923 | "FRV1",1130580001.101,"36,7",8)
|
|---|
| 1924 | MU VTE-5 DENOM RS
|
|---|
| 1925 | "FRV1",1130580001.101,"36,7",8,"F")
|
|---|
| 1926 | ;PXRM(810.4,
|
|---|
| 1927 | "FRV1",1130580001.101,"37,7",7)
|
|---|
| 1928 | MU VTE-6 NUMER RS
|
|---|
| 1929 | "FRV1",1130580001.101,"37,7",7,"F")
|
|---|
| 1930 | ;PXRM(810.4,
|
|---|
| 1931 | "FRV1",1130580001.101,"37,7",8)
|
|---|
| 1932 | MU VTE-6 DENOM RS
|
|---|
| 1933 | "FRV1",1130580001.101,"37,7",8,"F")
|
|---|
| 1934 | ;PXRM(810.4,
|
|---|
| 1935 | "FRV1",1130580001.101,"39,7",7)
|
|---|
| 1936 | MU NQF0421 BMI NUM ALL RS
|
|---|
| 1937 | "FRV1",1130580001.101,"39,7",7,"F")
|
|---|
| 1938 | ;PXRM(810.4,
|
|---|
| 1939 | "FRV1",1130580001.101,"39,7",8)
|
|---|
| 1940 | MU NQF0421 BMI DENOM ALL RS
|
|---|
| 1941 | "FRV1",1130580001.101,"39,7",8,"F")
|
|---|
| 1942 | ;PXRM(810.4,
|
|---|
| 1943 | "FRV1",1130580001.101,"39,7",9)
|
|---|
| 1944 | MU NQF0421 ADULT BMI
|
|---|
| 1945 | "FRV1",1130580001.101,"39,7",9,"F")
|
|---|
| 1946 | ;PXRM(810.2,
|
|---|
| 1947 | "FRV1",1130580001.101,"40,7",7)
|
|---|
| 1948 | MU NQF0013 HTN NUMER2 RS
|
|---|
| 1949 | "FRV1",1130580001.101,"40,7",7,"F")
|
|---|
| 1950 | ;PXRM(810.4,
|
|---|
| 1951 | "FRV1",1130580001.101,"40,7",8)
|
|---|
| 1952 | MU NQF0013 HTN DENOM2 RS
|
|---|
| 1953 | "FRV1",1130580001.101,"40,7",8,"F")
|
|---|
| 1954 | ;PXRM(810.4,
|
|---|
| 1955 | "FRV1",1130580001.101,"41,7",7)
|
|---|
| 1956 | MU NQF0028A TOBACCO SCREEN NUM RS
|
|---|
| 1957 | "FRV1",1130580001.101,"41,7",7,"F")
|
|---|
| 1958 | ;PXRM(810.4,
|
|---|
| 1959 | "FRV1",1130580001.101,"41,7",8)
|
|---|
| 1960 | MU NQF0028B TOBACCO INTERV DENOM RS
|
|---|
| 1961 | "FRV1",1130580001.101,"41,7",8,"F")
|
|---|
| 1962 | ;PXRM(810.4,
|
|---|
| 1963 | "FRV1",1130580001.101,"42,7",7)
|
|---|
| 1964 | MU NQF0041 FLU RS
|
|---|
| 1965 | "FRV1",1130580001.101,"42,7",7,"F")
|
|---|
| 1966 | ;PXRM(810.4,
|
|---|
| 1967 | "FRV1",1130580001.101,"42,7",8)
|
|---|
| 1968 | MU NQF0041 FLU DENOM RS
|
|---|
| 1969 | "FRV1",1130580001.101,"42,7",8,"F")
|
|---|
| 1970 | ;PXRM(810.4,
|
|---|
| 1971 | "FRV1",1130580001.101,"43,7",7)
|
|---|
| 1972 | MU NQF0024 BMI 2-17YR NUM RS
|
|---|
| 1973 | "FRV1",1130580001.101,"43,7",7,"F")
|
|---|
| 1974 | ;PXRM(810.4,
|
|---|
| 1975 | "FRV1",1130580001.101,"43,7",8)
|
|---|
| 1976 | MU NQF0024 BMI 2-17YRS DEM RS
|
|---|
| 1977 | "FRV1",1130580001.101,"43,7",8,"F")
|
|---|
| 1978 | ;PXRM(810.4,
|
|---|
| 1979 | "FRV1",1130580001.101,"45,7",7)
|
|---|
| 1980 | MU NQF0059 HBA1C NUM RS
|
|---|
| 1981 | "FRV1",1130580001.101,"45,7",7,"F")
|
|---|
| 1982 | ;PXRM(810.4,
|
|---|
| 1983 | "FRV1",1130580001.101,"45,7",8)
|
|---|
| 1984 | MU NQF0059 DM DENOM-ALL RS
|
|---|
| 1985 | "FRV1",1130580001.101,"45,7",8,"F")
|
|---|
| 1986 | ;PXRM(810.4,
|
|---|
| 1987 | "FRV1",1130580001.101,"46,7",7)
|
|---|
| 1988 | MU NQF0064 NUM LDL RS
|
|---|
| 1989 | "FRV1",1130580001.101,"46,7",7,"F")
|
|---|
| 1990 | ;PXRM(810.4,
|
|---|
| 1991 | "FRV1",1130580001.101,"46,7",8)
|
|---|
| 1992 | MU NQF0059 DM DENOM-ALL RS
|
|---|
| 1993 | "FRV1",1130580001.101,"46,7",8,"F")
|
|---|
| 1994 | ;PXRM(810.4,
|
|---|
| 1995 | "FRV1",1130580001.101,"47,7",7)
|
|---|
| 1996 | MU NQF0061 NUM DM BP<140/90 RS
|
|---|
| 1997 | "FRV1",1130580001.101,"47,7",7,"F")
|
|---|
| 1998 | ;PXRM(810.4,
|
|---|
| 1999 | "FRV1",1130580001.101,"47,7",8)
|
|---|
| 2000 | MU NQF0059 DM DENOM-ALL RS
|
|---|
| 2001 | "FRV1",1130580001.101,"47,7",8,"F")
|
|---|
| 2002 | ;PXRM(810.4,
|
|---|
| 2003 | "FRV1",1130580001.101,"81,7",7)
|
|---|
| 2004 | MU NQF0028B TOBACCO INTERV NUM2 RS
|
|---|
| 2005 | "FRV1",1130580001.101,"81,7",7,"F")
|
|---|
| 2006 | ;PXRM(810.4,
|
|---|
| 2007 | "FRV1",1130580001.101,"81,7",8)
|
|---|
| 2008 | MU NQF0028B TOBACCO INTERV DENOM RS
|
|---|
| 2009 | "FRV1",1130580001.101,"81,7",8,"F")
|
|---|
| 2010 | ;PXRM(810.4,
|
|---|
| 2011 | "FRV1",1130580001.101,"82,7",7)
|
|---|
| 2012 | MU NQF0024 BMI PERCENTILE 2-10Y RS
|
|---|
| 2013 | "FRV1",1130580001.101,"82,7",7,"F")
|
|---|
| 2014 | ;PXRM(810.4,
|
|---|
| 2015 | "FRV1",1130580001.101,"82,7",8)
|
|---|
| 2016 | MU NQF0024 BMI 2-10Y DENOM RS
|
|---|
| 2017 | "FRV1",1130580001.101,"82,7",8,"F")
|
|---|
| 2018 | ;PXRM(810.4,
|
|---|
| 2019 | "FRV1",1130580001.101,"83,7",7)
|
|---|
| 2020 | MU NQF0038 NUM1 DPT RS
|
|---|
| 2021 | "FRV1",1130580001.101,"83,7",7,"F")
|
|---|
| 2022 | ;PXRM(810.4,
|
|---|
| 2023 | "FRV1",1130580001.101,"83,7",8)
|
|---|
| 2024 | MU NQF0038 DENOM RS
|
|---|
| 2025 | "FRV1",1130580001.101,"83,7",8,"F")
|
|---|
| 2026 | ;PXRM(810.4,
|
|---|
| 2027 | "FRV1",1130580001.101,"83,7",9)
|
|---|
| 2028 | MU NQF0038 CHILDREN'S IMMUNIZATIONS
|
|---|
| 2029 | "FRV1",1130580001.101,"83,7",9,"F")
|
|---|
| 2030 | ;PXRM(810.2,
|
|---|
| 2031 | "FRV1",1130580001.101,"84,7",7)
|
|---|
| 2032 | MU NQF0038 NUM2 IPV RS
|
|---|
| 2033 | "FRV1",1130580001.101,"84,7",7,"F")
|
|---|
| 2034 | ;PXRM(810.4,
|
|---|
| 2035 | "FRV1",1130580001.101,"84,7",8)
|
|---|
| 2036 | MU NQF0038 DENOM RS
|
|---|
| 2037 | "FRV1",1130580001.101,"84,7",8,"F")
|
|---|
| 2038 | ;PXRM(810.4,
|
|---|
| 2039 | "FRV1",1130580001.101,"84,7",9)
|
|---|
| 2040 | MU NQF0038 CHILDREN'S IMMUNIZATIONS
|
|---|
| 2041 | "FRV1",1130580001.101,"84,7",9,"F")
|
|---|
| 2042 | ;PXRM(810.2,
|
|---|
| 2043 | "FRV1",1130580001.101,"85,7",7)
|
|---|
| 2044 | MU NQF0038 NUM3-ALL RS
|
|---|
| 2045 | "FRV1",1130580001.101,"85,7",7,"F")
|
|---|
| 2046 | ;PXRM(810.4,
|
|---|
| 2047 | "FRV1",1130580001.101,"85,7",8)
|
|---|
| 2048 | MU NQF0038 DENOM RS
|
|---|
| 2049 | "FRV1",1130580001.101,"85,7",8,"F")
|
|---|
| 2050 | ;PXRM(810.4,
|
|---|
| 2051 | "FRV1",1130580001.101,"85,7",9)
|
|---|
| 2052 | MU NQF0038 CHILDREN'S IMMUNIZATIONS
|
|---|
| 2053 | "FRV1",1130580001.101,"85,7",9,"F")
|
|---|
| 2054 | ;PXRM(810.2,
|
|---|
| 2055 | "FRV1",1130580001.101,"86,7",7)
|
|---|
| 2056 | MU NQF0038 NUM4 HIB RS
|
|---|
| 2057 | "FRV1",1130580001.101,"86,7",7,"F")
|
|---|
| 2058 | ;PXRM(810.4,
|
|---|
| 2059 | "FRV1",1130580001.101,"86,7",8)
|
|---|
| 2060 | MU NQF0038 DENOM RS
|
|---|
| 2061 | "FRV1",1130580001.101,"86,7",8,"F")
|
|---|
| 2062 | ;PXRM(810.4,
|
|---|
| 2063 | "FRV1",1130580001.101,"86,7",9)
|
|---|
| 2064 | MU NQF0038 CHILDREN'S IMMUNIZATIONS
|
|---|
| 2065 | "FRV1",1130580001.101,"86,7",9,"F")
|
|---|
| 2066 | ;PXRM(810.2,
|
|---|
| 2067 | "FRV1",1130580001.101,"87,7",7)
|
|---|
| 2068 | MU NQF0038 NUM5 RS
|
|---|
| 2069 | "FRV1",1130580001.101,"87,7",7,"F")
|
|---|
| 2070 | ;PXRM(810.4,
|
|---|
| 2071 | "FRV1",1130580001.101,"87,7",8)
|
|---|
| 2072 | MU NQF0038 DENOM RS
|
|---|
| 2073 | "FRV1",1130580001.101,"87,7",8,"F")
|
|---|
| 2074 | ;PXRM(810.4,
|
|---|
| 2075 | "FRV1",1130580001.101,"87,7",9)
|
|---|
| 2076 | MU NQF0038 CHILDREN'S IMMUNIZATIONS
|
|---|
| 2077 | "FRV1",1130580001.101,"87,7",9,"F")
|
|---|
| 2078 | ;PXRM(810.2,
|
|---|
| 2079 | "FRV1",1130580001.101,"88,7",7)
|
|---|
| 2080 | MU NQF0038 NUM6 VZV RS
|
|---|
| 2081 | "FRV1",1130580001.101,"88,7",7,"F")
|
|---|
| 2082 | ;PXRM(810.4,
|
|---|
| 2083 | "FRV1",1130580001.101,"88,7",8)
|
|---|
| 2084 | MU NQF0038 DENOM RS
|
|---|
| 2085 | "FRV1",1130580001.101,"88,7",8,"F")
|
|---|
| 2086 | ;PXRM(810.4,
|
|---|
| 2087 | "FRV1",1130580001.101,"88,7",9)
|
|---|
| 2088 | MU NQF0038 CHILDREN'S IMMUNIZATIONS
|
|---|
| 2089 | "FRV1",1130580001.101,"88,7",9,"F")
|
|---|
| 2090 | ;PXRM(810.2,
|
|---|
| 2091 | "FRV1",1130580001.101,"89,7",7)
|
|---|
| 2092 | MU NQF0038 NUM7 PCV RS
|
|---|
| 2093 | "FRV1",1130580001.101,"89,7",7,"F")
|
|---|
| 2094 | ;PXRM(810.4,
|
|---|
| 2095 | "FRV1",1130580001.101,"89,7",8)
|
|---|
| 2096 | MU NQF0038 DENOM RS
|
|---|
| 2097 | "FRV1",1130580001.101,"89,7",8,"F")
|
|---|
| 2098 | ;PXRM(810.4,
|
|---|
| 2099 | "FRV1",1130580001.101,"89,7",9)
|
|---|
| 2100 | MU NQF0038 CHILDREN'S IMMUNIZATIONS
|
|---|
| 2101 | "FRV1",1130580001.101,"89,7",9,"F")
|
|---|
| 2102 | ;PXRM(810.2,
|
|---|
| 2103 | "FRV1",1130580001.101,"90,7",7)
|
|---|
| 2104 | MU NQF0038 NUM8 HEP A RS
|
|---|
| 2105 | "FRV1",1130580001.101,"90,7",7,"F")
|
|---|
| 2106 | ;PXRM(810.4,
|
|---|
| 2107 | "FRV1",1130580001.101,"90,7",8)
|
|---|
| 2108 | MU NQF0038 DENOM RS
|
|---|
| 2109 | "FRV1",1130580001.101,"90,7",8,"F")
|
|---|
| 2110 | ;PXRM(810.4,
|
|---|
| 2111 | "FRV1",1130580001.101,"90,7",9)
|
|---|
| 2112 | MU NQF0038 CHILDREN'S IMMUNIZATIONS
|
|---|
| 2113 | "FRV1",1130580001.101,"90,7",9,"F")
|
|---|
| 2114 | ;PXRM(810.2,
|
|---|
| 2115 | "FRV1",1130580001.101,"91,7",7)
|
|---|
| 2116 | MU NQF0038 NUM9 RV RS
|
|---|
| 2117 | "FRV1",1130580001.101,"91,7",7,"F")
|
|---|
| 2118 | ;PXRM(810.4,
|
|---|
| 2119 | "FRV1",1130580001.101,"91,7",8)
|
|---|
| 2120 | MU NQF0038 DENOM RS
|
|---|
| 2121 | "FRV1",1130580001.101,"91,7",8,"F")
|
|---|
| 2122 | ;PXRM(810.4,
|
|---|
| 2123 | "FRV1",1130580001.101,"91,7",9)
|
|---|
| 2124 | MU NQF0038 CHILDREN'S IMMUNIZATIONS
|
|---|
| 2125 | "FRV1",1130580001.101,"91,7",9,"F")
|
|---|
| 2126 | ;PXRM(810.2,
|
|---|
| 2127 | "FRV1",1130580001.101,"92,7",7)
|
|---|
| 2128 | MU NQF0038 NUM10 INFLUENZA RS
|
|---|
| 2129 | "FRV1",1130580001.101,"92,7",7,"F")
|
|---|
| 2130 | ;PXRM(810.4,
|
|---|
| 2131 | "FRV1",1130580001.101,"92,7",8)
|
|---|
| 2132 | MU NQF0038 DENOM RS
|
|---|
| 2133 | "FRV1",1130580001.101,"92,7",8,"F")
|
|---|
| 2134 | ;PXRM(810.4,
|
|---|
| 2135 | "FRV1",1130580001.101,"92,7",9)
|
|---|
| 2136 | MU NQF0038 CHILDREN'S IMMUNIZATIONS
|
|---|
| 2137 | "FRV1",1130580001.101,"92,7",9,"F")
|
|---|
| 2138 | ;PXRM(810.2,
|
|---|
| 2139 | "FRV1",1130580001.101,"93,7",7)
|
|---|
| 2140 | MU NQF0038 NUM11 COMBO5 RS
|
|---|
| 2141 | "FRV1",1130580001.101,"93,7",7,"F")
|
|---|
| 2142 | ;PXRM(810.4,
|
|---|
| 2143 | "FRV1",1130580001.101,"93,7",8)
|
|---|
| 2144 | MU NQF0038 DENOM RS
|
|---|
| 2145 | "FRV1",1130580001.101,"93,7",8,"F")
|
|---|
| 2146 | ;PXRM(810.4,
|
|---|
| 2147 | "FRV1",1130580001.101,"93,7",9)
|
|---|
| 2148 | MU NQF0038 CHILDREN'S IMMUNIZATIONS
|
|---|
| 2149 | "FRV1",1130580001.101,"93,7",9,"F")
|
|---|
| 2150 | ;PXRM(810.2,
|
|---|
| 2151 | "FRV1",1130580001.101,"94,7",7)
|
|---|
| 2152 | MU NQF0038 NUM12 COMBO6 RS
|
|---|
| 2153 | "FRV1",1130580001.101,"94,7",7,"F")
|
|---|
| 2154 | ;PXRM(810.4,
|
|---|
| 2155 | "FRV1",1130580001.101,"94,7",8)
|
|---|
| 2156 | MU NQF0038 DENOM RS
|
|---|
| 2157 | "FRV1",1130580001.101,"94,7",8,"F")
|
|---|
| 2158 | ;PXRM(810.4,
|
|---|
| 2159 | "FRV1",1130580001.101,"94,7",9)
|
|---|
| 2160 | MU NQF0038 CHILDREN'S IMMUNIZATIONS
|
|---|
| 2161 | "FRV1",1130580001.101,"94,7",9,"F")
|
|---|
| 2162 | ;PXRM(810.2,
|
|---|
| 2163 | "FRV1K",1130580001.101,"104,7",7)
|
|---|
| 2164 | B
|
|---|
| 2165 | "FRV1K",1130580001.101,"104,7",7,1)
|
|---|
| 2166 | MU NQF0024 BMI PERCENTILE 11-17Y RS
|
|---|
| 2167 | "FRV1K",1130580001.101,"104,7",8)
|
|---|
| 2168 | B
|
|---|
| 2169 | "FRV1K",1130580001.101,"104,7",8,1)
|
|---|
| 2170 | MU NQF0024 BMI 11-17Y DENOM RS
|
|---|
| 2171 | "FRV1K",1130580001.101,"23,7",7)
|
|---|
| 2172 | B
|
|---|
| 2173 | "FRV1K",1130580001.101,"23,7",7,1)
|
|---|
| 2174 | MU ED-1 NUMER RS
|
|---|
| 2175 | "FRV1K",1130580001.101,"23,7",8)
|
|---|
| 2176 | B
|
|---|
| 2177 | "FRV1K",1130580001.101,"23,7",8,1)
|
|---|
| 2178 | MU ED-1 DENOM RS
|
|---|
| 2179 | "FRV1K",1130580001.101,"24,7",7)
|
|---|
| 2180 | B
|
|---|
| 2181 | "FRV1K",1130580001.101,"24,7",7,1)
|
|---|
| 2182 | MU ED-2 NUMER RS
|
|---|
| 2183 | "FRV1K",1130580001.101,"24,7",8)
|
|---|
| 2184 | B
|
|---|
| 2185 | "FRV1K",1130580001.101,"24,7",8,1)
|
|---|
| 2186 | MU ED-2 DENOM RS
|
|---|
| 2187 | "FRV1K",1130580001.101,"25,7",7)
|
|---|
| 2188 | B
|
|---|
| 2189 | "FRV1K",1130580001.101,"25,7",7,1)
|
|---|
| 2190 | MU STK-2 NUMER RS
|
|---|
| 2191 | "FRV1K",1130580001.101,"25,7",8)
|
|---|
| 2192 | B
|
|---|
| 2193 | "FRV1K",1130580001.101,"25,7",8,1)
|
|---|
| 2194 | MU STK-2 DENOM RS
|
|---|
| 2195 | "FRV1K",1130580001.101,"26,7",7)
|
|---|
| 2196 | B
|
|---|
| 2197 | "FRV1K",1130580001.101,"26,7",7,1)
|
|---|
| 2198 | MU STK-3 NUMER RS
|
|---|
| 2199 | "FRV1K",1130580001.101,"26,7",8)
|
|---|
| 2200 | B
|
|---|
| 2201 | "FRV1K",1130580001.101,"26,7",8,1)
|
|---|
| 2202 | MU STK-3 DENOM RS
|
|---|
| 2203 | "FRV1K",1130580001.101,"27,7",7)
|
|---|
| 2204 | B
|
|---|
| 2205 | "FRV1K",1130580001.101,"27,7",7,1)
|
|---|
| 2206 | MU STK-4 NUMER RS
|
|---|
| 2207 | "FRV1K",1130580001.101,"27,7",8)
|
|---|
| 2208 | B
|
|---|
| 2209 | "FRV1K",1130580001.101,"27,7",8,1)
|
|---|
| 2210 | MU STK-4 DENOM RS
|
|---|
| 2211 | "FRV1K",1130580001.101,"28,7",7)
|
|---|
| 2212 | B
|
|---|
| 2213 | "FRV1K",1130580001.101,"28,7",7,1)
|
|---|
| 2214 | MU STK-5 NUMER RS
|
|---|
| 2215 | "FRV1K",1130580001.101,"28,7",8)
|
|---|
| 2216 | B
|
|---|
| 2217 | "FRV1K",1130580001.101,"28,7",8,1)
|
|---|
| 2218 | MU STK-5 DENOM RS
|
|---|
| 2219 | "FRV1K",1130580001.101,"29,7",7)
|
|---|
| 2220 | B
|
|---|
| 2221 | "FRV1K",1130580001.101,"29,7",7,1)
|
|---|
| 2222 | MU STK-6 NUMER RS
|
|---|
| 2223 | "FRV1K",1130580001.101,"29,7",8)
|
|---|
| 2224 | B
|
|---|
| 2225 | "FRV1K",1130580001.101,"29,7",8,1)
|
|---|
| 2226 | MU STK-6 DENOM RS
|
|---|
| 2227 | "FRV1K",1130580001.101,"30,7",7)
|
|---|
| 2228 | B
|
|---|
| 2229 | "FRV1K",1130580001.101,"30,7",7,1)
|
|---|
| 2230 | MU STK-8 NUMER RS
|
|---|
| 2231 | "FRV1K",1130580001.101,"30,7",8)
|
|---|
| 2232 | B
|
|---|
| 2233 | "FRV1K",1130580001.101,"30,7",8,1)
|
|---|
| 2234 | MU STK-8 DENOM RS
|
|---|
| 2235 | "FRV1K",1130580001.101,"31,7",7)
|
|---|
| 2236 | B
|
|---|
| 2237 | "FRV1K",1130580001.101,"31,7",7,1)
|
|---|
| 2238 | MU STK-10 NUMER RS
|
|---|
| 2239 | "FRV1K",1130580001.101,"31,7",8)
|
|---|
| 2240 | B
|
|---|
| 2241 | "FRV1K",1130580001.101,"31,7",8,1)
|
|---|
| 2242 | MU STK-10 DENOM RS
|
|---|
| 2243 | "FRV1K",1130580001.101,"32,7",7)
|
|---|
| 2244 | B
|
|---|
| 2245 | "FRV1K",1130580001.101,"32,7",7,1)
|
|---|
| 2246 | MU VTE-1 NUMER RS
|
|---|
| 2247 | "FRV1K",1130580001.101,"32,7",8)
|
|---|
| 2248 | B
|
|---|
| 2249 | "FRV1K",1130580001.101,"32,7",8,1)
|
|---|
| 2250 | MU VTE-1 DENOM RS
|
|---|
| 2251 | "FRV1K",1130580001.101,"33,7",7)
|
|---|
| 2252 | B
|
|---|
| 2253 | "FRV1K",1130580001.101,"33,7",7,1)
|
|---|
| 2254 | MU VTE-2 NUMER RS
|
|---|
| 2255 | "FRV1K",1130580001.101,"33,7",8)
|
|---|
| 2256 | B
|
|---|
| 2257 | "FRV1K",1130580001.101,"33,7",8,1)
|
|---|
| 2258 | MU VTE-2 DENOM RS
|
|---|
| 2259 | "FRV1K",1130580001.101,"34,7",7)
|
|---|
| 2260 | B
|
|---|
| 2261 | "FRV1K",1130580001.101,"34,7",7,1)
|
|---|
| 2262 | MU VTE-3 NUMER RS
|
|---|
| 2263 | "FRV1K",1130580001.101,"34,7",8)
|
|---|
| 2264 | B
|
|---|
| 2265 | "FRV1K",1130580001.101,"34,7",8,1)
|
|---|
| 2266 | MU VTE-3 DENOM RS
|
|---|
| 2267 | "FRV1K",1130580001.101,"35,7",7)
|
|---|
| 2268 | B
|
|---|
| 2269 | "FRV1K",1130580001.101,"35,7",7,1)
|
|---|
| 2270 | MU VTE-4 NUMER RS
|
|---|
| 2271 | "FRV1K",1130580001.101,"35,7",8)
|
|---|
| 2272 | B
|
|---|
| 2273 | "FRV1K",1130580001.101,"35,7",8,1)
|
|---|
| 2274 | MU VTE-4 DENOM RS
|
|---|
| 2275 | "FRV1K",1130580001.101,"36,7",7)
|
|---|
| 2276 | B
|
|---|
| 2277 | "FRV1K",1130580001.101,"36,7",7,1)
|
|---|
| 2278 | MU VTE-5 NUMER RS
|
|---|
| 2279 | "FRV1K",1130580001.101,"36,7",8)
|
|---|
| 2280 | B
|
|---|
| 2281 | "FRV1K",1130580001.101,"36,7",8,1)
|
|---|
| 2282 | MU VTE-5 DENOM RS
|
|---|
| 2283 | "FRV1K",1130580001.101,"37,7",7)
|
|---|
| 2284 | B
|
|---|
| 2285 | "FRV1K",1130580001.101,"37,7",7,1)
|
|---|
| 2286 | MU VTE-6 NUMER RS
|
|---|
| 2287 | "FRV1K",1130580001.101,"37,7",8)
|
|---|
| 2288 | B
|
|---|
| 2289 | "FRV1K",1130580001.101,"37,7",8,1)
|
|---|
| 2290 | MU VTE-6 DENOM RS
|
|---|
| 2291 | "FRV1K",1130580001.101,"39,7",7)
|
|---|
| 2292 | B
|
|---|
| 2293 | "FRV1K",1130580001.101,"39,7",7,1)
|
|---|
| 2294 | MU NQF0421 BMI NUM ALL RS
|
|---|
| 2295 | "FRV1K",1130580001.101,"39,7",8)
|
|---|
| 2296 | B
|
|---|
| 2297 | "FRV1K",1130580001.101,"39,7",8,1)
|
|---|
| 2298 | MU NQF0421 BMI DENOM ALL RS
|
|---|
| 2299 | "FRV1K",1130580001.101,"39,7",9)
|
|---|
| 2300 | B
|
|---|
| 2301 | "FRV1K",1130580001.101,"39,7",9,1)
|
|---|
| 2302 | MU NQF0421 ADULT BMI
|
|---|
| 2303 | "FRV1K",1130580001.101,"40,7",7)
|
|---|
| 2304 | B
|
|---|
| 2305 | "FRV1K",1130580001.101,"40,7",7,1)
|
|---|
| 2306 | MU NQF0013 HTN NUMER2 RS
|
|---|
| 2307 | "FRV1K",1130580001.101,"40,7",8)
|
|---|
| 2308 | B
|
|---|
| 2309 | "FRV1K",1130580001.101,"40,7",8,1)
|
|---|
| 2310 | MU NQF0013 HTN DENOM2 RS
|
|---|
| 2311 | "FRV1K",1130580001.101,"41,7",7)
|
|---|
| 2312 | B
|
|---|
| 2313 | "FRV1K",1130580001.101,"41,7",7,1)
|
|---|
| 2314 | MU NQF0028A TOBACCO SCREEN NUM RS
|
|---|
| 2315 | "FRV1K",1130580001.101,"41,7",8)
|
|---|
| 2316 | B
|
|---|
| 2317 | "FRV1K",1130580001.101,"41,7",8,1)
|
|---|
| 2318 | MU NQF0028B TOBACCO INTERV DENOM RS
|
|---|
| 2319 | "FRV1K",1130580001.101,"42,7",7)
|
|---|
| 2320 | B
|
|---|
| 2321 | "FRV1K",1130580001.101,"42,7",7,1)
|
|---|
| 2322 | MU NQF0041 FLU RS
|
|---|
| 2323 | "FRV1K",1130580001.101,"42,7",8)
|
|---|
| 2324 | B
|
|---|
| 2325 | "FRV1K",1130580001.101,"42,7",8,1)
|
|---|
| 2326 | MU NQF0041 FLU DENOM RS
|
|---|
| 2327 | "FRV1K",1130580001.101,"43,7",7)
|
|---|
| 2328 | B
|
|---|
| 2329 | "FRV1K",1130580001.101,"43,7",7,1)
|
|---|
| 2330 | MU NQF0024 BMI 2-17YR NUM RS
|
|---|
| 2331 | "FRV1K",1130580001.101,"43,7",8)
|
|---|
| 2332 | B
|
|---|
| 2333 | "FRV1K",1130580001.101,"43,7",8,1)
|
|---|
| 2334 | MU NQF0024 BMI 2-17YRS DEM RS
|
|---|
| 2335 | "FRV1K",1130580001.101,"45,7",7)
|
|---|
| 2336 | B
|
|---|
| 2337 | "FRV1K",1130580001.101,"45,7",7,1)
|
|---|
| 2338 | MU NQF0059 HBA1C NUM RS
|
|---|
| 2339 | "FRV1K",1130580001.101,"45,7",8)
|
|---|
| 2340 | B
|
|---|
| 2341 | "FRV1K",1130580001.101,"45,7",8,1)
|
|---|
| 2342 | MU NQF0059 DM DENOM-ALL RS
|
|---|
| 2343 | "FRV1K",1130580001.101,"46,7",7)
|
|---|
| 2344 | B
|
|---|
| 2345 | "FRV1K",1130580001.101,"46,7",7,1)
|
|---|
| 2346 | MU NQF0064 NUM LDL RS
|
|---|
| 2347 | "FRV1K",1130580001.101,"46,7",8)
|
|---|
| 2348 | B
|
|---|
| 2349 | "FRV1K",1130580001.101,"46,7",8,1)
|
|---|
| 2350 | MU NQF0059 DM DENOM-ALL RS
|
|---|
| 2351 | "FRV1K",1130580001.101,"47,7",7)
|
|---|
| 2352 | B
|
|---|
| 2353 | "FRV1K",1130580001.101,"47,7",7,1)
|
|---|
| 2354 | MU NQF0061 NUM DM BP<140/90 RS
|
|---|
| 2355 | "FRV1K",1130580001.101,"47,7",8)
|
|---|
| 2356 | B
|
|---|
| 2357 | "FRV1K",1130580001.101,"47,7",8,1)
|
|---|
| 2358 | MU NQF0059 DM DENOM-ALL RS
|
|---|
| 2359 | "FRV1K",1130580001.101,"81,7",7)
|
|---|
| 2360 | B
|
|---|
| 2361 | "FRV1K",1130580001.101,"81,7",7,1)
|
|---|
| 2362 | MU NQF0028B TOBACCO INTERV NUM2 RS
|
|---|
| 2363 | "FRV1K",1130580001.101,"81,7",8)
|
|---|
| 2364 | B
|
|---|
| 2365 | "FRV1K",1130580001.101,"81,7",8,1)
|
|---|
| 2366 | MU NQF0028B TOBACCO INTERV DENOM RS
|
|---|
| 2367 | "FRV1K",1130580001.101,"82,7",7)
|
|---|
| 2368 | B
|
|---|
| 2369 | "FRV1K",1130580001.101,"82,7",7,1)
|
|---|
| 2370 | MU NQF0024 BMI PERCENTILE 2-10Y RS
|
|---|
| 2371 | "FRV1K",1130580001.101,"82,7",8)
|
|---|
| 2372 | B
|
|---|
| 2373 | "FRV1K",1130580001.101,"82,7",8,1)
|
|---|
| 2374 | MU NQF0024 BMI 2-10Y DENOM RS
|
|---|
| 2375 | "FRV1K",1130580001.101,"83,7",7)
|
|---|
| 2376 | B
|
|---|
| 2377 | "FRV1K",1130580001.101,"83,7",7,1)
|
|---|
| 2378 | MU NQF0038 NUM1 DPT RS
|
|---|
| 2379 | "FRV1K",1130580001.101,"83,7",8)
|
|---|
| 2380 | B
|
|---|
| 2381 | "FRV1K",1130580001.101,"83,7",8,1)
|
|---|
| 2382 | MU NQF0038 DENOM RS
|
|---|
| 2383 | "FRV1K",1130580001.101,"83,7",9)
|
|---|
| 2384 | B
|
|---|
| 2385 | "FRV1K",1130580001.101,"83,7",9,1)
|
|---|
| 2386 | MU NQF0038 CHILDREN'S IMMUNIZATIONS
|
|---|
| 2387 | "FRV1K",1130580001.101,"84,7",7)
|
|---|
| 2388 | B
|
|---|
| 2389 | "FRV1K",1130580001.101,"84,7",7,1)
|
|---|
| 2390 | MU NQF0038 NUM2 IPV RS
|
|---|
| 2391 | "FRV1K",1130580001.101,"84,7",8)
|
|---|
| 2392 | B
|
|---|
| 2393 | "FRV1K",1130580001.101,"84,7",8,1)
|
|---|
| 2394 | MU NQF0038 DENOM RS
|
|---|
| 2395 | "FRV1K",1130580001.101,"84,7",9)
|
|---|
| 2396 | B
|
|---|
| 2397 | "FRV1K",1130580001.101,"84,7",9,1)
|
|---|
| 2398 | MU NQF0038 CHILDREN'S IMMUNIZATIONS
|
|---|
| 2399 | "FRV1K",1130580001.101,"85,7",7)
|
|---|
| 2400 | B
|
|---|
| 2401 | "FRV1K",1130580001.101,"85,7",7,1)
|
|---|
| 2402 | MU NQF0038 NUM3-ALL RS
|
|---|
| 2403 | "FRV1K",1130580001.101,"85,7",8)
|
|---|
| 2404 | B
|
|---|
| 2405 | "FRV1K",1130580001.101,"85,7",8,1)
|
|---|
| 2406 | MU NQF0038 DENOM RS
|
|---|
| 2407 | "FRV1K",1130580001.101,"85,7",9)
|
|---|
| 2408 | B
|
|---|
| 2409 | "FRV1K",1130580001.101,"85,7",9,1)
|
|---|
| 2410 | MU NQF0038 CHILDREN'S IMMUNIZATIONS
|
|---|
| 2411 | "FRV1K",1130580001.101,"86,7",7)
|
|---|
| 2412 | B
|
|---|
| 2413 | "FRV1K",1130580001.101,"86,7",7,1)
|
|---|
| 2414 | MU NQF0038 NUM4 HIB RS
|
|---|
| 2415 | "FRV1K",1130580001.101,"86,7",8)
|
|---|
| 2416 | B
|
|---|
| 2417 | "FRV1K",1130580001.101,"86,7",8,1)
|
|---|
| 2418 | MU NQF0038 DENOM RS
|
|---|
| 2419 | "FRV1K",1130580001.101,"86,7",9)
|
|---|
| 2420 | B
|
|---|
| 2421 | "FRV1K",1130580001.101,"86,7",9,1)
|
|---|
| 2422 | MU NQF0038 CHILDREN'S IMMUNIZATIONS
|
|---|
| 2423 | "FRV1K",1130580001.101,"87,7",7)
|
|---|
| 2424 | B
|
|---|
| 2425 | "FRV1K",1130580001.101,"87,7",7,1)
|
|---|
| 2426 | MU NQF0038 NUM5 RS
|
|---|
| 2427 | "FRV1K",1130580001.101,"87,7",8)
|
|---|
| 2428 | B
|
|---|
| 2429 | "FRV1K",1130580001.101,"87,7",8,1)
|
|---|
| 2430 | MU NQF0038 DENOM RS
|
|---|
| 2431 | "FRV1K",1130580001.101,"87,7",9)
|
|---|
| 2432 | B
|
|---|
| 2433 | "FRV1K",1130580001.101,"87,7",9,1)
|
|---|
| 2434 | MU NQF0038 CHILDREN'S IMMUNIZATIONS
|
|---|
| 2435 | "FRV1K",1130580001.101,"88,7",7)
|
|---|
| 2436 | B
|
|---|
| 2437 | "FRV1K",1130580001.101,"88,7",7,1)
|
|---|
| 2438 | MU NQF0038 NUM6 VZV RS
|
|---|
| 2439 | "FRV1K",1130580001.101,"88,7",8)
|
|---|
| 2440 | B
|
|---|
| 2441 | "FRV1K",1130580001.101,"88,7",8,1)
|
|---|
| 2442 | MU NQF0038 DENOM RS
|
|---|
| 2443 | "FRV1K",1130580001.101,"88,7",9)
|
|---|
| 2444 | B
|
|---|
| 2445 | "FRV1K",1130580001.101,"88,7",9,1)
|
|---|
| 2446 | MU NQF0038 CHILDREN'S IMMUNIZATIONS
|
|---|
| 2447 | "FRV1K",1130580001.101,"89,7",7)
|
|---|
| 2448 | B
|
|---|
| 2449 | "FRV1K",1130580001.101,"89,7",7,1)
|
|---|
| 2450 | MU NQF0038 NUM7 PCV RS
|
|---|
| 2451 | "FRV1K",1130580001.101,"89,7",8)
|
|---|
| 2452 | B
|
|---|
| 2453 | "FRV1K",1130580001.101,"89,7",8,1)
|
|---|
| 2454 | MU NQF0038 DENOM RS
|
|---|
| 2455 | "FRV1K",1130580001.101,"89,7",9)
|
|---|
| 2456 | B
|
|---|
| 2457 | "FRV1K",1130580001.101,"89,7",9,1)
|
|---|
| 2458 | MU NQF0038 CHILDREN'S IMMUNIZATIONS
|
|---|
| 2459 | "FRV1K",1130580001.101,"90,7",7)
|
|---|
| 2460 | B
|
|---|
| 2461 | "FRV1K",1130580001.101,"90,7",7,1)
|
|---|
| 2462 | MU NQF0038 NUM8 HEP A RS
|
|---|
| 2463 | "FRV1K",1130580001.101,"90,7",8)
|
|---|
| 2464 | B
|
|---|
| 2465 | "FRV1K",1130580001.101,"90,7",8,1)
|
|---|
| 2466 | MU NQF0038 DENOM RS
|
|---|
| 2467 | "FRV1K",1130580001.101,"90,7",9)
|
|---|
| 2468 | B
|
|---|
| 2469 | "FRV1K",1130580001.101,"90,7",9,1)
|
|---|
| 2470 | MU NQF0038 CHILDREN'S IMMUNIZATIONS
|
|---|
| 2471 | "FRV1K",1130580001.101,"91,7",7)
|
|---|
| 2472 | B
|
|---|
| 2473 | "FRV1K",1130580001.101,"91,7",7,1)
|
|---|
| 2474 | MU NQF0038 NUM9 RV RS
|
|---|
| 2475 | "FRV1K",1130580001.101,"91,7",8)
|
|---|
| 2476 | B
|
|---|
| 2477 | "FRV1K",1130580001.101,"91,7",8,1)
|
|---|
| 2478 | MU NQF0038 DENOM RS
|
|---|
| 2479 | "FRV1K",1130580001.101,"91,7",9)
|
|---|
| 2480 | B
|
|---|
| 2481 | "FRV1K",1130580001.101,"91,7",9,1)
|
|---|
| 2482 | MU NQF0038 CHILDREN'S IMMUNIZATIONS
|
|---|
| 2483 | "FRV1K",1130580001.101,"92,7",7)
|
|---|
| 2484 | B
|
|---|
| 2485 | "FRV1K",1130580001.101,"92,7",7,1)
|
|---|
| 2486 | MU NQF0038 NUM10 INFLUENZA RS
|
|---|
| 2487 | "FRV1K",1130580001.101,"92,7",8)
|
|---|
| 2488 | B
|
|---|
| 2489 | "FRV1K",1130580001.101,"92,7",8,1)
|
|---|
| 2490 | MU NQF0038 DENOM RS
|
|---|
| 2491 | "FRV1K",1130580001.101,"92,7",9)
|
|---|
| 2492 | B
|
|---|
| 2493 | "FRV1K",1130580001.101,"92,7",9,1)
|
|---|
| 2494 | MU NQF0038 CHILDREN'S IMMUNIZATIONS
|
|---|
| 2495 | "FRV1K",1130580001.101,"93,7",7)
|
|---|
| 2496 | B
|
|---|
| 2497 | "FRV1K",1130580001.101,"93,7",7,1)
|
|---|
| 2498 | MU NQF0038 NUM11 COMBO5 RS
|
|---|
| 2499 | "FRV1K",1130580001.101,"93,7",8)
|
|---|
| 2500 | B
|
|---|
| 2501 | "FRV1K",1130580001.101,"93,7",8,1)
|
|---|
| 2502 | MU NQF0038 DENOM RS
|
|---|
| 2503 | "FRV1K",1130580001.101,"93,7",9)
|
|---|
| 2504 | B
|
|---|
| 2505 | "FRV1K",1130580001.101,"93,7",9,1)
|
|---|
| 2506 | MU NQF0038 CHILDREN'S IMMUNIZATIONS
|
|---|
| 2507 | "FRV1K",1130580001.101,"94,7",7)
|
|---|
| 2508 | B
|
|---|
| 2509 | "FRV1K",1130580001.101,"94,7",7,1)
|
|---|
| 2510 | MU NQF0038 NUM12 COMBO6 RS
|
|---|
| 2511 | "FRV1K",1130580001.101,"94,7",8)
|
|---|
| 2512 | B
|
|---|
| 2513 | "FRV1K",1130580001.101,"94,7",8,1)
|
|---|
| 2514 | MU NQF0038 DENOM RS
|
|---|
| 2515 | "FRV1K",1130580001.101,"94,7",9)
|
|---|
| 2516 | B
|
|---|
| 2517 | "FRV1K",1130580001.101,"94,7",9,1)
|
|---|
| 2518 | MU NQF0038 CHILDREN'S IMMUNIZATIONS
|
|---|
| 2519 | "IX",1130580001.101,1130580001.101,"B",0)
|
|---|
| 2520 | 1130580001.101^B^New-Style B Index. Will be used as part of the key.^R^^F^IR^I^1130580001.101^^^^^LS
|
|---|
| 2521 | "IX",1130580001.101,1130580001.101,"B",1)
|
|---|
| 2522 | S ^C0Q(101,"B",$E(X,1,30),DA)=""
|
|---|
| 2523 | "IX",1130580001.101,1130580001.101,"B",2)
|
|---|
| 2524 | K ^C0Q(101,"B",$E(X,1,30),DA)
|
|---|
| 2525 | "IX",1130580001.101,1130580001.101,"B",2.5)
|
|---|
| 2526 | K ^C0Q(101,"B")
|
|---|
| 2527 | "IX",1130580001.101,1130580001.101,"B",11.1,0)
|
|---|
| 2528 | ^.114IA^1^1
|
|---|
| 2529 | "IX",1130580001.101,1130580001.101,"B",11.1,1,0)
|
|---|
| 2530 | 1^F^1130580001.101^.01^30^1^F
|
|---|
| 2531 | "IX",1130580001.101,1130580001.101,"MU",0)
|
|---|
| 2532 | 1130580001.101^MU^MEANINGFUL USE YEAR KEY^R^^F^IR^I^1130580001.101^^^^^LS
|
|---|
| 2533 | "IX",1130580001.101,1130580001.101,"MU",1)
|
|---|
| 2534 | S ^C0Q(101,"MU",$E(X,1,30),DA)=""
|
|---|
| 2535 | "IX",1130580001.101,1130580001.101,"MU",2)
|
|---|
| 2536 | K ^C0Q(101,"MU",$E(X,1,30),DA)
|
|---|
| 2537 | "IX",1130580001.101,1130580001.101,"MU",2.5)
|
|---|
| 2538 | K ^C0Q(101,"MU")
|
|---|
| 2539 | "IX",1130580001.101,1130580001.101,"MU",11.1,0)
|
|---|
| 2540 | ^.114IA^1^1
|
|---|
| 2541 | "IX",1130580001.101,1130580001.101,"MU",11.1,1,0)
|
|---|
| 2542 | 1^F^1130580001.101^.3^30^1^F
|
|---|
| 2543 | "KEY",1130580001.101,1130580001.101,"A",0)
|
|---|
| 2544 | 1130580001.101^A^P^562
|
|---|
| 2545 | "KEY",1130580001.101,1130580001.101,"A",2,0)
|
|---|
| 2546 | ^.312IA^1^1
|
|---|
| 2547 | "KEY",1130580001.101,1130580001.101,"A",2,1,0)
|
|---|
| 2548 | .01^1130580001.101^1
|
|---|
| 2549 | "KEYPTR",1130580001.101,1130580001.101,"A")
|
|---|
| 2550 | 1130580001.101^B
|
|---|
| 2551 | "MBREQ")
|
|---|
| 2552 | 0
|
|---|
| 2553 | "PGL",1130580001.101,0,2,1)
|
|---|
| 2554 | NUMERATOR PATIENT LIST^P810.5'^PXRMXP(810.5,^0;2^Q
|
|---|
| 2555 | "PGL",1130580001.101,0,3,2)
|
|---|
| 2556 | DENOMINATOR PATIENT LIST^P810.5'^PXRMXP(810.5,^0;3^Q
|
|---|
| 2557 | "PGL",1130580001.101,7,2,1.1)
|
|---|
| 2558 | ALTERNATIVE NUMERATOR LIST^P1130580001.301'^C0Q(301,^7;2^Q
|
|---|
| 2559 | "PGL",1130580001.101,7,3,2.1)
|
|---|
| 2560 | ALTERNATIVE DENOMINATOR LIST^P1130580001.301'^C0Q(301,^7;3^Q
|
|---|
| 2561 | "PGL",1130580001.101,7,4,1.5)
|
|---|
| 2562 | NEGATIVE NUMERATOR LIST^P810.5'^PXRMXP(810.5,^7;4^Q
|
|---|
| 2563 | "PGL",1130580001.101,7,5,1.51)
|
|---|
| 2564 | ALTERNATE NEGATIVE NUM LIST^P1130580001.301'^C0Q(301,^7;5^Q
|
|---|
| 2565 | "PGL",1130580001.101,7,7,1.2)
|
|---|
| 2566 | NUMERATOR RULE SET^*P810.4'^PXRM(810.4,^7;7^S DIC("S")="I $P(^(0),U,3)=3" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
|
|---|
| 2567 | "PGL",1130580001.101,7,8,2.2)
|
|---|
| 2568 | DENOMINATOR RULE SET^*P810.4'^PXRM(810.4,^7;8^S DIC("S")="I $P(^(0),U,3)=3" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
|
|---|
| 2569 | "PGL",1130580001.101,7,9,2.5)
|
|---|
| 2570 | EXTRACT DEFINITION^P810.2'^PXRM(810.2,^7;9^Q
|
|---|
| 2571 | "PKG",215,-1)
|
|---|
| 2572 | 1^1
|
|---|
| 2573 | "PKG",215,0)
|
|---|
| 2574 | QUALITY MEASURES^C0Q^Tracks and Prints Quality Measures
|
|---|
| 2575 | "PKG",215,20,0)
|
|---|
| 2576 | ^9.402P^^
|
|---|
| 2577 | "PKG",215,22,0)
|
|---|
| 2578 | ^9.49I^1^1
|
|---|
| 2579 | "PKG",215,22,1,0)
|
|---|
| 2580 | 1.0^3120731^3120806^8
|
|---|
| 2581 | "PKG",215,22,1,"PAH",1,0)
|
|---|
| 2582 | 3^3120806^8
|
|---|
| 2583 | "PKG",215,22,1,"PAH",1,1,0)
|
|---|
| 2584 | ^^155^155^3120806
|
|---|
| 2585 | "PKG",215,22,1,"PAH",1,1,1,0)
|
|---|
| 2586 | Summary
|
|---|
| 2587 | "PKG",215,22,1,"PAH",1,1,2,0)
|
|---|
| 2588 | =======
|
|---|
| 2589 | "PKG",215,22,1,"PAH",1,1,3,0)
|
|---|
| 2590 | This build contains the Quality Measures file (#1130580001.101) fully
|
|---|
| 2591 | "PKG",215,22,1,"PAH",1,1,4,0)
|
|---|
| 2592 | populated with the Reminder Rule Sets and if applicable Reminder Extract
|
|---|
| 2593 | "PKG",215,22,1,"PAH",1,1,5,0)
|
|---|
| 2594 | definitions for use with the Quality Measures package for reporting for
|
|---|
| 2595 | "PKG",215,22,1,"PAH",1,1,6,0)
|
|---|
| 2596 | Meaningful use Stage I.
|
|---|
| 2597 | "PKG",215,22,1,"PAH",1,1,7,0)
|
|---|
| 2598 |
|
|---|
| 2599 | "PKG",215,22,1,"PAH",1,1,8,0)
|
|---|
| 2600 | Source, Copyright, & Licensing:
|
|---|
| 2601 | "PKG",215,22,1,"PAH",1,1,9,0)
|
|---|
| 2602 | ===============================
|
|---|
| 2603 | "PKG",215,22,1,"PAH",1,1,10,0)
|
|---|
| 2604 | This patch to WorldVistA 2.0 was produced by Sam Habiel on a copy of Dew
|
|---|
| 2605 | "PKG",215,22,1,"PAH",1,1,11,0)
|
|---|
| 2606 | Drop and tested on a virgin instance of WV EHR 3-09 patched with PXRM 2.0
|
|---|
| 2607 | "PKG",215,22,1,"PAH",1,1,12,0)
|
|---|
| 2608 | patches 12 and 17. The build was produced in July 2012.
|
|---|
| 2609 | "PKG",215,22,1,"PAH",1,1,13,0)
|
|---|
| 2610 | Copyright WorldVistA 2012.
|
|---|
| 2611 | "PKG",215,22,1,"PAH",1,1,14,0)
|
|---|
| 2612 | Licensed under GPL version 2 or later. Find it here:
|
|---|
| 2613 | "PKG",215,22,1,"PAH",1,1,15,0)
|
|---|
| 2614 | http://www.gnu.org/licenses/gpl-2.0.html
|
|---|
| 2615 | "PKG",215,22,1,"PAH",1,1,16,0)
|
|---|
| 2616 | Released through VISTA Forum.
|
|---|
| 2617 | "PKG",215,22,1,"PAH",1,1,17,0)
|
|---|
| 2618 |
|
|---|
| 2619 | "PKG",215,22,1,"PAH",1,1,18,0)
|
|---|
| 2620 | Functionality:
|
|---|
| 2621 | "PKG",215,22,1,"PAH",1,1,19,0)
|
|---|
| 2622 | ==============
|
|---|
| 2623 | "PKG",215,22,1,"PAH",1,1,20,0)
|
|---|
| 2624 | This patch is a pure data patch. It only installs reference data in the
|
|---|
| 2625 | "PKG",215,22,1,"PAH",1,1,21,0)
|
|---|
| 2626 | C0Q QUALITY MEASURE file (#1130580001.101). It relies on Reminder Package
|
|---|
| 2627 | "PKG",215,22,1,"PAH",1,1,22,0)
|
|---|
| 2628 | data (specifically rule sets and extracts) sent in C0Q*1.0*2.
|
|---|
| 2629 | "PKG",215,22,1,"PAH",1,1,23,0)
|
|---|
| 2630 |
|
|---|
| 2631 | "PKG",215,22,1,"PAH",1,1,24,0)
|
|---|
| 2632 | Package Elements:
|
|---|
| 2633 | "PKG",215,22,1,"PAH",1,1,25,0)
|
|---|
| 2634 | =================
|
|---|
| 2635 | "PKG",215,22,1,"PAH",1,1,26,0)
|
|---|
| 2636 | This build transports entries in the C0Q QUALITY MEASURE file.
|
|---|
| 2637 | "PKG",215,22,1,"PAH",1,1,27,0)
|
|---|
| 2638 |
|
|---|
| 2639 | "PKG",215,22,1,"PAH",1,1,28,0)
|
|---|
| 2640 | Routines:
|
|---|
| 2641 | "PKG",215,22,1,"PAH",1,1,29,0)
|
|---|
| 2642 | =========
|
|---|
| 2643 | "PKG",215,22,1,"PAH",1,1,30,0)
|
|---|
| 2644 | <None>
|
|---|
| 2645 | "PKG",215,22,1,"PAH",1,1,31,0)
|
|---|
| 2646 |
|
|---|
| 2647 | "PKG",215,22,1,"PAH",1,1,32,0)
|
|---|
| 2648 | Documentation:
|
|---|
| 2649 | "PKG",215,22,1,"PAH",1,1,33,0)
|
|---|
| 2650 | <None besides this KIDS description>
|
|---|
| 2651 | "PKG",215,22,1,"PAH",1,1,34,0)
|
|---|
| 2652 |
|
|---|
| 2653 | "PKG",215,22,1,"PAH",1,1,35,0)
|
|---|
| 2654 | Test Sites:
|
|---|
| 2655 | "PKG",215,22,1,"PAH",1,1,36,0)
|
|---|
| 2656 | ===========
|
|---|
| 2657 | "PKG",215,22,1,"PAH",1,1,37,0)
|
|---|
| 2658 | <None>
|
|---|
| 2659 | "PKG",215,22,1,"PAH",1,1,38,0)
|
|---|
| 2660 |
|
|---|
| 2661 | "PKG",215,22,1,"PAH",1,1,39,0)
|
|---|
| 2662 | Compliance:
|
|---|
| 2663 | "PKG",215,22,1,"PAH",1,1,40,0)
|
|---|
| 2664 | ===========
|
|---|
| 2665 | "PKG",215,22,1,"PAH",1,1,41,0)
|
|---|
| 2666 | This software complies with the VA MUMPS Programming Standards and
|
|---|
| 2667 | "PKG",215,22,1,"PAH",1,1,42,0)
|
|---|
| 2668 | Conventions (version 3 April 2007).
|
|---|
| 2669 | "PKG",215,22,1,"PAH",1,1,43,0)
|
|---|
| 2670 |
|
|---|
| 2671 | "PKG",215,22,1,"PAH",1,1,44,0)
|
|---|
| 2672 | Installation Instructions:
|
|---|
| 2673 | "PKG",215,22,1,"PAH",1,1,45,0)
|
|---|
| 2674 | ==========================
|
|---|
| 2675 | "PKG",215,22,1,"PAH",1,1,46,0)
|
|---|
| 2676 | Pre-installation:
|
|---|
| 2677 | "PKG",215,22,1,"PAH",1,1,47,0)
|
|---|
| 2678 |
|
|---|
| 2679 | "PKG",215,22,1,"PAH",1,1,48,0)
|
|---|
| 2680 | Prerequisite patches: (both found on the trac server here:
|
|---|
| 2681 | "PKG",215,22,1,"PAH",1,1,49,0)
|
|---|
| 2682 | https://trac.opensourcevista.net/svn/qrda/C0Q/trunk/kids/)
|
|---|
| 2683 | "PKG",215,22,1,"PAH",1,1,50,0)
|
|---|
| 2684 | C0Q*1.0*2
|
|---|
| 2685 | "PKG",215,22,1,"PAH",1,1,51,0)
|
|---|
| 2686 | QUALITY MEASURES 1.0
|
|---|
| 2687 | "PKG",215,22,1,"PAH",1,1,52,0)
|
|---|
| 2688 |
|
|---|
| 2689 | "PKG",215,22,1,"PAH",1,1,53,0)
|
|---|
| 2690 | Users can remain on the system while this patch is installed.
|
|---|
| 2691 | "PKG",215,22,1,"PAH",1,1,54,0)
|
|---|
| 2692 |
|
|---|
| 2693 | "PKG",215,22,1,"PAH",1,1,55,0)
|
|---|
| 2694 | Install Time - less than 1 minute.
|
|---|
| 2695 | "PKG",215,22,1,"PAH",1,1,56,0)
|
|---|
| 2696 |
|
|---|
| 2697 | "PKG",215,22,1,"PAH",1,1,57,0)
|
|---|
| 2698 | 1. LOAD TRANSPORT GLOBAL
|
|---|
| 2699 | "PKG",215,22,1,"PAH",1,1,58,0)
|
|---|
| 2700 |
|
|---|
| 2701 | "PKG",215,22,1,"PAH",1,1,59,0)
|
|---|
| 2702 | Choose the PackMan message containing this patch and invoke the
|
|---|
| 2703 | "PKG",215,22,1,"PAH",1,1,60,0)
|
|---|
| 2704 | INSTALL/CHECK MESSAGE PackMan option to unload the build, or
|
|---|
| 2705 | "PKG",215,22,1,"PAH",1,1,61,0)
|
|---|
| 2706 | Use the Load a Distribution option in KIDS to load it from a
|
|---|
| 2707 | "PKG",215,22,1,"PAH",1,1,62,0)
|
|---|
| 2708 | host file.
|
|---|
| 2709 | "PKG",215,22,1,"PAH",1,1,63,0)
|
|---|
| 2710 |
|
|---|
| 2711 | "PKG",215,22,1,"PAH",1,1,64,0)
|
|---|
| 2712 | 2. START UP KIDS
|
|---|
| 2713 | "PKG",215,22,1,"PAH",1,1,65,0)
|
|---|
| 2714 |
|
|---|
| 2715 | "PKG",215,22,1,"PAH",1,1,66,0)
|
|---|
| 2716 | Start up the Kernel Installation and Distribution System Menu
|
|---|
| 2717 | "PKG",215,22,1,"PAH",1,1,67,0)
|
|---|
| 2718 | [XPD MAIN]:
|
|---|
| 2719 | "PKG",215,22,1,"PAH",1,1,68,0)
|
|---|
| 2720 |
|
|---|
| 2721 | "PKG",215,22,1,"PAH",1,1,69,0)
|
|---|
| 2722 | Edits and Distribution ...
|
|---|
| 2723 | "PKG",215,22,1,"PAH",1,1,70,0)
|
|---|
| 2724 | Utilities ...
|
|---|
| 2725 | "PKG",215,22,1,"PAH",1,1,71,0)
|
|---|
| 2726 | Installation ...
|
|---|
| 2727 | "PKG",215,22,1,"PAH",1,1,72,0)
|
|---|
| 2728 |
|
|---|
| 2729 | "PKG",215,22,1,"PAH",1,1,73,0)
|
|---|
| 2730 | Select Kernel Installation & Distribution System Option: INStallation
|
|---|
| 2731 | "PKG",215,22,1,"PAH",1,1,74,0)
|
|---|
| 2732 | ---
|
|---|
| 2733 | "PKG",215,22,1,"PAH",1,1,75,0)
|
|---|
| 2734 | Load a Distribution
|
|---|
| 2735 | "PKG",215,22,1,"PAH",1,1,76,0)
|
|---|
| 2736 | Print Transport Global
|
|---|
| 2737 | "PKG",215,22,1,"PAH",1,1,77,0)
|
|---|
| 2738 | Compare Transport Global to Current System
|
|---|
| 2739 | "PKG",215,22,1,"PAH",1,1,78,0)
|
|---|
| 2740 | Verify Checksums in Transport Global
|
|---|
| 2741 | "PKG",215,22,1,"PAH",1,1,79,0)
|
|---|
| 2742 | Install Package(s)
|
|---|
| 2743 | "PKG",215,22,1,"PAH",1,1,80,0)
|
|---|
| 2744 | Restart Install of Package(s)
|
|---|
| 2745 | "PKG",215,22,1,"PAH",1,1,81,0)
|
|---|
| 2746 | Unload a Distribution
|
|---|
| 2747 | "PKG",215,22,1,"PAH",1,1,82,0)
|
|---|
| 2748 | Backup a Transport Global
|
|---|
| 2749 | "PKG",215,22,1,"PAH",1,1,83,0)
|
|---|
| 2750 |
|
|---|
| 2751 | "PKG",215,22,1,"PAH",1,1,84,0)
|
|---|
| 2752 | Select Installation Option:
|
|---|
| 2753 | "PKG",215,22,1,"PAH",1,1,85,0)
|
|---|
| 2754 |
|
|---|
| 2755 | "PKG",215,22,1,"PAH",1,1,86,0)
|
|---|
| 2756 | 3. Select Installation Option:
|
|---|
| 2757 | "PKG",215,22,1,"PAH",1,1,87,0)
|
|---|
| 2758 |
|
|---|
| 2759 | "PKG",215,22,1,"PAH",1,1,88,0)
|
|---|
| 2760 | NOTE: The following are OPTIONAL - (When prompted for the INSTALL
|
|---|
| 2761 | "PKG",215,22,1,"PAH",1,1,89,0)
|
|---|
| 2762 | NAME, enter C0Q*1.0*3):
|
|---|
| 2763 | "PKG",215,22,1,"PAH",1,1,90,0)
|
|---|
| 2764 |
|
|---|
| 2765 | "PKG",215,22,1,"PAH",1,1,91,0)
|
|---|
| 2766 | a. Backup a Transport Global - This option will create a backup
|
|---|
| 2767 | "PKG",215,22,1,"PAH",1,1,92,0)
|
|---|
| 2768 | message of any routines exported with this patch. It will not
|
|---|
| 2769 | "PKG",215,22,1,"PAH",1,1,93,0)
|
|---|
| 2770 | backup any other changes such as DD's or templates.
|
|---|
| 2771 | "PKG",215,22,1,"PAH",1,1,94,0)
|
|---|
| 2772 | b. Compare Transport Global to Current System - This option will
|
|---|
| 2773 | "PKG",215,22,1,"PAH",1,1,95,0)
|
|---|
| 2774 | allow you to view all changes that will be made when this patch
|
|---|
| 2775 | "PKG",215,22,1,"PAH",1,1,96,0)
|
|---|
| 2776 | is installed. It compares all components of this patch
|
|---|
| 2777 | "PKG",215,22,1,"PAH",1,1,97,0)
|
|---|
| 2778 | (routines, DD's, templates, etc.).
|
|---|
| 2779 | "PKG",215,22,1,"PAH",1,1,98,0)
|
|---|
| 2780 | c. Verify Checksums in Transport Global - This option will allow
|
|---|
| 2781 | "PKG",215,22,1,"PAH",1,1,99,0)
|
|---|
| 2782 | you to ensure the integrity of the routines that are in the
|
|---|
| 2783 | "PKG",215,22,1,"PAH",1,1,100,0)
|
|---|
| 2784 | transport global.
|
|---|
| 2785 | "PKG",215,22,1,"PAH",1,1,101,0)
|
|---|
| 2786 |
|
|---|
| 2787 | "PKG",215,22,1,"PAH",1,1,102,0)
|
|---|
| 2788 | 4. Select Installation Option: Install Package(s)
|
|---|
| 2789 | "PKG",215,22,1,"PAH",1,1,103,0)
|
|---|
| 2790 |
|
|---|
| 2791 | "PKG",215,22,1,"PAH",1,1,104,0)
|
|---|
| 2792 | **This is the step to start the installation of this KIDS patch:
|
|---|
| 2793 | "PKG",215,22,1,"PAH",1,1,105,0)
|
|---|
| 2794 |
|
|---|
| 2795 | "PKG",215,22,1,"PAH",1,1,106,0)
|
|---|
| 2796 | a. Choose the Install Package(s) option to start the patch install
|
|---|
| 2797 | "PKG",215,22,1,"PAH",1,1,107,0)
|
|---|
| 2798 | and enter "C0Q*1.0*3" at the INSTALL NAME prompt.
|
|---|
| 2799 | "PKG",215,22,1,"PAH",1,1,108,0)
|
|---|
| 2800 | b. When prompted 'Want KIDS to Rebuild Menu Trees Upon Completion of
|
|---|
| 2801 | "PKG",215,22,1,"PAH",1,1,109,0)
|
|---|
| 2802 | Install? NO//' answer NO
|
|---|
| 2803 | "PKG",215,22,1,"PAH",1,1,110,0)
|
|---|
| 2804 | c. When prompted 'Want KIDS to INHIBIT LOGONs during the install?
|
|---|
| 2805 | "PKG",215,22,1,"PAH",1,1,111,0)
|
|---|
| 2806 | NO//' answer NO
|
|---|
| 2807 | "PKG",215,22,1,"PAH",1,1,112,0)
|
|---|
| 2808 | d. When prompted 'Want to DISABLE Scheduled Options, Menu Options,
|
|---|
| 2809 | "PKG",215,22,1,"PAH",1,1,113,0)
|
|---|
| 2810 | and Protocols? NO//' answer NO
|
|---|
| 2811 | "PKG",215,22,1,"PAH",1,1,114,0)
|
|---|
| 2812 |
|
|---|
| 2813 | "PKG",215,22,1,"PAH",1,1,115,0)
|
|---|
| 2814 |
|
|---|
| 2815 | "PKG",215,22,1,"PAH",1,1,116,0)
|
|---|
| 2816 | Here is an example installation log.
|
|---|
| 2817 | "PKG",215,22,1,"PAH",1,1,117,0)
|
|---|
| 2818 | Select INSTALL NAME: C0Q*1.0*3 Loaded from Distribution Loaded
|
|---|
| 2819 | "PKG",215,22,1,"PAH",1,1,118,0)
|
|---|
| 2820 | from Di
|
|---|
| 2821 | "PKG",215,22,1,"PAH",1,1,119,0)
|
|---|
| 2822 | stribution 8/3/12@16:32:30
|
|---|
| 2823 | "PKG",215,22,1,"PAH",1,1,120,0)
|
|---|
| 2824 | => SDFGHJKL ;Created on Aug 03, 2012@16:31:28
|
|---|
| 2825 | "PKG",215,22,1,"PAH",1,1,121,0)
|
|---|
| 2826 |
|
|---|
| 2827 | "PKG",215,22,1,"PAH",1,1,122,0)
|
|---|
| 2828 | This Distribution was loaded on Aug 03, 2012@16:32:30 with header of
|
|---|
| 2829 | "PKG",215,22,1,"PAH",1,1,123,0)
|
|---|
| 2830 | SDFGHJKL ;Created on Aug 03, 2012@16:31:28
|
|---|
| 2831 | "PKG",215,22,1,"PAH",1,1,124,0)
|
|---|
| 2832 | It consisted of the following Install(s):
|
|---|
| 2833 | "PKG",215,22,1,"PAH",1,1,125,0)
|
|---|
| 2834 | C0Q*1.0*3
|
|---|
| 2835 | "PKG",215,22,1,"PAH",1,1,126,0)
|
|---|
| 2836 |
|
|---|
| 2837 | "PKG",215,22,1,"PAH",1,1,127,0)
|
|---|
| 2838 | Checking C0Q*1.0*3 for overlap with VOE 1.0 . OK
|
|---|
| 2839 | "PKG",215,22,1,"PAH",1,1,128,0)
|
|---|
| 2840 | No overlap found
|
|---|
| 2841 | "PKG",215,22,1,"PAH",1,1,129,0)
|
|---|
| 2842 | DEVICE: HOME// PHOME HOME PRINTER
|
|---|
| 2843 | "PKG",215,22,1,"PAH",1,1,130,0)
|
|---|
| 2844 |
|
|---|
| 2845 | "PKG",215,22,1,"PAH",1,1,131,0)
|
|---|
| 2846 |
|
|---|
| 2847 | "PKG",215,22,1,"PAH",1,1,132,0)
|
|---|
| 2848 | Install Started for C0Q*1.0*3 :
|
|---|
| 2849 | "PKG",215,22,1,"PAH",1,1,133,0)
|
|---|
| 2850 | Aug 03, 2012@16:35:24
|
|---|
| 2851 | "PKG",215,22,1,"PAH",1,1,134,0)
|
|---|
| 2852 |
|
|---|
| 2853 | "PKG",215,22,1,"PAH",1,1,135,0)
|
|---|
| 2854 | Build Distribution Date: Aug 03, 2012
|
|---|
| 2855 | "PKG",215,22,1,"PAH",1,1,136,0)
|
|---|
| 2856 |
|
|---|
| 2857 | "PKG",215,22,1,"PAH",1,1,137,0)
|
|---|
| 2858 | Installing Routines:.
|
|---|
| 2859 | "PKG",215,22,1,"PAH",1,1,138,0)
|
|---|
| 2860 | Aug 03, 2012@16:35:24
|
|---|
| 2861 | "PKG",215,22,1,"PAH",1,1,139,0)
|
|---|
| 2862 |
|
|---|
| 2863 | "PKG",215,22,1,"PAH",1,1,140,0)
|
|---|
| 2864 | Installing Data Dictionaries: ..
|
|---|
| 2865 | "PKG",215,22,1,"PAH",1,1,141,0)
|
|---|
| 2866 | Aug 03, 2012@16:35:24
|
|---|
| 2867 | "PKG",215,22,1,"PAH",1,1,142,0)
|
|---|
| 2868 |
|
|---|
| 2869 | "PKG",215,22,1,"PAH",1,1,143,0)
|
|---|
| 2870 | Installing Data:
|
|---|
| 2871 | "PKG",215,22,1,"PAH",1,1,144,0)
|
|---|
| 2872 | Aug 03, 2012@16:35:24
|
|---|
| 2873 | "PKG",215,22,1,"PAH",1,1,145,0)
|
|---|
| 2874 |
|
|---|
| 2875 | "PKG",215,22,1,"PAH",1,1,146,0)
|
|---|
| 2876 | Updating Routine file.....
|
|---|
| 2877 | "PKG",215,22,1,"PAH",1,1,147,0)
|
|---|
| 2878 |
|
|---|
| 2879 | "PKG",215,22,1,"PAH",1,1,148,0)
|
|---|
| 2880 | Updating KIDS files.......
|
|---|
| 2881 | "PKG",215,22,1,"PAH",1,1,149,0)
|
|---|
| 2882 |
|
|---|
| 2883 | "PKG",215,22,1,"PAH",1,1,150,0)
|
|---|
| 2884 | C0Q*1.0*3 Installed.
|
|---|
| 2885 | "PKG",215,22,1,"PAH",1,1,151,0)
|
|---|
| 2886 | Aug 03, 2012@16:35:24
|
|---|
| 2887 | "PKG",215,22,1,"PAH",1,1,152,0)
|
|---|
| 2888 |
|
|---|
| 2889 | "PKG",215,22,1,"PAH",1,1,153,0)
|
|---|
| 2890 | Not a VA primary domain
|
|---|
| 2891 | "PKG",215,22,1,"PAH",1,1,154,0)
|
|---|
| 2892 |
|
|---|
| 2893 | "PKG",215,22,1,"PAH",1,1,155,0)
|
|---|
| 2894 | NO Install Message sent
|
|---|
| 2895 | "QUES","XPF1",0)
|
|---|
| 2896 | Y
|
|---|
| 2897 | "QUES","XPF1","??")
|
|---|
| 2898 | ^D REP^XPDH
|
|---|
| 2899 | "QUES","XPF1","A")
|
|---|
| 2900 | Shall I write over your |FLAG| File
|
|---|
| 2901 | "QUES","XPF1","B")
|
|---|
| 2902 | YES
|
|---|
| 2903 | "QUES","XPF1","M")
|
|---|
| 2904 | D XPF1^XPDIQ
|
|---|
| 2905 | "QUES","XPF2",0)
|
|---|
| 2906 | Y
|
|---|
| 2907 | "QUES","XPF2","??")
|
|---|
| 2908 | ^D DTA^XPDH
|
|---|
| 2909 | "QUES","XPF2","A")
|
|---|
| 2910 | Want my data |FLAG| yours
|
|---|
| 2911 | "QUES","XPF2","B")
|
|---|
| 2912 | YES
|
|---|
| 2913 | "QUES","XPF2","M")
|
|---|
| 2914 | D XPF2^XPDIQ
|
|---|
| 2915 | "QUES","XPI1",0)
|
|---|
| 2916 | YO
|
|---|
| 2917 | "QUES","XPI1","??")
|
|---|
| 2918 | ^D INHIBIT^XPDH
|
|---|
| 2919 | "QUES","XPI1","A")
|
|---|
| 2920 | Want KIDS to INHIBIT LOGONs during the install
|
|---|
| 2921 | "QUES","XPI1","B")
|
|---|
| 2922 | NO
|
|---|
| 2923 | "QUES","XPI1","M")
|
|---|
| 2924 | D XPI1^XPDIQ
|
|---|
| 2925 | "QUES","XPM1",0)
|
|---|
| 2926 | PO^VA(200,:EM
|
|---|
| 2927 | "QUES","XPM1","??")
|
|---|
| 2928 | ^D MG^XPDH
|
|---|
| 2929 | "QUES","XPM1","A")
|
|---|
| 2930 | Enter the Coordinator for Mail Group '|FLAG|'
|
|---|
| 2931 | "QUES","XPM1","B")
|
|---|
| 2932 |
|
|---|
| 2933 | "QUES","XPM1","M")
|
|---|
| 2934 | D XPM1^XPDIQ
|
|---|
| 2935 | "QUES","XPO1",0)
|
|---|
| 2936 | Y
|
|---|
| 2937 | "QUES","XPO1","??")
|
|---|
| 2938 | ^D MENU^XPDH
|
|---|
| 2939 | "QUES","XPO1","A")
|
|---|
| 2940 | Want KIDS to Rebuild Menu Trees Upon Completion of Install
|
|---|
| 2941 | "QUES","XPO1","B")
|
|---|
| 2942 | NO
|
|---|
| 2943 | "QUES","XPO1","M")
|
|---|
| 2944 | D XPO1^XPDIQ
|
|---|
| 2945 | "QUES","XPZ1",0)
|
|---|
| 2946 | Y
|
|---|
| 2947 | "QUES","XPZ1","??")
|
|---|
| 2948 | ^D OPT^XPDH
|
|---|
| 2949 | "QUES","XPZ1","A")
|
|---|
| 2950 | Want to DISABLE Scheduled Options, Menu Options, and Protocols
|
|---|
| 2951 | "QUES","XPZ1","B")
|
|---|
| 2952 | NO
|
|---|
| 2953 | "QUES","XPZ1","M")
|
|---|
| 2954 | D XPZ1^XPDIQ
|
|---|
| 2955 | "QUES","XPZ2",0)
|
|---|
| 2956 | Y
|
|---|
| 2957 | "QUES","XPZ2","??")
|
|---|
| 2958 | ^D RTN^XPDH
|
|---|
| 2959 | "QUES","XPZ2","A")
|
|---|
| 2960 | Want to MOVE routines to other CPUs
|
|---|
| 2961 | "QUES","XPZ2","B")
|
|---|
| 2962 | NO
|
|---|
| 2963 | "QUES","XPZ2","M")
|
|---|
| 2964 | D XPZ2^XPDIQ
|
|---|
| 2965 | "SEC","^DD",1130580001.101,1130580001.101,3.1,9)
|
|---|
| 2966 |
|
|---|
| 2967 | "SEC","^DIC",1130580001.101,1130580001.101,0,"AUDIT")
|
|---|
| 2968 | @
|
|---|
| 2969 | "SEC","^DIC",1130580001.101,1130580001.101,0,"DD")
|
|---|
| 2970 | @
|
|---|
| 2971 | "SEC","^DIC",1130580001.101,1130580001.101,0,"DEL")
|
|---|
| 2972 | @
|
|---|
| 2973 | "SEC","^DIC",1130580001.101,1130580001.101,0,"LAYGO")
|
|---|
| 2974 | @
|
|---|
| 2975 | "SEC","^DIC",1130580001.101,1130580001.101,0,"RD")
|
|---|
| 2976 | @
|
|---|
| 2977 | "SEC","^DIC",1130580001.101,1130580001.101,0,"WR")
|
|---|
| 2978 | @
|
|---|
| 2979 | "VER")
|
|---|
| 2980 | 8.0^22.0
|
|---|
| 2981 | "^DD",1130580001.101,1130580001.101,0)
|
|---|
| 2982 | FIELD^^.3^18
|
|---|
| 2983 | "^DD",1130580001.101,1130580001.101,0,"DDA")
|
|---|
| 2984 | N
|
|---|
| 2985 | "^DD",1130580001.101,1130580001.101,0,"DT")
|
|---|
| 2986 | 3111201
|
|---|
| 2987 | "^DD",1130580001.101,1130580001.101,0,"ID",.7)
|
|---|
| 2988 | W:$D(^(5)) " ",$P(^(5),U,1)
|
|---|
| 2989 | "^DD",1130580001.101,1130580001.101,0,"IX","B",1130580001.101,.01)
|
|---|
| 2990 |
|
|---|
| 2991 | "^DD",1130580001.101,1130580001.101,0,"NM","C0Q QUALITY MEASURE")
|
|---|
| 2992 |
|
|---|
| 2993 | "^DD",1130580001.101,1130580001.101,0,"PT",1130580001.2011,.01)
|
|---|
| 2994 |
|
|---|
| 2995 | "^DD",1130580001.101,1130580001.101,0,"VRPK")
|
|---|
| 2996 | C0Q
|
|---|
| 2997 | "^DD",1130580001.101,1130580001.101,.01,0)
|
|---|
| 2998 | NAME^RF^^0;1^K:$L(X)>30!($L(X)<1)!'(X'?1P.E) X
|
|---|
| 2999 | "^DD",1130580001.101,1130580001.101,.01,.1)
|
|---|
| 3000 | MEASURE NAME
|
|---|
| 3001 | "^DD",1130580001.101,1130580001.101,.01,1,0)
|
|---|
| 3002 | ^.1
|
|---|
| 3003 | "^DD",1130580001.101,1130580001.101,.01,1,1,0)
|
|---|
| 3004 | 1130580001.101^B
|
|---|
| 3005 | "^DD",1130580001.101,1130580001.101,.01,1,1,1)
|
|---|
| 3006 | S ^C0Q(101,"B",$E(X,1,30),DA)=""
|
|---|
| 3007 | "^DD",1130580001.101,1130580001.101,.01,1,1,2)
|
|---|
| 3008 | K ^C0Q(101,"B",$E(X,1,30),DA)
|
|---|
| 3009 | "^DD",1130580001.101,1130580001.101,.01,3)
|
|---|
| 3010 | Answer must be 1-30 characters in length
|
|---|
| 3011 | "^DD",1130580001.101,1130580001.101,.01,"DT")
|
|---|
| 3012 | 3101012
|
|---|
| 3013 | "^DD",1130580001.101,1130580001.101,.3,0)
|
|---|
| 3014 | MU YEAR KEY^F^^7;6^K:$L(X)>30!($L(X)<1) X
|
|---|
| 3015 | "^DD",1130580001.101,1130580001.101,.3,.1)
|
|---|
| 3016 | MEANINGFUL USE YEAR KEY
|
|---|
| 3017 | "^DD",1130580001.101,1130580001.101,.3,3)
|
|---|
| 3018 | Answer must be 1-30 characters in length.
|
|---|
| 3019 | "^DD",1130580001.101,1130580001.101,.3,"DT")
|
|---|
| 3020 | 3111201
|
|---|
| 3021 | "^DD",1130580001.101,1130580001.101,.5,0)
|
|---|
| 3022 | TITLE^F^^1;1^K:$L(X)>240!($L(X)<3) X
|
|---|
| 3023 | "^DD",1130580001.101,1130580001.101,.5,.1)
|
|---|
| 3024 | MEASURE TITLE
|
|---|
| 3025 | "^DD",1130580001.101,1130580001.101,.5,3)
|
|---|
| 3026 | Answer must be 3-240 characters in length
|
|---|
| 3027 | "^DD",1130580001.101,1130580001.101,.5,"DT")
|
|---|
| 3028 | 3110430
|
|---|
| 3029 | "^DD",1130580001.101,1130580001.101,.61,0)
|
|---|
| 3030 | VERY LONG DESCRIPTION^1130580001.111^^6;0
|
|---|
| 3031 | "^DD",1130580001.101,1130580001.101,.7,0)
|
|---|
| 3032 | DISPLAY NAME^F^^5;1^K:$L(X)>240!($L(X)<3) X
|
|---|
| 3033 | "^DD",1130580001.101,1130580001.101,.7,.1)
|
|---|
| 3034 | QRDA DISPLAY NAME
|
|---|
| 3035 | "^DD",1130580001.101,1130580001.101,.7,3)
|
|---|
| 3036 | Answer must be 3-240 characters in length
|
|---|
| 3037 | "^DD",1130580001.101,1130580001.101,.7,"DT")
|
|---|
| 3038 | 3101012
|
|---|
| 3039 | "^DD",1130580001.101,1130580001.101,.8,0)
|
|---|
| 3040 | REPORTING NAME^F^^7;1^K:$L(X)>30!($L(X)<3) X
|
|---|
| 3041 | "^DD",1130580001.101,1130580001.101,.8,.1)
|
|---|
| 3042 | REPORTING MEASURE NAME
|
|---|
| 3043 | "^DD",1130580001.101,1130580001.101,.8,3)
|
|---|
| 3044 | Answer must be 3-30 characters in length
|
|---|
| 3045 | "^DD",1130580001.101,1130580001.101,.8,"DT")
|
|---|
| 3046 | 3110615
|
|---|
| 3047 | "^DD",1130580001.101,1130580001.101,1,0)
|
|---|
| 3048 | NUMERATOR PATIENT LIST^P810.5'^PXRMXP(810.5,^0;2^Q
|
|---|
| 3049 | "^DD",1130580001.101,1130580001.101,1,.1)
|
|---|
| 3050 | MEASURE NUMERATOR PATIENT LIST
|
|---|
| 3051 | "^DD",1130580001.101,1130580001.101,1,"DT")
|
|---|
| 3052 | 3101012
|
|---|
| 3053 | "^DD",1130580001.101,1130580001.101,1.1,0)
|
|---|
| 3054 | ALTERNATIVE NUMERATOR LIST^P1130580001.301'^C0Q(301,^7;2^Q
|
|---|
| 3055 | "^DD",1130580001.101,1130580001.101,1.1,"DT")
|
|---|
| 3056 | 3110805
|
|---|
| 3057 | "^DD",1130580001.101,1130580001.101,1.2,0)
|
|---|
| 3058 | NUMERATOR RULE SET^*P810.4'^PXRM(810.4,^7;7^S DIC("S")="I $P(^(0),U,3)=3" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
|
|---|
| 3059 | "^DD",1130580001.101,1130580001.101,1.2,3)
|
|---|
| 3060 | Enter the reminder rule set to use for this measure.
|
|---|
| 3061 | "^DD",1130580001.101,1130580001.101,1.2,12)
|
|---|
| 3062 | If the type of the reminder list rule is a Rule Set.
|
|---|
| 3063 | "^DD",1130580001.101,1130580001.101,1.2,12.1)
|
|---|
| 3064 | S DIC("S")="I $P(^(0),U,3)=3"
|
|---|
| 3065 | "^DD",1130580001.101,1130580001.101,1.2,21,0)
|
|---|
| 3066 | ^^5^5^3120716^
|
|---|
| 3067 | "^DD",1130580001.101,1130580001.101,1.2,21,1,0)
|
|---|
| 3068 | This is the numerator reminder rule set to use for the quality measure.
|
|---|
| 3069 | "^DD",1130580001.101,1130580001.101,1.2,21,2,0)
|
|---|
| 3070 |
|
|---|
| 3071 | "^DD",1130580001.101,1130580001.101,1.2,21,3,0)
|
|---|
| 3072 | The rule set is used to generate a patient list, which this package
|
|---|
| 3073 | "^DD",1130580001.101,1130580001.101,1.2,21,4,0)
|
|---|
| 3074 | referneces. The contents of the patient list will produce the count for
|
|---|
| 3075 | "^DD",1130580001.101,1130580001.101,1.2,21,5,0)
|
|---|
| 3076 | the measure. This count is for the numerator.
|
|---|
| 3077 | "^DD",1130580001.101,1130580001.101,1.2,"DT")
|
|---|
| 3078 | 3120716
|
|---|
| 3079 | "^DD",1130580001.101,1130580001.101,1.5,0)
|
|---|
| 3080 | NEGATIVE NUMERATOR LIST^P810.5'^PXRMXP(810.5,^7;4^Q
|
|---|
| 3081 | "^DD",1130580001.101,1130580001.101,1.5,.1)
|
|---|
| 3082 | LIST OF PATIENTS THAT DO NOT MEET THE REQUIREMENTS
|
|---|
| 3083 | "^DD",1130580001.101,1130580001.101,1.5,"DT")
|
|---|
| 3084 | 3110809
|
|---|
| 3085 | "^DD",1130580001.101,1130580001.101,1.51,0)
|
|---|
| 3086 | ALTERNATE NEGATIVE NUM LIST^P1130580001.301'^C0Q(301,^7;5^Q
|
|---|
| 3087 | "^DD",1130580001.101,1130580001.101,1.51,.1)
|
|---|
| 3088 | NEGATIVE NUMERATOR LIST IN C0Q PATIENT LIST FILE
|
|---|
| 3089 | "^DD",1130580001.101,1130580001.101,1.51,"DT")
|
|---|
| 3090 | 3110809
|
|---|
| 3091 | "^DD",1130580001.101,1130580001.101,2,0)
|
|---|
| 3092 | DENOMINATOR PATIENT LIST^P810.5'^PXRMXP(810.5,^0;3^Q
|
|---|
| 3093 | "^DD",1130580001.101,1130580001.101,2,.1)
|
|---|
| 3094 | MEASURE DENOMINATOR PATIENT LIST
|
|---|
| 3095 | "^DD",1130580001.101,1130580001.101,2,"DT")
|
|---|
| 3096 | 3101012
|
|---|
| 3097 | "^DD",1130580001.101,1130580001.101,2.1,0)
|
|---|
| 3098 | ALTERNATIVE DENOMINATOR LIST^P1130580001.301'^C0Q(301,^7;3^Q
|
|---|
| 3099 | "^DD",1130580001.101,1130580001.101,2.1,"DT")
|
|---|
| 3100 | 3110805
|
|---|
| 3101 | "^DD",1130580001.101,1130580001.101,2.2,0)
|
|---|
| 3102 | DENOMINATOR RULE SET^*P810.4'^PXRM(810.4,^7;8^S DIC("S")="I $P(^(0),U,3)=3" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
|
|---|
| 3103 | "^DD",1130580001.101,1130580001.101,2.2,3)
|
|---|
| 3104 | Enter the reminder rule set to use for this measure.
|
|---|
| 3105 | "^DD",1130580001.101,1130580001.101,2.2,12)
|
|---|
| 3106 | If the type of the reminder list rule is a Rule Set.
|
|---|
| 3107 | "^DD",1130580001.101,1130580001.101,2.2,12.1)
|
|---|
| 3108 | S DIC("S")="I $P(^(0),U,3)=3"
|
|---|
| 3109 | "^DD",1130580001.101,1130580001.101,2.2,21,0)
|
|---|
| 3110 | ^^5^5^3120716^
|
|---|
| 3111 | "^DD",1130580001.101,1130580001.101,2.2,21,1,0)
|
|---|
| 3112 | This is the denominator reminder rule set to use for the quality measure.
|
|---|
| 3113 | "^DD",1130580001.101,1130580001.101,2.2,21,2,0)
|
|---|
| 3114 |
|
|---|
| 3115 | "^DD",1130580001.101,1130580001.101,2.2,21,3,0)
|
|---|
| 3116 | The rule set is used to generate a patient list, which this package
|
|---|
| 3117 | "^DD",1130580001.101,1130580001.101,2.2,21,4,0)
|
|---|
| 3118 | referneces. The contents of the patient list will produce the count for
|
|---|
| 3119 | "^DD",1130580001.101,1130580001.101,2.2,21,5,0)
|
|---|
| 3120 | the measure. This count is for the denominator.
|
|---|
| 3121 | "^DD",1130580001.101,1130580001.101,2.2,"DT")
|
|---|
| 3122 | 3120716
|
|---|
| 3123 | "^DD",1130580001.101,1130580001.101,2.5,0)
|
|---|
| 3124 | EXTRACT DEFINITION^P810.2'^PXRM(810.2,^7;9^Q
|
|---|
| 3125 | "^DD",1130580001.101,1130580001.101,2.5,3)
|
|---|
| 3126 | Select a Reminder Extract Definition for this measure
|
|---|
| 3127 | "^DD",1130580001.101,1130580001.101,2.5,21,0)
|
|---|
| 3128 | ^^4^4^3120726^
|
|---|
| 3129 | "^DD",1130580001.101,1130580001.101,2.5,21,1,0)
|
|---|
| 3130 | If this measure depends upon a reminder extract definition, you can add
|
|---|
| 3131 | "^DD",1130580001.101,1130580001.101,2.5,21,2,0)
|
|---|
| 3132 | this extract definition here. This will alter how the Quality Measures
|
|---|
| 3133 | "^DD",1130580001.101,1130580001.101,2.5,21,3,0)
|
|---|
| 3134 | package computes the measure to use the extract in addition and prior to
|
|---|
| 3135 | "^DD",1130580001.101,1130580001.101,2.5,21,4,0)
|
|---|
| 3136 | the rule sets.
|
|---|
| 3137 | "^DD",1130580001.101,1130580001.101,2.5,"DT")
|
|---|
| 3138 | 3120726
|
|---|
| 3139 | "^DD",1130580001.101,1130580001.101,3,0)
|
|---|
| 3140 | QRDA TEMPLATE ROOT^F^^0;4^K:$L(X)>120!($L(X)<3) X
|
|---|
| 3141 | "^DD",1130580001.101,1130580001.101,3,.1)
|
|---|
| 3142 | MEASURE TEMPLATE ROOT FOR QRDA DOCUMENT
|
|---|
| 3143 | "^DD",1130580001.101,1130580001.101,3,3)
|
|---|
| 3144 | Answer must be 3-120 characters in length
|
|---|
| 3145 | "^DD",1130580001.101,1130580001.101,3,"DT")
|
|---|
| 3146 | 3101012
|
|---|
| 3147 | "^DD",1130580001.101,1130580001.101,3.1,0)
|
|---|
| 3148 | QRDA MEASURE SYSTEM OID^CJ^^ ; ^S X="2.16.840.1.113883.3.249.12"
|
|---|
| 3149 | "^DD",1130580001.101,1130580001.101,3.1,.1)
|
|---|
| 3150 | QRDA SYSTEM OID (FIXED)
|
|---|
| 3151 | "^DD",1130580001.101,1130580001.101,3.1,9.01)
|
|---|
| 3152 |
|
|---|
| 3153 | "^DD",1130580001.101,1130580001.101,3.1,9.1)
|
|---|
| 3154 | S X="2.16.840.1.113883.3.249.12"
|
|---|
| 3155 | "^DD",1130580001.101,1130580001.101,3.1,"DT")
|
|---|
| 3156 | 3101012
|
|---|
| 3157 | "^DD",1130580001.101,1130580001.101,3.2,0)
|
|---|
| 3158 | QRDA CODE^F^^4;1^K:$L(X)>80!($L(X)<1) X
|
|---|
| 3159 | "^DD",1130580001.101,1130580001.101,3.2,.1)
|
|---|
| 3160 | QRDA MEASURE CODE
|
|---|
| 3161 | "^DD",1130580001.101,1130580001.101,3.2,3)
|
|---|
| 3162 | Answer must be 1-80 characters in length
|
|---|
| 3163 | "^DD",1130580001.101,1130580001.101,3.2,"DT")
|
|---|
| 3164 | 3101012
|
|---|
| 3165 | "^DD",1130580001.101,1130580001.111,0)
|
|---|
| 3166 | VERY LONG DESCRIPTION SUB-FIELD^^.01^1
|
|---|
| 3167 | "^DD",1130580001.101,1130580001.111,0,"DT")
|
|---|
| 3168 | 3101013
|
|---|
| 3169 | "^DD",1130580001.101,1130580001.111,0,"NM","VERY LONG DESCRIPTION")
|
|---|
| 3170 |
|
|---|
| 3171 | "^DD",1130580001.101,1130580001.111,0,"UP")
|
|---|
| 3172 | 1130580001.101
|
|---|
| 3173 | "^DD",1130580001.101,1130580001.111,.01,0)
|
|---|
| 3174 | VERY LONG DESCRIPTION^Wx^^0;1
|
|---|
| 3175 | "^DD",1130580001.101,1130580001.111,.01,.1)
|
|---|
| 3176 | LONGER DESCRIPTION - IF IT DOESN'T FIT IN .6
|
|---|
| 3177 | "^DD",1130580001.101,1130580001.111,.01,3)
|
|---|
| 3178 | LONGER DESCRIPTION - INSTEAD OF LONG DESCRIPTION
|
|---|
| 3179 | "^DD",1130580001.101,1130580001.111,.01,"DT")
|
|---|
| 3180 | 3101013
|
|---|
| 3181 | "^DIC",1130580001.101,1130580001.101,0)
|
|---|
| 3182 | C0Q QUALITY MEASURE^1130580001.101
|
|---|
| 3183 | "^DIC",1130580001.101,1130580001.101,0,"GL")
|
|---|
| 3184 | ^C0Q(101,
|
|---|
| 3185 | "^DIC",1130580001.101,"B","C0Q QUALITY MEASURE",1130580001.101)
|
|---|
| 3186 |
|
|---|
| 3187 | **END**
|
|---|
| 3188 | **END**
|
|---|
